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Abstract 
It is becoming increasingly clear by current research that the continuum of physiological 
anxiety up to psychopathology is not merely dependent on genes, but is orchestrated by the 
interplay of genetic predisposition, gene x environment and epigenetic interactions. To 
consider this interplay, we here took advantage of the rigid genetic predisposition of a 
selectively bred mouse model exhibiting high anxiety-related behavior (HAB) and tested 
whether and how enriched environment, a manipulation of housing conditions, is capable 
of rescuing the genetically driven high anxiety phenotype via gene x environment and/or 
epigenetic interactions. Indeed, enriched environment exerts a significant anxiolytic effect 
on HABs of both sexes indicating for the first time that even a rigid genetic predisposition 
of high anxiety can be rescued by beneficial environmental stimuli. Thereby, a reduced 
neophobia and a bigger behavioral repertoire of HABs (e.g. social interactions) have been 
observed with a stronger anxiolysis in males than in females. The behavioral shift is 
accompanied by an attenuated release of corticosterone after application of a mild stressor. 
A hyperreactive hypothalamic-pituitary-adrenal (HPA) axis and amygdala constitute the 
most common symptoms of anxiety disorders, and decreased corticosterone release seems 
to entail a reduced release of noradrenaline from locus caeruleus (LC) to the medial 
prefrontal cortex (mPFC), thereby increasing the top-down control of mPFC on amygdala. 
This would entail less activation of amygdala and thus HPA axis, a consequence we indeed 
can observe as decreased neuronal activity flow through the amygdala of enriched housed 
(EE) compared to standard housed (SE) HABs. We suggest that corticotropin-releasing 
hormone receptor 1 (Crhr1) is critically involved in this phenomenon since (i) HABs 
compared to low anxiety-related behavior (LAB) mice exhibit higher Crhr1 mRNA in the 
basolateral amygdala (BLA), (ii) this overexpression can be significantly reduced when 
HABs are housed in enriched environment and (iii) a bilateral application of a CRHR1 
antagonist in the BLA of SE HABs induced a significant anxiolytic effect. Subsequent 
pyrosequencing identified that enriched environment increased methylation at a CpG site 
in the promoter of Crhr1, which is located next to a transcription factor binding site (TFB) 
of the epigenetic transcription factor Yin Yang 1 (YY1), whose mRNA levels are indeed 
decreased in EE HABs. In silico analysis identified Nr4a1 and D3Ertd300e as critical co-
transcription factors, whereas Nr4a1 seems to be regulated by the quantity of available 
glucocorticoid receptor (GR) and D3Ertd300e positively regulates YY1. Thus, we 
hypothesize that reduced corticosterone release decreases the availability and thus binding 
of corticosterone to GR in the BLA. This, in turn decreases the binding affinity of Nr4a1 to 
D3Ertd300e, which then cannot positively regulate YY1 to decrease or even prevent 
methylation at the identified CpG site of Crhr1. This would finally result in a differentially 
methylated region (DMR) with higher methylation levels in EE HABs, which underlies the 
observed gene expression differences. The identified DMR might therefore be used as a 
biomarker for high or pathological anxiety. This hypothesized mechanism highlights the 
possibility that even a rigid genetic predisposition modeling pathological anxiety might be 
rescued by an epigenetic process that seems to be triggered by beneficial environmental 
stimuli, thereby raising the exciting possibility for new treatment strategies, which can be 
utilized complementary to already existing ones. 
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1.1 Fear, anxiety and the stress response 
Evolution gave rise to at least two distinct behavioral systems, which assess emotion and 
originate from a common background: fear and anxiety (Flanelly et al, 2007). An 
increasing body of literature suggests the independence of both systems due to different 
neurological, hormonal, peptidergic and genetic underpinnings. Fear constitutes a reaction 
to an immediate threat that inherently endangers the individuals live - like a sudden sound, 
which might indicate the presence of a predator. These aversive stimuli are unconditioned, 
i.e. the animal shows an immediate innate “fight-or-flight” response to these discrete and 
specific stimuli. Contrary to fear, anxiety is a prolonged state of negative emotions to 
stimuli associated with an elevated potential risk of danger (e.g. open spaces and 
unfamiliarity) elicited by unavoidable stimuli characterized by the same stimulus features 
like stress - unpredictability and uncontrollability. Thus, fear represents a brief response to 
stimuli critical for survival and is mainly mediated by the amygdala, whereas anxiety is a 
prolonged reaction to a variety of stimuli characterized by uncertainty, which is primarily 
carried by the bed nucleus of the stria terminalis (BNST) and the hypothalamic-pituitary-
adrenal (HPA) axis (Depue et al, 2009). 
Though fear and anxiety serve different purposes, both are capable of triggering the body’s 
stress response by sensing potentially adverse changes in the environment denoted as 
stress. This in turn, modifies neuronal activity and thus, behavior rapidly and enduringly in 
response to life-threatening stimuli, achieved through an evolutionary conserved and 
highly complex modulation of neuronal functioning at several levels of the central nervous 
system (CNS) (Joels et al, 2009). The pattern and magnitude of this complex stress 
response depends on “[…] the duration of stress exposure (acute versus chronic), the type 
of stress (physical versus psychological), the stress context (for example, time of day), the 
developmental stage of the animal (newborn, adult or aged), the animal’s sex and genetic 
background” (Joels et al, 2009). The stress response per se comprises two waves of stress 
mediator actions, which are separated in most instances temporarily and spatially. The 
acute effects of stress take place within a time frame of seconds to minutes and are carried 
by monoamines like noradrenaline (NA), dopamine or serotonin as well as neuropeptides 
like corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP). These rapid 
stress mediators promote appraisal of the situation, alertness, vigilance and the choice of an 
optimal strategy to face the situation. These actions quickly subside due to the short 
availability of their mediators and for this reason, the second wave of stress mediators 
comprises steroids like cortisol (humans) and CORT (rodents) which act within hours to 
days primarily upon glucocorticoid receptors (GRs) and thus facilitate the consolidation of 
information associated with the stressor (i.e. memory) (Joels et al, 2009). These two waves 
of stress mediators are carried by two different systems working complementary to 
guarantee an optimal function: the sympatho-adrenomedullary (SAM) system one the one 
and the HPA axis on the other hand. 
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1.2 Maintenance of homeostasis 
 
The fast-acting SAM system is predominantly activated by fear and orchestrates the 
immediate “fight-or-flight” response by secreting monoamines and neuropeptides 
compared to the HPA axis, which finally causes the secretion of steroids to moderate the 
adaptive long term response that can’t be controlled by the “fight-or-flight” mechanism 
(fig. 1). Both mechanisms aim to maintain or reinstate homeostasis during stress. 
 
Every individual maintains its inner environment (e.g. temperature, pH) in an intricate 
equilibrium denoted as homeostasis. External threats or stimuli (i.e. stressors) aim to 
compromise this equilibrium every time an animal encounters a (potentially) live-
threatening situation that ensues fear or anxiety, which in turn activates the SAM system 
and HPA-axis. Both neuroendocrine protection systems maintain or reinstate the 
homeostasis to a new point of equilibrium, which enables the animal to cope optimally 
with the encountered situation. (Engelmann et al, 2004) 
Upon stress, the fast-acting SAM system activates the chromaffin cells of the adrenal 
medulla via a series of preganglionic sympathetic neurons and paravertebral ganglia (fig. 1, 
Fig. 1: Stress exposure activates the rapid SAM system (NA) and a prolonged stress 
response via the HPA axis, which releases a series of neuropeptides entailing the 
secretion of cortisol (humans) or CORT (rodents) from the adrenal cortex. Blue and red 
dots depict the sympathetic and parasympathetic nervous system, respectively. 
adrenocorticotropic hormone (ACTH), noradrenaline (NA), paraventricular nucleus of 
the hypothalamus (PVN). Picture adopted from Ulrich-Lai and Hermann (2009). 
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shown in blue; Ulrich-Lai and Hermann, 2009). As a consequence, heart rate, 
vasoconstriction, respiratory rate and energy mobilization are increased to ensure that the 
animal is able to escape the situation quickly and actively (Engelmann et al, 2004; Ulrich-
Lai and Hermann, 2009). 
With a higher latency of ca. 2-3min., the HPA axis activates parvocellular neurons in the 
paraventricular nucleus of the hypothalamus (PVN), which secrete the hypophysiotrophic 
hormones CRH and AVP from axon terminals in the Zona externa of the median eminence 
in the hypothalamo-pituitary portal circulation and further to the adenohypophysis. These 
releasing hormones in turn, promote the synthesis and processing of proopiomelanocortin 
(POMC) to adrenocorticotropic hormone (ACTH), which travels via the blood stream to its 
effector organ - the adrenal cortex. Finally, glucocorticoid hormones, i.e. cortisol (humans) 
or CORT (rodents) are synthesized and released from the Zona fasciculata of the adrenal 
cortex into the blood stream (fig. 2) (de Kloet et al, 2005; Engelmann et al, 2004; Ulrich-
Lai and Hermann, 2009). 
 
 
Circulating glucocorticoids then promote the mobilization of stored energy by lipolysis and 
gluconeogenesis, inhibition of growth and reproductive systems and induce behavioral 
changes like suppression of feeding, increased arousal, vigilance and cognition and 
Fig. 2: Stress exposure activates the HPA axis by releasing CRH from the PVN, which 
in turn secretes ACTH into the blood stream to finally cause a release of cortisol 
(humans) or corticosterone (rodents) from the adrenal cortex. Picture adapted and 
modified from Walker et al (2010). 
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potentiate numerous sympathetically mediated effects, such as peripheral vasoconstriction 
(Charmandari et al, 2005; Engelmann et al, 2004; Ulrich-Lai and Herrmann, 2009). 
Moreover, direct innervation of the adrenal cortex by the sympathetic nervous system can 
regulate corticosteroid release highlighting the largely complementary actions that the 
SAM system and the HPA-axis have during stress (Ulrich-Lai and Herrmann, 2009). 
When the animal has successfully escaped the live-threatening situation or the stressor, it is 
of highest importance to end the body’s stress response and restore homeostasis to the pre-
stress point of equilibrium. This is achieved via a negative feedback mechanism, which is 
tightly regulated by mineralglucocorticoid (MR) and glucocorticoid (GR) receptors. MRs 
are primarily localized in the hippocampus (HC), lateral septum and medial amygdala 
(MA), whereas GRs are mainly expressed in the PVN (Joels et al, 2004). Both receptors 
are expressed in the cytosol during their inactive state, each together with a complex 
assembly of heat shock proteins including HSP90 and members of the Fkbp5 family. The 
negative feedback of the HPA axis is achieved through a difference in binding affinity of 
glucocorticoids with MRs exhibiting a tenfold higher affinity compared to GRs. Under 
basal conditions, glucocorticoids diffuse passively through the phospholipid membrane to 
occupy MRs, whereat a stressor drastically increases glucocorticoid availability and thus, 
entails GR occupancy and transduction of the ligand-activated receptors from the cytosol 
to the nucleus to bind to glucocorticoid response elements to up- or downregulate the 
expression of various genes (Charmandari et al, 2005; de Kloet et al, 2005; Pariante and 
Miller, 2001). Thereby, glucocorticoids regulate their own production via a negative 
feedback loop, which inhibits the synthesis of ACTH and CRH at the level of the pituitary 
or HC and hypothalamus (HT), respectively (Raison and Miller, 2003). 
To summarize, a stressor challenges the homeostasis of an animal facing a live-threatening 
situation. This encounter causes fear or anxiety, which in turn leads to the activation of two 
complementary systems denoted as SAM and HPA axis to adjust the equilibrium to a new 
set-point to maximize the chance of survival by promoting energy mobilization as well as 
arousal, vigilance and cognition. After successful escape, the stress response is terminated 
by a negative feedback mechanism at the level of PVN, HC and HT by utilizing the low 
affinity of GRs to glucocorticoids. Two members of the stress response, the amygdala and 
the release of CRH as well as the availability of the associated receptors, play an 
outstanding role in the regulation of anxiety and in the etiology of psychiatric disorders. 
 
1.3 CRH system and the critical role of the amygdala 
 
The role of CRH in the cause and consequences of anxiety, depression and chronic stress 
have been extensively documented and thus, may be a main pathway through which the 
effects of stress can shape brain development (Andrus et al., 2012; Arborelius et al, 1999, 
Dunn et al, 1990). Chang and Hsu (2004) propose a clear evolutionary trail for the origin 
of the CRH/CRH receptor system.  A coevolution gave rise to diuretic hormone and its 
associated receptors in insects and CRH/CRH receptors in vertebrates. The latter gained 
the regulation of the stress response to environmental stimuli early during their evolution 
and exactly this regulatory mechanism of the CRH system emphasizes its importance in 
anxiety and may explain its homology among a huge class of species. 
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Fig. 3: The two different receptors of CRH, 
denoted as R1 and R2 possess different 
affinities for the peptides of the CRH family. 
Figure adapted and modified from 
Dautzenberg et al (2002).  
The CRH system comprises a family of peptides on the one and two types of receptors on 
the other hand. The CRH family of peptides includes CRH, urocortin (Ucn) as well as Ucn 
2 and 3, which are distinct from the CRH and Ucn. Among these peptides, CRH is a 41 
amino-acid neuropeptide, which is expressed peripherally (e.g. blood vessels, skin) and 
centrally (e.g. amygdala) underpinning its critical role in integrating the activity of diverse 
physiological systems by coordinating the behavioral, neuro-endocrine, and autonomic 
responses to stress. It acts in the brain through at least two different receptor subtypes, 
referred to as R1 (Crhr1) and R2 (Crhr2) (Binder and Nemeroff, 2010; Heinrichs et al, 
1995; Rotzinger et al, 2010; Vale et al, 1981).  These two receptors share approximately 
70% identity on the amino acid level but exhibit significant differences at the N-terminal 
extracellular domain, which might account for their agonist selectivity. Fig. 3 depicts the 
binding affinities of the two receptor types R1 and R2 for the different peptides of the CRH 
family. R1 can merely bind CRH (also denoted as CRF) as well as Ucn and seems to be 
implicated in the stress-producing 
effects of CRH (Chen et al, 1993; Hsu 
and Hsueh, 2001; Lewis et al., 2001; 
Lovenberg et al, 1995; Reyes et al, 
2001; Rotzinger et al, 2010; Vaughan et 
al, 1995). R2 binds all Ucns with 
significantly higher affinity in relation 
to CRH indicating that these peptides 
might be its natural ligands. Moreover, 
R2 is involved primarily in functions 
not related to anxiety or depression, e.g. 
suppression of feeding or decreasing 
blood pressure (Dautzenberg et al, 
2002; Grammatopoulos et al, 2012). 
The importance of the CRH system is 
further corroborated by studies that 
have shown recently that CRH is not 
only released after stress from axonal 
terminals of the median eminence but is 
additionally expressed in neuronal 
populations of the amygdala (Koob, 
2008; Swanson et al, 1983), HC (Chen 
et al, 2001) and locus caeruleus (LC, 
earlier referred to as locus coeruleus) 
(Joels et al, 2009; Valentino and Bockstaele, 2008). CRH acts locally and exerts its 
neuromodulatory effects within seconds after its release to modify neuronal firing patterns 
(Aldenhoff et al, 1983; Baram and Hatalski, 1998; Gallagher et al, 2008), gene expression 
and behavior (Bale et al, 2000; Chen et al, 2006; Coste et al, 2000; Koob, 2008; Muller et 
al. 2003). Joels et al. (2009) propose the existence of strategic hubs denoted as “hot spots”, 
where different stress mediator receptors are expressed and networks, involved in different 
aspects of the stress response, are connected: the prefrontal cortex (PFC), amygdala, HC 
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and LC constitute such a network and strengthen the concept of spatial convergence of 
action (Bloom, 1984) (fig. 4). 
 
The presence of monoamine (β1R), neuropeptide (Crhr1/2) and glucocorticoid receptors 
(MR/GR) within the three major nuclei of the amygdala (CeA, MA, BLA) emphasizes its 
role in anxiety and stress regulation. The amygdala seems to exhibit two main functions: 
first, to detect and evaluate the salience, significance, ambiguity and unpredictability of 
stimuli of biological relevance and to link these stimuli to current estimates of biological 
value (Davis and Whalen, 2001; Pessoa, 2010; Pessoa and Adolphs, 2011; Whalen, 1998). 
In other words, the amygdala separates the significant from the mundane by establishing 
affective significance by highlighting some stimuli so as to receive additional processing 
by other brain regions, while at the same time other stimuli are deemphasized or discarded 
(Pessoa, 2010). Neuroimaging studies conducted in humans have confirmed preclinical 
experiments performed in rodents and non-human primates: “[…] the amygdala responds 
to negative as well as positively valenced stimuli (Breiter et al., 1996; Somerville et al., 
2004; Hennenlotter et al., 2005), suggesting it supports learning about the emotional 
significance of the environment in general” (Tottenham and Sheridan, 2010). Thus, the 
amygdala constitutes a brain region to determine the relative safety or danger of a 
situation, which is especially important during early life when the need to evaluate danger 
of novel events will be greater (Tottenham et al. 2009a). Indeed, the amygdala has a mostly 
modulatory role in a wide array of networks and thus, is extensively interconnected with 
cortical and subcortical structures like the ventral subiculum (vSub), LC, PFC and HC  
(Pessoa and Adolphs, 2011). 
Fig. 4: The receptors MR, GR, Crhr1 and 2 as well as the β1-adrenoceptor for 
noradrenaline cluster in hot spots of the brain, where at least two of the former receptors 
are highly expressed to orchestrate different aspects of the stress response including 
decision making, learning and memory and autonomic and emotional responses. β1-
adrenoceptor (β1R), basolateral amygdala (BLA), cornu ammonis 1/3 (CA1/3), dentate 
gyrus (DG), dorsal raphe nuclei (DR), medial amygdala (MA), nucleus tractus soltarii 
(NTS). Picture adopted from Joels et al. (2009). 
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Fig. 5: The amygdala allocates processing resources to 
stimuli by modulating brain structures required to 
prioritize particular features of information processing 
in a given situation. Figure adapted and modified from 
Belujon and Grace (2011).  
Fig. 5 depicts the extensive 
interconnectedness of the 
amygdala: the mPFC inhibits 
activation of BLA under basal 
conditions, whereas stressful 
conditions relieve BLA from 
cortical inhibition via 
dopaminergic neurotrans-
mission (Kröner et al., 2005; 
Rosenkranz and Grace, 1999). 
This relieve initiates the HPA 
cascade in the amygdala, 
where cells within in the 
amygdala are quickly 
activated by stress and 
participate in the earliest 
reaction to environmental 
stressors (Honkaniemi et al., 
1992). The BLA sends 
excitatory inputs into CeA, 
which in turn activates LC 
NA release via CRH (Belujon 
and Grace, 2011). 
Furthermore, LC and BLA 
have reciprocal connections by which LC can modulate BLA activity via α- and β-
adrenergic receptors to allow the integration of the stress mediators NA and CRH (Belujon 
and Grace, 2011; Joels et al, 2009). Hippocampally-mediated memory formation can be 
influenced by the amygdala and the hippocampus per se influences the response of the 
amygdala when emotional stimuli are encountered (Phelps, 2004). Thereby, mPFC, 
amygdala and HC coordinate their actions during emotional learning: HC inhibits mPFC in 
new environmental contexts, followed by a release of the amygdala from mPFC inhibition 
(Kim and Richardson, 2010; Tottenham and Sheridan, 2010). After cessation of the 
stressful situation, BLA and LC modify vSub activity, which is thought to participate in the 
decrease of HPA axis activity (Lowry, 2002). Thus, the amygdala allocates processing 
resources to stimuli by modulating brain structures required to prioritize particular features 
of information processing in a given situation (Pessoa and Adolphs, 2011) and is not 
surprising that “[…] stress-induced changes in the amygdala may have downstream effects 
on the HPA axis that over time can change the structure and function of later stages in the 
axis” (Brunson et al., 2001b; Tottenham and Sheridan, 2010). It is now well established 
that susceptibility to psychiatric disorders is due to the combined effects of genetic, 
environmental and epigenetic factors. The CRH system, with the amygdala being a brain 
region of major importance and involvement, may serve as an epigenetic key interface 
between environmental stressors and the etiology of psychiatric disorders (Binder and 
Nemeroff, 2010). Genetic predisposition might lead to variation in an individual’s response 
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Tab. 1: Summary of functions thought to be fulfilled by DNA methylation. Functions of 
particular interest for this thesis are highlighted in red. 
to stressful events and as a consequence, both, the genetic load and epigenetic factors 
participate in the onset of anxiety disorders or depression.  
 
1.4 Epigenetics - the missing link in psychopathology? 
 
The last two decades of research gradually shifted the view of complex disease etiology 
from genocentric towards gene x environment (GxE) interactions by recognizing the 
importance of environmental and epigenetic mechanisms (Jaenisch and Bird, 2003; Rutter, 
2006). “DNA is no more considered to be the master blueprint […] operating […] in an 
ecological vacuum. Rather, DNA outlines the overall adaptive potential of an organism 
through broadly outlined […] physical and behavior dispositions which serve as building 
material for the final phenotypic outcome in response to specific environmental stimuli” 
(Templeton 2006). Indeed, accumulating evidence suggests that epigenetics constitutes one 
of the main and previously missing links among genetics, environment and disease (Barros 
and Offenbacher, 2009). We refer to epigenetics as heritable processes that regulate the 
activity status of at least one gene by molecular factors and processes without altering 
DNA sequence (Skinner et al, 2010; Svrakic et al, 2010). These processes include DNA 
methylation, posttranslational modifications of histone tails and RNA interference (RNAi). 
Though the chronology and grade of interconnectedness of these mechanisms is still a 
matter of debate, it is increasingly accepted that these processes are not independent of 
each other (Bossdorf et al, 2008). They finally ensue inaccessibility of genes for the 
transcription machinery via a condensed chromatin structure (Szyf et al, 2008) enabling 
organisms to integrate environmental signals into their genome (Murgatroyd et al, 2009). 
DNA methylation is one major epigenetic research subject (Barros and Offenbacher, 2009) 
and has been linked inter alia to: 
Function Reference(s) 
alternative splicing Shukla  et al. (2011) 
cellular differentiation Illingworth and Bird (2009) 
genomic imprinting Sasaki and Matsui (2008) 
genomic stability Antequera (2003) 
inactivation of alternative promoters Illingworth and Bird (2009) 
regulation of gene expression 
Cedar and Bergmann (2009) 
Suzuki and Bird (2008) 
silencing of molecular parasites Antequera (2003) 
transgenerational transmission Jablonka et al. (2009) 
X-chromosome inactivation Sasaki and Matsui (2008) 
In mammals, DNA methylation predominantly occurs in CpG dinucleotides located within 
a region denoted as CpG island (CGi). Takai and Jones (2003) defined a CGi as a non-
random distribution of methylated CpGs, which encompasses a region of ≥500bp with a 
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Tab. 2: Comparison of features of CpG islands (CGis) and bulk DNA in mammals. 
Transcription start site (TSS). Data adapted from Antequera, 2003; Lander et al, 2001. 
G+C content ≥55% and an observed over expected CpG ratio of ≥65% (tab. 2). This 
definition has been proven as the most efficient and reliable in silico analysis tool until 
nowadays (Zhan and Han, 2009). 
Feature CGi Bulk DNA 
G+C content ≥55% 20-25% 
CpG [observed/expected] ≥65% 20-21% 
methylated no yes 
transcriptionally active yes no 
chromatin structure open closed 
associated with TSSs yes no 
Mazzio and Soliman (2012) summarize the mechanisms that are thought to cause 
epigenetic silencing of a gene: the enzyme DNA methyltransferase (DNMT) adds methyl 
groups from the methyl donor S-adenosylmethionine to the 5’ carbon atom of cytosines 
(fig. 6A). This in turn, attracts methyl binding proteins (MBP) like methyl CpG binding 
domain protein (MBD) 1, MBD2 and methyl CpG binding protein 2 (MeCP2), which act 
as docking stations for potent repressor complexes. These complexes comprise co-
repressors (e.g. Sin3, N-CoR, Mi-Nu2-NuRD) and histone deacetylases (HDACs, e.g. 
HDAC1/2), which alter histone stability and nucleosome positioning by controlling 
modifications of H3 and H4 histone tails. 
These histones become deacetlyated and 
histone cores are exchanged by more stable 
variants (e.g. H2A replaced by H2ABbd) to 
prevent nucleosomal ejection/displacement. 
These processes are accompanied by 
stabilization of the linker histone H1 via the 
proteins HP1α/β. These proteins tether further 
silencing elements to tightly crowd methylated 
DNA to nucleosomes. Finally, 
lamins position heterochromatin 
along the nuclear envelope, which 
causes permanent silencing of a 
gene (fig. 6B). 
 
Fig. 6: The enzyme DNA methyltransferase (DNMT) transfers a CH3 group from S-
adenosylmethionine (SAMe) to cytosines (A), thereby initiating a cascade, which  
finally silences gene expression (B). Methionine  adenosyltransferase (MAT), S-
adenosylhomocysteine (SAH), S-adenosylhomocysteine hydrolase (SAHH). Pictures  
adapted and modified from Barros et al. (2009), Foley et al. (2008), Jaenisch et al.  
(2003). 
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CGis seem to be located mainly at three different sites: most of them are associated with 
the promoter region of a gene, rendering them as potent targets for gene regulation. 
Besides the promoter region, CGis can be found in exons (often denoted as “gene body 
methylation”; Brenet et al, 2011) as well as in CpG shores (Doi et al, 2009). CpG shores 
are defined as regions within 2000bp of the TSS without being part of a CGi, explaining 
the term “shore”. 
The process of DNA methylation is highly dynamic and - of highest importance - 
reversible. The ten eleven translocation (Tet) family of proteins is capable to stepwise 
oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), further to 5-formyl-
cytosine (5fC) and finally to 5-carboxylcytosine (5CaC), which is then excised by 
thymine-DNA-glycosylase (TDG) and replaced by cytosine (He et al, 2011; Inoue et al, 
2011). DNA methylation can occur during the whole lifespan of an individual and even 
exerts influence prenatally and transgenerationally, thereby possibly affecting the health of 
future generations (Jirtle and Skinner, 2007; for a review refer to Masterpasqua, 2009). The 
following examples will illustrate the potential and time frame in which DNA methylation 
can take place: Waterland and Jirtle (2003) found evidence that maternal diet (i.e. a 
prenatal influence) can alter DNA methylation in the offspring: the agouti allele in mice 
causes a yellow coat color, overweight and diabetes. If pregnant mothers carrying the 
agouti allele were provided food supplemented with folic acid (a methyl donor), the agouti 
allele becomes silenced via DNA methylation generating offspring with brown coat color, 
which is not overweight and not diabetic. The research group of Meaney provided the 
maybe most popular evidence that the early postnatal environment and the adjacent post-
weaning environment can have a dramatic influence on the phenotype of the offspring and 
grand-offspring (Champagne and Meaney, 2007). Rodents exhibit natural variations in 
maternal care (Champagne et al, 2003) seen as high vs. low levels of licking/grooming 
(LG) and arched-back nursing (ABN) in the first week postpartum. Offspring, which 
received low compared to high levels of LG and ABN had lower levels of hippocampal 
GR expression and an increased HPA-response to stress. This seems to be caused by high 
methylation levels of the transcription factor binding site (TFB) of the nerve growth-
inducible factor A (NGFI-A) within the GR gene, thereby sterically hindering binding of 
NGFI-A and thus, expression of GR. This TFB site is highly methylated already at birth 
and becomes increasingly demethylated when offspring receives high levels of maternal 
care, whereas low levels of LG and ABN do not alter methylation causing lower 
expression of GR and finally an increased reactivity of the HPA-axis (Weaver et al, 2009). 
It was shown that the phenotype of the offspring can be reversed by manipulating housing 
conditions of the offspring after weaning. When offspring of high and low LG/ABN 
mothers was raised in an enriched environment (EE, please refer to section 1.7) or isolation 
respectively, their phenotype was reversed to low and high LG/ABN respectively. 
Importantly, the phenotype altered by housing conditions was transmitted to the next 
generation (Champagne and Meaney, 2007), indicating “[…] that "good" environments 
[…] can ameliorate "bad" epigenomes and "bad" environments (i.e., those provoking fear) 
can pathologize "good" epigenomes” (Svrakic et al, 2011). 
The discovery of epigenetic mechanisms, which allow the transmission of traits to the next 
generation led to the concept of modern synthesis (Bard, 2011) emphasizing that the 
environment acts on genes to fine-tune and adapt the organism in the best way possible to 
the environment it is facing (Bonduriansky et al, 2009). An increasing body of literature 
corroborates the existence of traits that can be inherited transgenerationally: vinclozolin-
induced transgenerational adult-onset disease in rats (Anway et al, 2005), transgenerational 
promotion of long-term potentiation by altered environment in mice (Arai et al, 2009), 
transgenerational inheritance of maternal care reversible by housing conditions 
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(Champagne and Meaney, 2007) and gender bias in multiple sclerosis following epigenetic 
changes in HLA class III risk haplotypes in humans (Chao et al, 2009). 
The aforementioned examples highlight the possibility that DNA methylation can act 
throughout the whole lifetime and beyond. Fig. 7 depicts factors thought to influence the 
epigenetic profile and thus, methylation of an individual:  
Hatchwell and Greally (2007) suggest at least three categories of factors, which influence 
the phenotype of an individual: i) epigenetic factors like age, sex or drug use, ii) genetic 
heterogeneity comprising single nucleotide polymorphisms (SNPs) and copy number 
variants (CNVs) and iii) non-deterministic factors including stochastic factors (e.g. 
developmental noise) and environmental influences. 
Taken together, DNA methylation can activate or silence genes throughout the whole 
lifetime and beyond and is able to translate environmental influences into the genome. 
These features enable DNA methylation to crucially influence the phenotype of an 
individual to the better or the worse (Belsky et al, 2009), depending on the genetic 
predisposition and the environment the individual is living in and thus, makes it a 
promising candidate to identify new mechanisms contributing to the onset of anxiety 
disorders. 
 
1.5 From normal to pathological anxiety 
 
Mental illnesses, with anxiety disorders being the most common in Europe and the USA, 
constitute the leading cause of disability worldwide (Andlin-Sobocki et al, 2005; Kessler et 
al, 2005). A lifetime prevalence of 28.8%, the high comorbidity of anxiety with, amongst 
others, depression (Bateson et al, 2011), substance abuse and tobacco dependence (Thayer 
and Kuzawa, 2011; Tottenham and Sheridan, 2010) as well as a high rate of individuals 
responding only partially or not at all to the prescribed drug treatment might indicate why 
affected individuals suffer extremely (Bateson et al, 2011; Kessler et al, 2005). Thus, it is 
not surprising that both disorders rank among the most common and proliferating health 
problems in the world and cause direct (treatment) and indirect (e.g. absence to work) costs 
Fig. 7: At least three different categories of factors contribute to the etiology of complex 
human diseases: epigenetic factors, genetic heterogeneity and non-deterministic factors. 
Picture adapted from Hatchwell and Greally (2007).  
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in the range of hundreds of millions dollar worldwide (Johnston et al, 2009; Wong et al, 
2001, 2004). Mental disorders are classified either via the “international classification of 
diseases” (ICD-10-GM2012) of the WHO or the “diagnostic and statistical manual” (DSM 
IV) of the American Psychiatric Association. Despite intense characterization, correct 
classification and subsequent treatment remains challenging due to overlapping symptoms 
(Svrakic et al., 2011) and patients not responding to treatment - either due to a wrong 
diagnosis or since they do not respond to the prescribed drug(s). Nowadays, six forms of 
pathological anxiety are described: social and simple phobia, panic disorder (PD), 
generalized anxiety disorder (GAD), obsessive compulsive disorders (OCD) and 
posttraumatic stress disorder (PTSD; ICD-10). The diagnostic and treatment difficulties 
highlight the multigenic and complex nature of anxiety, which is likely to be shaped by 
environmentally-driven plasticity at the genomic level. In other words, “a single gene may 
contribute additively and interchangeably to vulnerability […], but its contribution is 
neither necessary nor sufficient for manifesting the expression of the phenotype of […]” 
(Lee et al, 2005) an anxiety disorder. 
Affected individuals show one to several behavioral, physiological and (epi-) genetic 
alterations absent in healthy persons with “normal” or average anxiety: persons suffering 
from anxiety disorders exhibit a bias to interpret harmless or neutral stimuli as rather 
dangerous (Kim and Gorman, 2005), a bias to favor a negative association when assessing 
the emotional quality of a situation (Landgraf, 2001) as well as a hyperreactive HPA-axis 
(Reul and Holsboer, 2002) and amygdala (Shin and Liberzon, 2010). A hyperreactive 
HPA-axis causes a prolonged release of glucocorticoids, which might damage brain 
regions important for the negative feedback mechanism (e.g. HIP) leading to a feed-
forward mechanism that drives glucocorticoid synthesis indefinitely under the presence of 
ongoing stressors (Raison and Miller, 2003). Anxiety per se is protective in many settings, 
whereas an excessive form promotes disability. Pathological anxiety ensues a series of 
behavioral manifestations comprising phases of “excessive anxiety and worries” that are 
consistent over at least 6 months (DSM-IV). Disruption of sleep (hyper- or hyposomnia), 
weight gain or loss, withdrawal from usual activities, concentration problems, fatigue, 
feeling tensed or restless represent some, but by far not all, criteria (DSM-IV; Leonardo 
and Hen, 2006). 
Despite intensive research over the last decades, a lot of questions remain merely partially 
or not answered at all: What are the factors contributing to the onset of pathological 
anxiety? Is pathological anxiety merely an extreme form of normal anxiety? And what 
does “normal” mean? Svrakic et al. (2011) propose the term adaption disorders instead of 
personality disorders since maladaptation might reflect the core deficit. A poor or deviant 
adaptation to the environment and not extreme behavioral traits (though extreme traits may 
have interfered with successful adaptation) seem to constitute the gist of the matter. Many 
researchers agree that extreme behavioral traits per se do not necessarily reflect a 
maladaption or an evolved dysfunction. These traits are operating functionally if they 
maximize survival and reproduction within a given environment, even if a mechanism is 
producing distress or impairs quality of life (Bateson et al, 2011; Sachser et al, 2011). 
Moreover, the term adaption disorders explicitly include the environment as an important 
source in the etiology of psychiatric disorders. 
The crucial question is which mechanisms might be amenable and/or show a maladaption 
in pathological anxiety? In particular, evidence is provided that stress facilitates or causes a 
dysregulation of the endocrine system (Elizalde et. al, 2010; Toth et al, 2008) rendering 
regulation of the HPA-axis as a promising candidate. Myriads of papers indicate that 
psychiatric disorders indeed cause a severe dysregulation of the HPA-axis, which seems to 
be mediated, at least partially, by the CRH/CRH receptor system. CRH is the major 
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regulator of HPA-axis activity and alterations in CNS CRH-containing neuronal circuits 
are implicated in the pathopsychology of anxiety and depression (Binder and Nemeroff, 
2010; Mathew et al, 2008; Reul and Holsboer, 2002, Risbrough and Stein, 2006). Patients 
suffering from psychiatric disorders show - in most cases - a hyperreactive HPA-axis likely 
due to a hyperreactive central CRH system (Reul and Holsboer, 2002). 
In addition, patients suffering from anxiety disorders (PTSD, PD, GAD, specific and social 
phobia) often show a hyperreactive amygdala likely due to a decreased inhibition of mPFC 
(Shin and Liberzon, 2010) as well as a dysregulation of monoamine systems in limbic 
structures (Elizalde et. al, 2010; Toth et al, 2008) highlighting amygdala as another 
potential candidate brain region important for pathological anxiety (Tottenham and 
Sheridan, 2010). LC and amygdala are closely connected (Itoi and Sugimoto, 2010) and 
the CRH system innervates both brain regions, which in turn activate the SAM system and 
CNS noradrenergic production (Valentino et al, 1983). Increased fear and alertness, 
responses relevant for the fight-or-flight reaction are associated with the release of CRH in 
limbic brain regions, which is mainly mediated by CRHR1 and is dysregulated in 
depression and anxiety disorders (Arborelious et al, 1999; Heinrichs et al, 1997; Nemeroff, 
2009; Reul and Holsboer, 2002).  
Less synapses formed in the hippocampus (Bessa et al, 2009), a smaller hippocampal 
volume (Gilbertson et al., 2002) and a dysregulated negative feedback of the HPA-axis in 
patients suffering from anxiety disorders (Reul and Holsboer, 2002) qualify HIP as an 
additional candidate important for adaption processes and thus, regulation of anxiety. The 
negative feedback of the HPA-axis (i.e. termination of the stress response) is controlled by 
MRs and GRs in HIP and indeed, affected persons seem to have lower levels of GRs and a 
reduced neurogenesis in HIP (Elizalde et. al, 2010; Reul and Holsboer, 2002; Toth et al, 
2008). The dysregulation of amygdala, HIP and the CRH system in affected individuals 
offers the possibility that HPA-axis dysregulation can occur at several stages or levels. 
Research has begun to identify environmental conditions, which are likely to be associated 
and/or contribute to the onset of psychiatric disorders. An increasing number of researchers 
emphasize the existence of genetically influenced individual variations in exposure to risky 
or protective environments (Jaffe and Price, 2007; Kendler and Baker, 2007). “With 
respect to depression and anxiety, the key focus is on the fact that environments are not 
randomly distributed. Social selection means that there needs to be a concern regarding the 
origins of risk environments as well as focus on their effects” (Rutter, 2010). This 
hypothesis is strengthened by the fact that an individual’s social position is closely related 
to the amount of perceived psychosocial stress with a low social position linked to an 
increased amount of psychosocial stress (Thayer and Kuzawa, 2011). This increase in 
perceived stress further impacts on blood pressure, stress hormone metabolism and 
immune function (Bindon et al, 1997; Flinn and England, 1997). Recent animal studies 
have begun to unravel first mechanisms. Chronic stress exposure in adult mice 
demethylates the Crh gene within the hypothalamus (Elliott et al, 2010) and highlights the 
potential of psychosocial stress to induce epigenetic changes linked to pathological 
physiology and behavior (Thayer and Kuzawa, 2011). Moreover, adverse early life 
experiences (i.e. traumas) like physical assault or sexual abuse, especially in combination 
with negative immediate onset-provoking adolescent or adult life experiences (e.g. death of 
a loved one, job loss) are thought to contribute to the onset of psychiatric disorders (Rutter, 
2010). These studies highlight that the life history, i.e. the interaction of environmental and 
epigenetic factors with the genetic predisposition, is crucial for the onset of a psychiatric 
disorder. Further evidence comes from twin studies consistently showing that 
environmental influences account for a substantial proportion of the population variance 
including anxiety and depression (Plomin et al. 2008). 
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The interplay of brain regions involved in emotional regulation (e.g. amygdala, HIP, LC, 
mPFC), neuropeptides (CRH, UCN) and receptors (CRHR1) seems to indicate that chronic 
stress - in combination with and/or because of the exposure to adverse (i.e. stressful) 
environments - might cause a dysregulation of the HPA-axis, which causes a gradual shift 
from normal to pathological anxiety and comorbid depression. Therefore, it is not 
surprising that the majority of treatment strategies tries to reverse the aforementioned 
pathological alterations.  
 
1.6 Limitation of actual treatment strategies for pathological anxiety 
 
In general, actual treatment strategies can be divided in two main fields: the prescription of 
one or a combination of drugs aiming to restore neurotransmitter levels in a specific brain 
region and non-pharmacological therapies. The latter comprise electroconvulsive therapy, 
transcranial magnetic stimulation, deep brain stimulation, sleep deprivation and different 
forms of therapies offered by psychotherapists trying to reverse the maladaptive behavioral 
repertoire acquired by affected individuals (Fava and Kendler, 2000). Since anxiety and 
depression show a high level of comorbidity, it is assumed that they share some 
neurobiological features and thus, many drugs prescribed for depression are also used for 
the treatment of anxiety disorders (Moehler, 2011). 
This highlights the first problem in actual treatment for pathological anxiety. Current 
research still has not identified exact mechanisms, environmental stimuli or a combination 
thereof to develop a more effective treatment strategy for pathological anxiety. This 
hypothesis is corroborated by the estimation that up to 60% of patients suffering from 
anxiety disorders are resistant or refractory to first-line treatment (Lanouette and Stein, 
2010). Nonetheless, affected patients must be taken care of in order to attenuate their 
suffering. Thereby, benzodiazepines (e.g. Alprazolam, Diazepam, Flurazepam) and 
selective serotonin reuptake inhibitors (SSRIs, e.g. citalopram, fluoxetine, paroxetine) are 
the current first-line treatment for most anxiety-disorders (Cryan and Sweeney, 2011; 
Ravindram and Stein, 2010; Sartori et al, 2011) though tricyclic antidepressants, 
monoamine oxidase inhibitors and serotonin norepinephrine reuptake inhibitors are also 
used as treatment options (Black, 2006). All of these drugs have in common that they aim 
to restore or maintain one or more neurotransmitters in a specific brain region. The second 
and major problem of these drugs and therefore actual treatment is that they act throughout 
the whole brain at their target receptors (e.g. GABAA receptors for benzodiazepines) and 
not solely in the brain region where it is required. These drugs induce - partially very 
heavy - side effects, which sometimes cause patients to drop out from treatment or severely 
impairs their quality of life (though their actual symptoms might be reduced) (personal 
communication with Dr. Rohrbacher). Drug treatment tries to reestablish brain physiology 
from pathological back to pre-pathological (i.e. normal or physiological) conditions, 
whereas psychotherapy follows a different strategy. 
Up to now, there are a plethora of different psychotherapies comprising inter alia 
mindfulness-based therapy (Segal, Williams, & Teasdale, 2002), cognitive behavioral 
therapy (Black, 2006), psychoeducation (Rummel-Kluge et al, 2009), cognitive therapy, 
exposure therapy, ritual prevention therapies and psychoanalysis (Black, 2006). Most of 
these psychotherapeutic methodologies try to identify crucial situations in the life history 
of an individual, which likely contributed to the onset of pathological anxiety and finally 
led to a behavioral repertoire, which enables the affected person to circumvent aversive 
conditions. This is exemplified by the following example:  affected persons retreat to their 
homes instead of pursuing their work - by doing so, they try to circumvent even small 
problems, which regularly occur during every day work, since even the smallest problem 
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can cause feelings of helplessness and/or panic due to their bias to interpret neutral stimuli 
as dangerous (personal communication with Dr. Rohrbacher). Psychotherapies enable the 
individual to relearn or change behavioral strategies and to adopt techniques to circumvent 
or attenuate feelings of anxiety and panic (e.g. mindfulness, i.e. focusing on a specific task 
so extensively and exclusively that the patient has no resources to feel anxious or think 
about adverse situations). 
The third problem complicating the treatment of anxiety disorders is the high comorbidity 
with other disorders like depression or substance abuse (particularly alcoholism) 
(Tottenham and Sheridan, 2010). Interestingly, alcoholism, binge drinking and anxiety 
disorders seem to share molecular underpinnings, namely CRHR1 (Treutlein et al, 2006). 
Animal studies in alcohol preferring msP rats indicate that ad libitum access to alcohol 
downregulates Crhr1 in the amygdala and nucleus accumbens (Hansson et al, 2007), 
whereas a history of alcohol dependence in male Wistar rats causes an upregulation of 
Crhr1 within the amygdala (Sommer et al, 2008). Both brains regions are involved in the 
control of emotionality. This highlights the possibility that improved treatment not only 
improves the quality of life from people suffering from pathological anxiety but that 
individuals suffering from other disorders may be treated too. 
Though it is not clear whether a combinatory treatment of drugs and psychotherapy is 
superior to monotherapy (Black, 2006), many experts recommend it likely since both 
treatments pursue a different treatment strategy. Drug treatment tries to establish a pre-
pathological brain physiology, whereas psychotherapy changes the way an individual 
behaves when facing a potential anxiety or panic-provoking situation. Both treatment 
options aim to improve or reverse the consequences of pathological anxiety and to identify 
the adverse environmental situations contributing or causing anxiety disorders. 
Importantly, there is a third possible treatment strategy - to identify beneficial 
environments, which might prevent or ameliorate pathological anxiety. This strategy is of 
preventive nature and might be well combined with already existing treatments. In the 
recent years, positive psychology was paid increasing attention likely belonging to the 
aforementioned third category since it exactly focuses on the effects of positive 
environments, situations or behaviors (Proyer et al, 2012). In animal research, EE seems to 
fulfill the same criteria like positive psychology in human research. Thayer and Kuzuwa 
(2011) state that “[…] we need to know more about whether EE might have positive 
effects on biology and health via epigenetic modification […] as an addition to the current 
focus on strategies to avoid the negative health effects of environmental stress. […] Based 
upon past work on the epigenetic effects of environmental stressors, one exciting 
possibility is that the health benefits of EE might also carry across multiple generations 
through epigenetic inheritance”. This statement clearly emphasizes the potential of EE to 
identify protective environments and new targets for drug development. 
 
1.7 The beneficial effects of enriched environment 
 
Rosenzweig et al. (1978) were the first researchers who examined the consequences of 
beneficial housing conditions combining “complex inanimate and social stimulation” on 
rodent behavior and physiology. They therewith created a paradigm nowadays denoted as 
EE. It offers laboratory mice an enlarged home environment and provides biological 
relevant stimuli like group housing, shelter, additional nesting material, climbing structures 
and deep bedding to facilitate manipulation of their microenvironment. These 
arrangements create a semi-natural environment with a higher complexity, predictability 
and controllability. It allows physical exercise to improve motor performance and enhances 
sensory (e.g. visual; Sale et al, 2004) and cognitive capacities (Olsson and Dahlborn, 2002; 
 
22 
Würbel and Garner, 2007). It is of utmost importance to recognize that the design of EE 
must be according to the needs of the underlying research subject. There are no universal 
but just rough guidelines how to design an appropriate EE since the designing process is as 
unique as the research subject and keeps some fallacies (Würbel and Garner, 2007). Many 
researchers agree that the plurality of different EEs and utilized mouse strains has led to 
partially controversial results (Chapillon et al, 1999; Nevison et al, 1999; Van de Weerd et 
al, 1994), which can be circumvented by a well-chosen and self-designed paradigm (fig. 8; 
it is hard to imagine that every researcher will use the same paradigm or mouse strain). 
A well designed EE induces a variety of beneficial effects, which can be attributed to either 
the “arousal” (Walsh and Cummins, 1975) or “learning and memory” hypothesis (tab. 3; 
Rosenzweig and Bennett, 1996):  
 
Hypothesis Effect Reference(s) 
learning & 
memory 
learning and memory Nithianantharajah and Hannan (2006) 
neural connectivity Nakamura et al. (1999) 
increased neurogenesis Bruel-Jungerman et al. (2005) 
altered brain region activity van Praag et al. (1999) 
arousal 
more naturalistic behavioral 
pattern 
Kempermann et al. (2010) 
object exploration Renner and Rosenzweig (1986) 
increase in locomotor and 
exploratory activity 
Prior and Sachser (1995) 
anxiolytic and anti-
depressive effects 
Benaroya-Milshtein et al. (2004); Meshi 
et al, 2006; Olsson and Dahlborn, 2002 
 
The arousal hypothesis favors the possibility that animals housed in an EE are confronted 
with higher environmental complexity and often novelty (e.g. changed toys), whereas the 
learning and memory hypothesis tries to attribute observed changes in brain structures and 
cellular mechanisms to underlying learning processes. Both hypotheses do not encompass 
Tab. 3: Beneficial effects elicited after housing rodents in EE. Topics of major interest 
for this thesis are highlighted in red. 
Fig. 8: Stylized picture depicting toys with different color and shape, which may be 
used to design an EE. Picture adapted and modified from Bengoetxea et al, 2012. 
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all possible factors nor do they rule out each other and should be viewed complementary to 
our view. Independent of the hypothesis, EE does not solely induce a variety of beneficial 
effects, it can also offset many of the negative neurobehavioral and physiological 
consequences of early life adversity (Bredy et al, 2003, 2004; Francis et al, 2002; Laviola 
et al., 2004; Morley-Fletcher et al, 2003). 
Though EE can induce effects during the whole lifespan of an individual, there seems to be 
a sensitive period in mammals where animals are more susceptible to environmental 
influences. Champagne and Curley (2005) suggest the postnatal phase as this period since 
brain circuits are highly plastic as synaptic connections are elaborated and refined. This 
phase includes the formation of neuronal circuits mediating anxiety and depression-like 
behavior in mice and raises the possibility that this period may be critical for setting HPA-
axis reactivity (Leonardo and Hen, 2006). In spite of intense studies, researchers were not 
able to delineate variables (i.e. no specific toy, cage size etc.) contributing to or eliciting 
beneficial effects, pointing towards EE as an emergent phenomenon strengthening the 
importance of a well-suited design. 
Despite difficulties to identify variables important for the design, researchers have begun 
to unravel mechanisms likely to contribute to one of the most robust findings of EE - 
anxiolysis (Sztainberg et al, 2010a). The following examples highlight some of the 
different mechanisms thought to cause or contribute to the observed anxiolytic effect 
elicited EE. A study performed by Sztainberg et al. (2010b) indicated that EE decreased 
Crhr1 mRNA levels in the BLA of C57BL/6 mice compared to controls and might be 
accounted for the anxiolytic effect. Findings from Okuda et al. (2009) support the potential 
of EE to influence the amygdala, a brain region of major importance for the regulation of 
anxiety. They were able to show that progenitor cell proliferation and differentiation are 
increased in enriched housed C57BL/6 mice compared to controls and suggest that these 
effects contribute to the anxiolytic effects of their EE procedure. 
Besides the amygdala, HIP seems to be another brain region amenable for the effects of 
EE. Increased hippocampal neurogenesis is of the most robust findings elicited by EE and 
there is increasing evidence that it may contribute to the observed anxiolytic effects 
(Revest et al, 2009). The beneficial effects of EE on neurogenesis are thought to be 
multifactorial comprising inter alia brain-derived neurotropic factor (BDNF; Rossi et al, 
2006), which is known to be regulated epigenetically. Indeed, EE increases hippocampal 
BDNF mRNA expression compared to controls by increasing the trimethylation at lysine 4 
of histone 3 (H3K4me3, marker for actively transcribed genes) and reduces lysine 9 and 
lysine 27 histone 3 trimethylation (H3k9me3 and H3k27me3, respectively; markers for 
silenced genes) (Kuzumaki et al, 2011). EE is capable of modulating HIP by altering 
epigenetic modifications highlighting the possibility of EE as a tool to study epigenetic and 
GxE interactions. Importantly, HIP - like amygdala - is another brain region important for 
the regulation of emotion 
A plethora of studies shows that EE reverses adverse early life or prenatal stress effects 
inter alia by normalizing a dysregulated HPA-axis (Francis et al, 2002) indicating that EE 
has the potential to attenuate detrimental effects thought to contribute to pathological 
anxiety. An even more fascinating and intriguing possibility has been revealed by recent 
literature. It suggests that EE has the potential to pass its beneficial effects from one 
generation to the next. Arai et al. (2009) were able to show that two weeks of EE not 
merely increased the long-term potential (LTP) in the hippocampus of ras-grf 1/2 knock-
out (KO) mice via the activation of an alternative cAMP/p38 MAP kinase signaling 
pathway, in addition increased LTP was passed from EE-housed ras-grf 1/2 KO mothers to 
their offspring, which has never been housed in an EE. An experiment by Leshem and 
Schulkin (2011) strengthens the possibility of transgenerational inheritance. To evaluate 
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whether EE can reverse the effects of prenatal stress, female rats were exposed to stress 
from PND 27-29 and subsequently split in two groups: one was housed in EE and the other 
in a standard environment SE until mating. The offspring of prenatally stressed rats housed 
in SE until mating was further distributed to EE or SE. By doing so, the authors were able 
to evaluate whether the prenatal effect of EE on mothers on the one and the postnatal effect 
of EE on the offspring of prenatally stressed mothers on the other hand can reverse the 
effects of prenatal stress. Indeed, prenatal stress caused a transgenerational effect of 
adversity in SE offspring of prenatally stressed mothers, which was ameliorated by both, 
parental and offspring EE. This highlights the exciting possibility of EE to influence the 
health of future generations by attenuating or rescuing pathological phenotypes. 
Taken together, EE raises the possibility to be a valuable tool to study the impact of 
epigenetic and GxE interactions on pathological anxiety since it exerts significant impact 
on nearly all brain regions or metabolic processes important in the regulation of emotion - 
amygdala, HIP and regulation of the HPA-axis - not only in the present, but likely in future 
generations too. Thus, it is surprising that almost all EE studies performed so far rely on 
“normal” rodents to identify mechanism contributing to pathological anxiety. This raises 
several problems: first, normal laboratory animals do not exhibit the pathological genetic 
predisposition of affected individuals and second, these studies miss the possibility to 
explore the interaction how environmental stimuli may act on and shape a rigid genetic 
predisposition, thereby creating a whole new scenario almost completely neglected so far. 
 
1.8 High anxiety-related behavior mice - a mouse model of pathological anxiety. 
 
Before considering any model organism, one should pay attention to the criteria a good 
model organism has to meet in order to produce valid and valuable results. A model 
organism suited for the study of pathological anxiety must fulfill validity criteria and 
should meet an acceptable cost-benefit ratio. Mice are easy to breed, have a short-
reproductive cycle, are amenable for genetic and environmental manipulations and exhibit 
low maintenance costs, i.e. exhibit an excellent cost-benefit ratio (Cryan and Holmes, 
2005). They possess all prerequisites to detect threatening stimuli - perception of a threat 
per se, association with a specific context and recalling of the respective memory - and 
thereby, to experience anxiety (Belzung and Philippot, 2007). Moreover, mice offer 
remarkable similarities with humans at the molecular, anatomical and physiological level 
(Leonardo and Hen, 2006) empowering them as good animal models for psychiatric 
disorders. Clément et al. (2002) propose that an appropriate animal model should meet 
three validity criteria: the same underlying rationale (construct validity), a close 
approximation of symptoms including psychopathology (e.g. genetic, neuroendocrine and 
behavioral concomitants of trait anxiety; face validity) and a reverse of symptoms after 
pharmacological intervention, i.e. an anxiolytic response after receiving anxiolytics (face 
validity) (Finn et al, 2003; Gordon and Hen, 2004). It is generally accepted that a complex 
disorder like depression or certain characteristics thereof can’t be adequately mimicked or 
modeled in mice (e.g. a mouse is not “depressed” or has suicidal thoughts), which led to 
the concept of “endophenotypes”. Endophenotypes represent a characteristic or symptom 
of a disorder that can indeed be modeled in the mouse (e.g. hyposomnia, HPA-axis 
dysregulation etc.) or reflects a behavioral dimension that is necessary to study psychiatric 
disorders in a preclinical environment (Cryan et al, 2002). Therefore, a good animal 
exhibits multiple phenotypes on the one and meets as many validity criteria as possible on 
the other hand. 
Almost all prerequisites are met by a mouse model of pathological anxiety, which has been 
bred for >45 generations at the Max Planck Institute of Psychiatry in Munich. These mice 
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were bidirectionally and selectively bred from a genetically heterogeneous CD-1 
population for high (HAB), “normal” (NAB) or low (LAB) anxiety-related behavior with 
percent time spent on open arms as key criterion (fig. 9). 
 
 
Intrastrain comparisons by selective bidirectional breeding approaches hold the potential to 
investigate the genetic variability of complex, polygenic traits like anxiety (Sartori et al, 
2011; Swallow and Garland, 2005) and thus, to unravel mechanisms contributing to 
pathological anxiety by focusing on particular traits associated with anxiety disorders 
(Landgraf and Wigger, 2003), differences in receptor functions likely to be associated with 
differences in anxiety (Overstreet et al, 2003) or avoidance behavior (Brush, 2003).  
Selective bidirectional breeding increases the frequency of genes associated with a 
particular trait by shifting the animals' phenotype bidirectionally from the strain mean 
(Falconer and Mackay, 1996; Krömer et al, 2005) and clusters it around the extremes of 
the total spectrum typically observed in an outbred strain (Sartori et al, 2011). HAB mice 
(HABs) were generated by using exactly this procedure and indeed exhibit a series of 
endophenotypes closely mimicking pathological characteristics of patients suffering from 
anxiety disorders and - at the same time - meet a variety of criteria of construct, face and 
predictive validity. 
Converging evidence from more than one behavioral test confirms the face validity of a 
modeled endophenotype (Cryan et al, 2002). Indeed, the high anxiety trait of HABs 
compared to NABs and LABs has been confirmed by a reduced time spent in the aversive 
zone in a multitude of tests including inter alia open field (OF), elevated plus maze (EPM), 
light dark box (LD)  (Kromer et al, 2005; Markt unpublished data, 2009; Markt and 
Sotnikov, in preparation; Muigg et al, 2009) as well as by an increased aversion to fox odor 
(Sotnikov, Markt et al, 2011) and an increased number of ultrasonic vocalizations (Kessler, 
Fig. 9: Breeding course of high (HAB), “normal” (NAB) and low (LAB) anxiety-related 
behavior mice with percent time spent on open arms a key breeding criterion. All 
sublines originate from an outbred CD1 population. 
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2006). These findings are largely independent of sex, age, maternal care and intrauterine 
environment (Landgraf et al, 2007). Recent studies (Gaburro et al, 2011; Sartori et al, 
2011b) succeeded to show that HABs display enhanced fear learning in contextual and 
learned conditioning paradigms, which is associated with a lower heart rate variability in 
comparison to NABs and might indicate a weaker ability to inhibit fear responses or a 
stronger fear memory. This positive association has been confirmed in patients with 
anxiety disorders (Lissek et al, 2005). Importantly, the high anxiety phenotype has been 
confirmed independently in different laboratories corroborating the robustness of the trait 
(Landgraf et al, 2007; Muigg et al, 2009). 
Further evidence comes from genetic studies showing that a two-SNP haplotype of the 
recently identified candidate gene Tmem123d is associated with PD in three independent 
human samples. In addition, risk genotypes of PD were associated with higher mRNA 
levels of Tmem123d in the frontal cortex. Likewise, HABs exhibit high mRNA expression 
levels of Tmem123d in the mPFC with the SNP rs13478518 being positively correlated 
with anxiety-related behavior on the EPM (Erhardt et al, 2011). Neuropeptide S receptor 1 
(Npsr1) is associated with PD too (Okamura et al, 2007) and similar to Tmem132d, 
Slattery, Naik et al. (in preparation) were able to show that Npsr1 plays an important role 
for the high anxiety phenotype of HABs. 
Neuronal activation (i.e. brain metabolism) within the amygdala and neuronal propagation 
are suggested as biomarkers of endophenotypes associated with anxiety disorders 
(Norrholm and Ressler, 2009). Indeed, voltage-sensitive dye imaging (VSDI) studies 
revealed that HABs compared to LABs show an increased neuronal propagation within the 
amygdala indicating an inherent stronger activation (i.e. more fear and/or anxiety) 
independent of the stimulus (Avrabos, Markt et al, in preparation). Exposure of HABs to a 
mild stressor (open arm exposure or novel environment) ensued an increased c-Fos 
expression (i.e. a hyperactivation) inter alia of the amygdala, several hypothalamic nuclei 
and LC (Muigg et al, 2007; Sotnikov, unpublished data). All of these brain regions are 
thought to be involved in the etiology of anxiety disorders. Remember, for example, the 
hyperreactive amygdala in patients suffering from PD, GAD, OCD, social or specific 
phobia (Shin and Liberzon, 2010). 
As expected, predictive validity is met by application of a benzodiazepine or the selective 
neurokinin-1 receptor antagonist L-822,429, which reversed the enhanced fear- and 
anxiety-related behavior (Sartori et al, 2001b). It has to be mentioned that some drugs (e.g. 
Paroxetine, Fluoxetine) seems to exert no anxiolytic effect on male adult HABs (Landgraf, 
unpublished data) indicating that several pathways - likely involving GxE or epigenetic 
interactions - contribute to the overall high anxiety trait phenotype. 
These examples highlight the excellent validity of the HAB mouse model and the high 
degree of similarity with characteristics of pathological anxiety indicated by shared genetic 
and neuronal underpinnings. We would like to take advantage of the rigid and pathological 
genetic predisposition towards high anxiety to study the potential of environmental 
influences to mitigate even seemingly rigid genetic drives, thus revealing genetic X 
epigenetic interactions at multiple levels. 
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2 Aims of the thesis 
 
This thesis focuses on the interaction of gene x environment and/or epigenetic interactions. 
There is increasing evidence that the interplay of these factors possesses an important role 
in the etiology of psychiatric disorders.  EE might be one way to model exactly these GxE 
interactions and thereby expand our knowledge about mechanisms likely to be important 
for mental disorders. Thus, we would like to combine both aspects, a rigid genetic 
predisposition and an environmental manipulation like EE to study the interplay of all 
factors contributing to pathological anxiety. Therefore, the following aims were 
specifically addressed: 
 
a) We would like to verify whether even the high anxiety and comorbid depression 
phenotype of our selectively bred HAB mice can be rescued by a beneficial 
environmental manipulation like EE. Male adult HABs do not respond to a variety of 
drugs like Diazepam or Paroxetine though they respond as juveniles and thus, we are 
interested whether it is possible to rescue a rigid genetic predisposition with EE though 
it is difficult to do so by pharmacological intervention. 
Thus, we subjected male and female HABs to EE lasting 4 weeks and utilized OF, 
EPM, LD and SIH to assess the anxiety-related behavior as well as FST and TST to 
evaluate coping style. Moreover, we monitored home cage locomotion and exploration 
to identify a possibly masking effect thereof. 
 
b) Since we conducted EE several times, we are interested to evaluate effect sizes as well 
as reproducibility and reliability of our paradigm. Therefore, we performed a meta-
analysis to identify the overall impact of EE on HABs. 
We used z-scores to compare effect sizes between different experiments and to assess 
the overall effect on anxiety-related behavior and coping style. 
 
c) We would like to compare the impact of EE on genetically heterogeneous CD1 mice to 
that of HAB and NAB mice exhibiting a strong genetic predisposition with only the 
former showing high anxiety-related behavior. 
CD1 and NAB mice were housed for 4 weeks in EE and behaviorally phenotyped 
similar to HABs. 
 
d) In addition to the possibility to identify possible new targets or mechanisms likely to be 
involved in anxiety, we would like to verify whether it is possible to increase the 
anxiolytic effect size elicited by EE. 
To test our hypothesis, we conducted EE for 10 instead of 4 weeks. 
 
e) We would like to identify factors contributing to the beneficial effects of EE since the 
environmental stimuli eliciting a certain effect are as important as the effect per se. 
Thus, we intensively monitored maternal, pup and early adolescent behavior and 
controlled whether mice indeed use the provided toys and possibility to manipulate 
their environment. 
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f) After the intense behavioral phenotyping, we are interested to unravel which genes and 
proteins might be involved in the behavioral shift observed after EE. 
We used qPCR and if necessary, adjacent WB to verify the involvement of several 
candidate genes and their associated protein products. 
 
g) One of our major aims is to identify which epigenetic mechanism(s) may contribute to 
the transcriptional regulation of identified candidate genes. 
We used in silico analyses to detect genes amenable for epigenetic regulation via 5-mC 
and subsequently used a pyrosequencing service to verify promoter methylation. 
Finally, we were interested to identify transcription factors possibly regulating gene 
transcription together with 5-mC. 
 
h) We are interested in shifting the rigid genetic phenotype of HABs from SE to EE or 
vice versa by applying epigenetic drugs. Is it possible to pharmacologically mimic the 
phenotype created by EE? Beyond that, we would like to identify whether there might 
be an additive effect of environmental manipulation and drug treatment. Do 
pharmacological and environmental manipulations act on the same or different 
molecular underpinnings? 
Thus, we applied either the DNMTi valproic acid or the HDACi 5-Aza-2’-
deoxyuridine IP three times weekly in the 2nd and 3rd week of EE to SE and EE HABs.  
 
i) We would like to know whether the anxiolytic effect of EE can be passed on to the 
next generation. Does a transgenerational effect exist for such a complex disease like 
anxiety and comorbid depression? 
Therefore, we mated male and female HABs housed for 4 weeks in EE to generate F1, 
which has never been in contact with EE and was raised in SE directly from birth. We 
continued mating to F3 and assessed anxiety-related behavior with OF, EPM and LD in 
all generations compared to respective SE controls. Moreover, we monitored coping 
style via FST in F3 to detect a possible additive effect of EE by housing up to 3 
generations successively in it. 
 
 
 
 
 
 
 
 
 
 
 
 
29 
3 Material and Methods 
3.1 Animals and housing conditions 
 
Normal and high anxiety-related animals used for experiments were either bred in the 
facility of the Max Planck Institute of Psychiatry or Biochemistry, Munich and originated 
generations 33-43. CD1 mice were purchased from Charles River, Sulzfeld, Germany. 
Prior to experiments, all mice were transferred from their respective breeding facility to a 
room adjacent to the testing room and kept under standard housing conditions (room 
temperature 22.5±1°C, relative air humidity 45±5%, 12h/12h light/dark cycle with lights 
on at 8 a.m.) and were provided with food (Altromin 1314 TPF; protein 22.5%, fat 5%, 
fibre 4.5%, ash 6%) and tap water ad libitum. Housing conditions in the respective 
breeding facilities and the testing room were kept as similar as possible and all animals 
were granted a habituation of at least 5 days after transfer and before the beginning of any 
behavioral testing. Mice were housed in same sex groups of three animals, denoted as trios, 
either under standard or enriched housing conditions. Both included the use of wood chips 
and litter (Lie E – 001 and NBG E – 012, ABEDD-LAB and VET Service GmbH, Vienna, 
Austria) and macrolone cages with their respective lids (Ehret Labor- und Pharmatechnik 
GmbH und Co.KG, Emmendingen, Germany) 
Standard housing: Type two cages (207 x 140 x 265mm) providing a floor space of 
363cm² were covered with an iron chopper bar breech lid (article no. 15050). The cage 
bottom was covered with wood chips and a handful of wood wool was provided to ensure 
proper nest building and to meet animal welfare guidelines. 
Enriched housing: Type IV cages (380 x 200 x 590mm) offering a floor space of 1815cm² 
were covered with an iron lid with heightened design (article no. 40051) to further improve 
cage size since movement in all three spatial directions is important for mice (e.g. 
climbing).  To increase predictability, controllability and complexity, biologically relevant 
stimuli were provided: i) a 5cm layer of wood chips to facilitate manipulation of the 
microenvironment, ii) a plastic inset (22 x 16 x 8cm) and tunnel (19.5 x 6 x 6cm) as retreat 
possibilities as well as iii) a wooden latter and scaffold to offer climbing structures. These 
manipulanda, in combination with a bigger home cage, allowed mice to accomplish highly 
motivated natural behaviors, while creating as few stressors as possible. To circumvent an 
increase in CORT and testosterone levels, accompanied by increased aggression, areas and 
toys that might lead to monopolization of cage structures, toys or nutrition were omitted 
(Olsson & Dahlborn, 2002; Nevison et al., 1999). Therefore, we did not supply the animals 
with a running wheel to bypass locomotor-induced anxiolysis (Henderson et al., 2004). 
Furthermore, transfer of half of the nesting material during the weekly cage change 
allowed preservation of olfactory designation for the mice, which additionally ensured less 
aggression (Olsson & Dahlborn, 2002). Design of EE was adapted from Touma (2008) and 
modified to further increase the observed anxiolytic effect. The EE paradigm was adapted 
from Arai et al. (2009) and expanded by a self-designed enrichment paradigm lasting for 
14 more days. Thus, EE comprised two 14-day periods, called partial and full enrichment: 
from PND 15-28, pups and their respective damn were transferred for 6h/day to EE (partial 
enrichment, adapted from Arai et al., 2009), whereas from PND28 pups were weaned, 
grouped in trios and subjected to EE permanently until PND 42 (full enrichment, self-
designed paradigm). 
All experiments were conducted with the approval of the local authorities (Regierung von 
Oberbayern, §9 Abs. 1 Satz 4 referring to BGBI.IS.1105 as amended on May 25th, 1998). 
 
 
30 
3.2 Behavioral Testing 
All behavioral tests were conducted between 09:00 a.m. and 01:00 p.m. to minimize 
differences in basal CORT levels induced by the daily rhythm - variations in these levels 
offer profound effects on the behavior of the tested animals and should be circumvented 
(Romero, 2004). To exclude any confounding effects, all three animals of a particular cage 
were tested simultaneously in the respective test and the experimental design was 
counterbalanced for all known variables (e.g. sex, housing condition, litter size, weight 
etc.). To minimize olfactory effects between tested mice, the open field (OF), elevated plus 
maze (EPM) and light-dark box (LD) apparatuses were cleaned with water containing 
detergent after every tested animal and additionally with 10% ethanol before the sex of the 
tested mice changed from male to female or vice versa. To ensure complete volatilization, 
a pause of 5min. was maintained. To guarantee identical test conditions during the tail 
suspension (TST) and elevated platform (EP) test, secreted fecal boli and urine were 
removed from the test chamber after every tested cage. Likewise, water used during the 
forced swim test was renewed after every tested mouse. 
Tests of OF, EPM and LD were videotaped and analyzed using Anymaze (version 4.84, 
Stoelting Co., Wood Dale, USA); TST, FST and EP were analyzed via Event Log event 
recorder (version 1.0, EMCO, Robert Henderson). The criteria for entering a compartment 
during a behavioral test was met when a mouse entered it with ≥40% of its body (related to 
its barycenter), while an exit was scored when ≤25% of its body remained in a 
compartment or area, respectively. These criteria approximated a two-paw entry. 
To obtain a broad overview of the behavioral changes elicited by EE, a wide series of 
behavioral tests, assessing the following parameters, were conducted: anxiety-related 
behavior, exploratory behavior and locomotion, anhedonia, coping style and stress 
reactivity.  
Assessment of anxiety-related behavior: Marker of enhanced anxiety like avoidance, 
escape and freezing behavior are thought to reflect the emotional component of anxiety in 
mice and are easily accessible. Therefore, these behaviors are denoted as anxiety-related 
behavior rather than anxiety per se and are categorized in ethological based unconditioned 
and conditioned, i.e. learned paradigms (Hadley, 1995; Gray, 1982; Sartori et al., 2011). 
The first utilize a spontaneous, natural-like innate approach-avoidance conflict by 
providing areas of relative safety contrasting open, brightly lit spaces. Conditioned 
paradigms pair a neutral with a stress- and painful stimulus (e.g. electric foot shock) and 
require several training sessions (Hascoët and Bourin, 2009). We omitted conditioned tests 
to minimize possible confounding effects of motivational or perceptual states arising from 
interference with learning/memory, hunger/thirst or nociceptive mechanisms (Rodgers et 
al., 1997), but performed a variety of unconditioned paradigms since different tests of 
anxiety-related behavior may represent different forms of murine anxiety. For this reason, 
we conducted the most established tests exploiting an approach-avoidance conflict: OF, 
EPM and LD (Bouwknecht and Paylor, 2008; Sartori et al., 2011). In addition, we 
performed one non-exploratory driven test referred to as stress-induced hyperthermia 
(SIH), which used a physiological instead of a behavioral readout. 
Elevated plus maze: Percent time spent on and entries made into open arms (File, 1992; 
Rodgers and Cole 1994) were recorded as anxiety-related indices. Entries into closed arms 
were used as a locomotor index during the 5min. test interval. The EPM was made of gray 
polyvinyl chloride and consisted of two open (30 x 5cm) and closed arms (30 x 5 x 15cm), 
connected via a central platform (5 x 5cm) 40cm above the floor. Light intensity attenuated 
gradually from 300lux on the most outer part of the open arms to 50lux on the central 
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platform, whereas illumination was <10lux in the closed arms. Animals with high levels of 
anxiety will quickly cross from one closed arm to the other and avoid the brightly lit open 
arms, whereas less anxious animals will spent more time on the open arms (Bouwknecht 
and Paylor, 2008). 
Light dark box: The test was conducted for 5min., measuring percent time and distance 
travelled in the light compartment as well as entries and latency to enter the light 
compartment. The LD box comprised a dark (16 x 27 x 27cm) and light compartment (32 x 
27 x 27cm) illuminated with 400lux and <20lux, respectively. Compartments were 
separated by a wall offering a small opening (5 x 5cm) to enable travelling between both 
compartments. Mice exhibiting lower levels of anxiety will enter the light compartment 
faster, more often, spend more time and travel more distance in it (Hascoët and Bourin, 
2009). 
Stress induced hyperthermia: To prepare for a fight-or-flight reaction, body temperature 
is increased as a consequence of a physiological or psychological stressor. SIH takes 
advantage of the stress-induced activation of the autonomic nervous system by measuring 
the body temperature rectally before (T1) and after stress exposure (T2). The increase in 
body temperature, denoted as psychogenic fever, rises body temperature within 15min. up 
to 1.5°C and usually returns to basal levels within 2h. The SIH response (∆T) is calculated 
by subtracting the stress from basal temperature (∆T = T2 - T1) (Vinkers et al., 2009; 
Zethof et al., 1995). It seems to be relatively independent of locomotor activity, its curve 
parallels HPA-axis activity (Groenink et al., 1994; Spooren et al., 2002; Veening et al., 
2004) and anxiolytic drugs like CRF receptor antagonists have been shown to selectively 
and dose-dependently reduce the SIH response. Any treatment reducing the SIH response 
is indicative of an anxiolytic effect (Bouwknecht el., 2007). 
Evaluation of exploratory behavior and locomotion: Animals with high locomotor 
activity usually display lower levels of anxiety-related and depression-like behavior 
(Ferguson et al., 2004), determining suppression of locomotion as one of the cross-test 
dimensions of anxiety (Henderson et al., 2004). We analyzed locomotor activity during the 
OF as well as during a more ethological situation like in the home cage since both analyses 
contribute with different aspects to facilitate interpretation of differences related to 
locomotion. 
Open field: We used this test to measure the quality and quantity of the general activity in 
rodents. Quality comprised exploratory and stress-related behavior, quantity comprehended 
the total distance travelled (Miyata et al., 2007). At the beginning of the test, every animal 
was placed into the OF with its head facing the south wall and was allowed to freely 
explore the arena for 5min. This short length of time emphasizes exploratory behavior and 
response to novelty, rather than baseline activity (Gould et al., 2009) and is an ideal 
extension to home cage activity. Total distance travelled, percent time and distance 
travelled in the inner zone, latency to enter and total entries to the inner zone were scored 
(Belzung and Prut, 2002). EE seems to increase exploratory behavior and thus, we counted 
rearings performed during the test (Gould et al., 2009). Rearing was defined as a behavior 
where the mouse was standing solely on its hind limbs in an upright posture to actively 
explore its environment, either at the wall or in the arena itself. The OF consisted of a grey, 
circular PVC arena with a diameter of 60cm for the outer and 30cm for the virtual inner 
zone. Illumination decreased successively from 50lux in the center to ca. 15lux near the 
wall by using a spot-like white light source. Highly anxious animals show higher levels of 
thigmotaxis (i.e. walking close to the wall using their whiskers to detect it), enter the inner 
zone with a higher latency and spent less time within (Bouwknecht and Paylor, 2008). 
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Elevated platform: At the beginning of the test, each mouse was placed on the platform 
with its head facing towards the camera. The apparatus consisted of a wooden cylinder 
40cm in height, with a circular platform (Ø 10cm) fixed on top. Light intensity during the 
trials was 300lux. The height and small size of the platform were used as a psychological 
stressor to monitor duration and frequency of freezing behavior as well as the total amount 
of rearings and head-dippings during the 5min. test interval. Freezing was defined as 
absence of movement excluding respiration (Miyata et al. 2007); head dipping was counted 
when a mouse lowered its head completely below the circular platform, i.e. snout, scull and 
ears were unambiguously lower than the bottom edge of the circular platform. The primary 
use of EP is to detect differences related to exploration, but freezing behavior can be used 
as an index of anxiety, especially because this readout seems to be sensitive to serotonergic 
anxiolytics (Miyata et al. 2007), in contrast to EPM, where drugs that affect serotonergic 
neurotransmission vary greatly depending on the report (Dunn et al, 1989; Hascoët et al., 
2000; Koks et al., 2001; Kostowski et al., 1992; Moser, 1989; Pinheiro et al., 2007; Treit et 
al., 1993). Thus, it is an excellent supplement to control whether the serotonergic system is 
involved in observed behavioral changes caused by EE. 
Behavioral tests of anhedonia, coping style and stress reactivity: Individual variation in 
stress reactivity is an important factor, which determines vulnerability for stress-related 
diseases and is influenced by environmental demands and the capacity to cope with them. 
“Understanding the origin and underlying mechanisms of this individual coping capacity 
and hence individual disease vulnerability is one of the major challenges of modern 
biomedical research” (Koolhaas, 2007). Some, but not all, important characteristics of 
psychiatric disorders include anhedonia (disability to feel joy or delight), psychomotor 
retardation (significant decrease of activity) and an in- or decreased HPA-axis reactivity 
(Diagnostic and Statistical Manual of Mental Disorders IV). Because anxiety often entails 
depression as a comorbid disorder (Johnston et al., 2009; O’ Leary and Cryan, 2009) and 
the onset of both diseases seem to depend to a big extend on the experienced life-stress, it 
is essential to perform behavioral tests assessing i) coping style (formerly denoted as 
depression-like behavior), ii) anhedonia and iii) to determine reactivity of the HPA-axis. 
Therefore, we conducted TST and FST to assess coping style, the sucrose consumption test 
to evaluate anhedonic behavior and the stress reactivity test (SRT) to determine HPA-axis 
reactivity. 
Tail suspension test: Mice were suspended to an iron bar located 75cm above the floor for 
6min. by fixing the last 3-4cm of their tail via adhesive tape to one of four 15cm long 
appendages protruding from the iron bar. The suspension of the mouse represented an 
inescapable stressor that caused escape-orientated behavior like running movements, body 
jerks and torsions (summarized as struggling) attempting to catch the suspending 
apparatus, followed by increasing bouts of immobility (O’ Leary and Cryan, 2009). 
Duration of immobility was originally described as an index of “behavioral despair’’ 
(Porsolt et al., 1977; 1978) at which the animal stopped its effort to escape the situation. 
More recent literature suggests immobility as a measure of coping or adaptation, whereby 
immobility disengages the animal from active forms of coping with a stressful situation 
(Lucki, 2001; O’ Leary and Cryan, 2009; Thierry et al., 1984). An animal was considered 
immobile when it stopped all limb and body movements except breathing and minor, slow 
head movements. In general, two different coping styles are described in the literature: the 
active response, represented by high levels of escape-orientated behavior, aggression, 
sympathetic nervous system and often HPA-axis activity (Henry and Stephens, 1977; 
Koolhaas, 1997) and the passive response characterized by low levels of aggression, 
escape-orientated behavior and high levels of immobility (Engel and Schmale, 1972; 
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Koolhaas, 1997). TST exhibits a high predictive value since the following antidepressants 
significantly increased the time animals engaged in escape-orientated behavior (O’Leary 
and Cryan, 2009): selective norepinephrine reuptake inhibitors (SNRIs) (Cryan et al., 
2004), tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) (Cryan et 
al., 2005; O’Leary et al., 2007), atypical antidepressants such as bupropion (Steru et al., 
1987), monoamine oxidase inhibitors, as well as electroconvulsive shock (Teste et al., 
1990). Importantly, aforementioned antidepressants belong to different classes and act on 
different neurotransmitter systems. Animals exhibiting an active coping style (or reduced 
depression-like behavior) engage more often (frequency) and for a longer total time in 
struggling behavior. 
Forced swim test: FST was performed for 6min., scoring the total amount and percent 
time spent immobile. Immobility was considered when the animal was floating or made 
minor limb movements to avoid drowning. Two liters of water with room temperature 
(22.5±1°C), filled in a cylinder with a diameter of 135mm and height of 280mm were used. 
Importantly, the mouse was not able to touch the ground of the cylinder by its tail and sight 
barriers circumvented distraction of animals during testing. Though both, TST and FST 
assess coping style and their predictive validity overlaps to a certain extent, research 
suggests that they obviously measure different aspects of coping behavior (Chatterjee et 
al., 2012; Cryan et al., 2005). Thus, we additionally used this test to guarantee a better 
interpretation of coping style. 
Stress reactivity test: To evaluate HPA-axis reactivity to a stressor, two different versions 
of a SRT were employed: a moderate (Touma et al., 2008) and more severe (Sotnikov, in 
preparation) version. We used for the moderate version a 15min. restraint period in a 50ml 
plastic tube, with a hole for ventilation and an aperture in the cap for the tail. Basal 
samples were collected prior to and reactive samples immediately after restraint stress. 
Instead of restraint stress, we used a 6min. FST for the more severe version. Reactive 
samples were collected 30min. after the end of the FST, while basal samples were taken 
two days later, prior to killing animals. Blood samples were collected from the ventral tail 
vessel in less than two minutes to ensure basal CORT levels according to Dürschlag et al. 
(1996, with slight modifications) using Microvette® CB300 coated with potassium-EDTA 
(code: 16444, Sarstedt, Nümbrecht, Germany). Cellular constituents were removed by 
centrifugation (10min., 4000rpm, 4°C) and plasma was frozen at -20 °C until further 
analysis. 
Home cage activity: Existing behavioral assays mostly examine a single behavioral 
domain over a short period of time (de Visser et al., 2006; Tecott and Nestler, 2004) and 
completely neglect the rich behavioral repertoire of mice that can merely be analyzed in 
their home cage. These behaviors are highly motivated, possess exceptionally ethological 
validity and reflect the function and interaction of numerous behavioral and physiological 
systems. “Detailed assessment of these patterns thus has the potential to provide a powerful 
tool for understanding basic aspects of behavioral regulation and their perturbation by 
disease processes” (Goulding et al., 2008). Because litter size and sex composition 
influences maternal behavior in rodents (Lonstein and Flemming, 2001), we culled litters 
on PND 1 to a size of eight, comprising in each case 4 male and female pups. To 
complement the read out of classical behavioral tests, we analyzed four different aspects of 
home cage activity (HCA): maternal, juvenile and early adolescent behavior as well as 
circadian rhythm: 
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Type of HCA PND Time of observation Housing condition 
maternal behavior 15 and 17 09:00 a.m. - 03:00 p.m. EE or SE 
16 08:00 p.m. - 02:00 a.m. home cage 
juvenile behavior 22 and 24 09:00 a.m. - 03:00 p.m. EE or SE 
23 08:00 p.m. - 02:00 a.m. 
early adolescence 
behavior 
35 09:00 a.m. - 03:00 p.m. EE or SE 
circadian rhythm 35-42 72h per animal type 3 cage 
 
Maternal behavior: A vast body of literature indicates that maternal behavior can 
influence behavior of the offspring. A prominent example was given by Champagne et al. 
(2003): it was shown that LG and ABN in rats have profound effects on anxiety-related 
behavior and HPA-axis reactivity of the offspring. In adulthood, pups of high 
licking/grooming and ABN mothers showed increased expression of GR in the 
hippocampus and decreased expression of CRH in the hypothalamus (Weaver, 2007). 
These expression changes caused by maternal behavior are of epigenetic nature and ensued 
an enhanced glucocorticoid feedback sensitivity, which resulted in a less anxious 
phenotype of the offspring (for a detailed review see Weaver, 2007). In our paradigm, 
different treatment of SE and EE offspring started on PND 15. SE mice were transferred 
for 6h per day to a new cage identical with their home cage (to exclude handling effects), 
whereas EE mice were allowed to explore an EE cage during that time. Thereby, dams 
together with their pups were transferred since offspring wasn’t capable to take care for 
itself. The different environments might have caused changes in maternal behavior, which 
contributed to effects elicited by EE. Thus, we analyzed the two general categories of 
maternal responses: active and quiescent behaviors (Lonstein and Flemming, 2001). 
 
Active behaviors Quiescent behaviors 
licking/grooming sitting together with body contact 
time spent with pups 
(licking/grooming/body contact/nursing) 
nursing 
locomotion   
digging  
 
Licking/grooming was defined as an active caretaking behavior of the damn by using her 
tongue and/or paws to groom her pups. We counted “time spent with pups” when the damn 
performed licking/grooming or was sitting together with body contact with her pups. If the 
mother is in body contact with pups, she lies either on top of the pups (sitting together with 
body contact) or nurses them. We omitted counting of different nursing styles because 
Kessler (2006) showed that from PND15 onwards HAB dams were merely engaged in the 
nursing style “lying on the side”. Litters were videotaped each for 6h during the light and 
6h during the dark phase to investigate whether maternal behaviors differed when dams 
were housed either in their respective environment (SE or EE, light phase) or their home 
cage (dark phase). We analyzed the videotaped behavior every 10min. for 60s via 1/0 
sampling in 15s intervals (Martin and Bateson, 2007) giving rise to 144 monitored 
intervals in total. 1 and 0 were noted when a certain behavior was conducted during a 15s 
interval or not, respectively. This procedure ignored multiple occurrences of a certain 
behavior per 15s interval, but this drawback might be neglected almost completely since 
parameters we monitored were performed for a considerable amount of time (e.g. sitting 
together with body contact). All occurrences of a respective behavior were added from the 
144 intervals and expressed as arbitrary units. A similar procedure was performed earlier 
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by Kessler (2006) and yielded reliable results. Thus, we used this method too, to analyze 
juvenile and early adolescence behavior. 
Juvenile behavior: Pups open their eyes around PND 15 and actively start to explore their 
environment and to engage in social interactions. Therefore, the time period from PND 15-
25 is denoted as socialization period and the perceived stimuli during this time are of 
utmost importance for the development and refinement of a species-specific behavioral 
repertoire including motor, cognitive and social skills. This seems to be necessary to foster 
a general disposition for neurobehavioral plasticity (Martin and Caro, 1985; Terranova and 
Laviola, 2005). A key component of the natural behavioral repertoire of developing 
animals is amicable and playful behavior like chasing and horizontal and vertical jumping. 
Interestingly, EE facilitates cognitive, sensory and motor stimulation and leads to the 
expression of a much wider range of social interactions. Moreover, the enhanced spatial 
complexity leads to increased exploratory behavior and reduced neophobia since animals 
are confronted regularly with novel objects. The defense of territories, marking and 
sheltering indicate that these animals indeed demonstrate a more naturalistic behavioral 
pattern (Kempermann et al. 2010). Thus, we monitored juvenile behavior on PND 22 and 
24 during the light phase and on PND 23 during the dark phase by observing the following 
behaviors: 
Monitored behavior Category Definition 
sitting together with body 
contact 
sociopositive 
 
direct body contact of animals without 
movement 
play/amicable behavior sociopositive chasing, horizontal and vertical jumping, 
grooming 
toy use/environmental 
manipulation 
exploration digging and burying, usage of provided 
toys 
 
Sitting together with body contact implied direct body contact of animals without 
movement excepted very short movements like head raising (e.g. due to noise), moaning or 
changing position. Play/amicable behavior included chasing, horizontal and vertical 
jumping as well as grooming of a companion (allogrooming). Toy use/environmental 
manipulation comprehended manipulation of the microenvironment via digging and 
burying and usage of provided toys for a variety of possible behaviors like retreat, 
exploration etc. 
Early adolescent behavior: Juvenile animals were weaned on PND 28 to transfer them in 
their respective environment in same sex groups of three animals (beginning of permanent 
enrichment). Thus, mice were confronted with two important changes: reduction of group 
size from eight (different sex) to three (same sex) and the onset of early adolescence. To 
investigate the effect of EE on these changes, we videotaped the animals on PND 35 and 
scored the following additional behaviors compared to juvenile behavior (tab. 4): 
Monitored behavior Category Definition 
activity locomotion movement for 3s consecutively 
eating/drinking energy balance food intake and/or water consumption 
 
Animals were housed in trios from PND 28 – 42 and a certain behavior was counted when 
2 out of 3 animals were engaged in it. Activity was defined as a behavior which comprised 
movement for at least 3s consecutively (e.g. patrolling). This precaution minimized 
Tab. 4: Summary and definitions of behaviors monitored during early adolescent 
behavior. 
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confounding movements like head lifting or changing position when sitting together with 
body contact to be counted as activity. 
Circadian rhythm: Activity, i.e. locomotion and exploration significantly varies 
depending on the scene of measurement. Activity in the home cage is predominantly 
influenced by the activity rhythm, in contrast to behavioral tests, where mice are placed in 
an unfamiliar environment, which affects fear and anxiety due to neophobia. We quantified 
home cage activity via an automated system (Inframot; TSE, Bad Homburg, Germany) 
over a period of 72h. Eight animals were tracked simultaneously, each in a type 3 cage 
offering 825cm² (265 x 150 x420mm). The cage was covered with an iron lid harboring a 
photo beam sensor on top. Every time an animal passed the sensor, an activity was 
counted. Activity was analyzed by the hour for 72h in total. The first 12h of observation 
were granted to permit habituation of animals to the new cage: thus, three dark and two 
light cycles were completely analyzed. 
Assessment of transgenerational inheritance: Epigenetic or transgenerational 
inheritance is defined as transmission of phenotypic variations to subsequent generations 
of cells (mitotic) or organisms (meiotic) and does not stem from variations in DNA 
sequence (Jablonka et al., 2009). The idea of passing on acquired traits was originally 
coined by Lamarck (1809) and stands vis-à-vis the evolutionary synthesis proposed by 
Darwin (1859) suggesting that mutations within individuals lead to genetic variation within 
a population (Bard, 2011). For this reason, Lamarck’s theory is denoted as “soft 
inheritance” (non-genomic inheritance) in contrast to Darwin’s “hard inheritance” 
(genomic inheritance like SNPs etc.). It is becoming increasingly clear that epigenetic 
inheritance seems indeed to exist and moreover, might be ubiquitously present as examples 
in bacteria, protists, fungi, plants and animals corroborate (for a review see Jablonka et al., 
2009). As a consequence, current biology tries to unite both theories to a new concept 
referred to as “modern synthesis”, allowing fast (epigenetic) and slow (genomic) adaption 
to environmental demands by inherited phenotypic variation. This implies that the health 
of future generations might be compromised and highlights the importance to provide 
novel preventative and therapeutic approaches before the disease systems develop (Jirtle 
and Skinner, 2007). Thus, we tried to determine whether beneficial effects of EE might be 
transmitted to the offspring (fig. 10): 
 
Fig. 10: Experimental schedule depicting the set-up to evaluate possible transgenerational 
inheritance of anxiety-related behavior in HAB mice. 
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Animals were housed and tested as described until PND 47. Subsequently, animals of the 
respective environment were mated according to their performance in the behavioral tests. 
We used the parameters “% time spent in inner zone” (OF), “% time spent on open arms” 
(EPM) and “% time spent in light compartment” (LD) to rank mice. Therefore, we 
calculated the average time for every of the three parameters for SE housed mice and 
attributed points according to the following rules: 
Ranking rule Points 
EE mouse spent more time in a respective compartment compared to the SE 
average 
2 
EE mouse spent the same amount of time (±1%) in a respective compartment 
compared to the SE average 
1 
EE mouse spent less time in a respective compartment compared to the SE 
average 
0 
 
Whenever applicable, EE animals that scored ≥4 and SE mice that scored ≤1 point(s) 
(ranking was conducted vice versa to EE) were mated to generate offspring. Mating was 
allowed for 14 days, whereat SE mice were mated in type 3 and EE animals in EE cages, 
respectively. Males were removed from their respective females when pregnancy was 
observed during the daily examination. Pregnant EE females were transferred by an 
experienced person 2-3 days before parturition to SE to exclude any contact of neonates 
with EE. From that day on, offspring of EE and SE was raised and tested as described in 
SE housing. Breeding was continued until F3 and anxiety-related behavior of every 
generation was assessed in a behavioral test battery comprising OF, EPM and LD. 
Killing of animals, tissue harvesting and blood collection: Animals were deeply 
anesthetized with Forene (ABBOTT GmbH, Wiesbaden, Germany) before decapitation. 
We harvested brains from experimental animals for further molecular analyses. Blood was 
collected either 48h prior to killing from the tail vessel (Dürschlag et al., 1996; with slight 
modifications) or after decapitation (trunk blood) to determine CORT concentration. 
3.3 in silico and molecular analyses 
In silico analysis to identify candidate genes: Czibere (2008) performed gene expression 
profiling (MPI24K-platform) covering the whole genome to identify expression 
differences between HAB and LAB mice. A second genome-wide screening approach 
identified 267 SNPs differing between the two sublines, to finally achieve a list of 
candidate genes relevant for anxiety-related and depression-like behavior in our mouse 
model of extreme trait anxiety. To expand our list of candidate genes by another layer of 
transcriptional regulation in addition to SNPs, we performed in silico analyses to identify 
genes amenable for epigenetic regulation.  Therefore, we used CpG Island Searcher 
(default settings, Release 29.10.04) to identify CpGIs within promoter regions of earlier 
identified candidate genes. These epigenetic candidate genes were further analyzed for 
expression differences via qPCR and, if differences were detected, subsequently analyzed 
for differences in promoter methylation (fig. 11). 
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Tissue collection and micropunching: Harvested brains were cut from rostral to caudal 
into 200µm slices using a cryostat (MH50, Microm, Walldorf, Germany) and mounted to 
Superfrost microscope slides (Menzel, Braunschweig, Germany). Desired brain regions 
(tab. 5) were acquired from the slices by micropuncture through a method described by 
Palkovites (1973) utilizing autoclaved punchers with a diameter of either 0.5mm or 1.0mm 
(Fine Science Tools, Heidelberg, Germany). 
Brain region Interaural (mm) Bregma (mm) Ø of puncher (mm) 
cingulate cortex 4.90 - 3.58 1.10 to -0.22 1.0 
basolateral amygdala 3.22 - 1.98 -0.58 to -1.82 0.5 
paraventricular nucleus of 
the hypothalamus 
3.22 - 2.86 -0.58 to -0.94 0.5 
locus caeruleus -1.54 to -1.88 -5.34 to -5.68 0.5 
 
These tissue punches were used either for the extraction of proteins or simultaneous 
extraction of RNA and DNA. 
Simultaneous extraction of DNA and RNA: To give a reliable statement about the 
relation of promoter methylation and gene expression, it is of highest importance to extract 
DNA and RNA simultaneously from the desired tissue. Therefore, we employed a protocol 
established by Bettscheider et al. (2011): tissue punches were homogenized in 400µl of 
guanidinium thiocyanate buffer (4.5M guanidium thiocyanate, 2% N-lauroylsarcosine, 
50mM EDTA pH 8, 25mM Tris-HCl pH 7.5, 0.1M beta-mercaptoethanol, 0.2% antifoam 
A) by passing five times through a hypodermic syringe (30G) and split in equal parts for 
RNA and DNA isolation. 
 
Fig. 11: Workflow depicting the conducted procedures after extraction of RNA, DNA 
and proteins to infer from methylation status to gene transcription. 
Tab. 5: Stereotaxic coordinates of brain regions extracted via micropunching. 
Coordinates originate from Allen Brain Atlas 2nd edition. 
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RNA extraction: 20µl of 3M sodium acetate pH 5.2, 200µl of acidic phenol (product 
number A980.3, Carl Roth) and 100µl of chloroform:isoamyl alcohol (24:1) were added to 
every sample and mixed vigorously. Samples were incubated on ice for 10min. and 
subsequently centrifuged for 20min. at 4°C with 13000rpm. Aqueous phase was 
transferred into a new sterile 1.5ml Eppendorf tube and 350µl of 70% ethanol were added. 
Samples were transferred into spin columns (RNeasy mini Kit, Qiagen GmbH) and further 
steps were performed according to the manufacturer’s protocol. Samples were stored at -
80°C until further used. 
DNA extraction: 200µl of Buffer AL and 200µl of 100% ethanol were added to every 
sample and mixed vigorously. Samples were transferred into spin columns and further 
steps were performed according to manufacturer’s protocol (Qiagen, DNeasy Blood and 
Tissue Kit). Samples were eluted with 200µl of pre-warmed (70°C) Buffer AE to 
maximize yield. To increase DNA concentration, all samples were vacuum-centrifuged 
(Speed Vac Plus SC210A, Savant, Bachofer Laboratoriumsgeräte, Germany) until the 
remaining liquid evaporated and finally resuspended in 20µl of water. Samples were stored 
at -20°C until further used. 
Reverse transcription: 100ng of extracted total RNA was reverse transcribed to 
complementary DNA (cDNA) using the High-Capacity cDNA reverse transcription kit 
(Applied Biosystems, Darmstadt, Germany) according to manufacturer’s instructions. 
Reverse transcription uses a retroviral enzyme called “reverse transcriptase” to generate 
cDNA from a RNA template by using random primers to amplify all existing RNA. 
Quantitative real-time PCR: The following genes (tab. 6) were analyzed by utilizing the 
QuantiFast SYBR Green PCR Kit (Qiagen, Hilden, Germany) according to manufacturer’s 
instructions: 
Gene 
symbol 
Region Orien-
tation 
Primer sequence 5’- 3’ Product 
size 
Avp PVN forward TCG CCA GGA TGC TCA ACA C 
164 
 reverse TTG GTC CGA AGC AGC GTC 
Crhr1 BLA forward GCC CCA TGA TCC TGG TCC TGC 
187 
 reverse CCA TCG CCG CCA CCT CTT CC 
Crh BLA forward GCA GTG CGG GCT CAC CTA CC 
109 
 reverse GGC AGG CAG GAC GAC AGA GC 
Dbh LC forward AGA GAG CCC CTT CCC CTA CCA CAT C 
232 
 reverse TTT CCG GTC ACT CCA GGC ATC 
Npsr1 
 
BLA forward CTC TTC ACT GAG GTG GGC TC 
196 
reverse CCA GTC CTT CAG TGA ACG TC 
Tmem132d CG forward CAT CCC TTC TTC AGC CAG AG 
187 
 reverse AGT GAG AAC CGC TGA ATG CT 
Ucn BLA forward CAC TGG GCA GAC ACT CCG 
121 
 reverse GCA GCC AGT GGA GCC C 
 
Primer pairs were designed using “Primer 3” (Rozen and Skaletzky, 2000) with default 
settings except “primers must span an exon-exon junction” and “Mus musculus (taxid: 
10090)” was selected as organism. Spanning of an exon-exon junction is important to 
avoid co-amplification of genomic DNA. Experiments were performed in duplicates on the 
Lightcycler®2.0 instrument (Roche Diagnostics, Mannheim, Germany) under the following 
Tab. 6: List of genes analyzed via quantitative real-time PCR. 
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PCR conditions: 10min at 95°C for initial denaturation, followed by 40 cycles of 
denaturation (95°C for 10s) and a combined annealing and extension phase (60°C for 30s).  
To ensure the quality of the PCR product, a melting curve (50-95°C with 0.1°C/s) was 
generated at the end of every run. LightCycler® Software 4.05 (Roche Diagnostics) 
calculated crossing points (CP) by utilizing the absolute quantification fit points method. 
For this, noise band and threshold were set to the same level in all compared runs (Czibere, 
2008). Relative gene expression was determined by the comparative Ct method (Livak and 
Schmittgen, 2001) and CPs were normalized to the housekeeping genes Pol13, B2mg and 
Rflp13a or any combination thereof. If expression differences were confirmed for a gene, 
proteins were extracted from tissue punches to perform WB to evaluate whether expression 
differences ensued differences in protein quantity. 
Protein extraction: Proteins were extracted from tissue punches either as total fraction 
using an in-house protocol or separated by nuclear, mitochondrial and cytosolic fraction 
with a method described earlier by Djordjevic et al. (2009). 
Total protein extraction: Punches were homogenized in 200µl of ice-cold RIPA buffer 
(R0278, Sigma-Aldrich, Hamburg, Germany) comprising 2µl of both, protease and 
phosphatase inhibitor cocktail (P8340 and P0044, Sigma Aldrich, Hamburg, Germany). 
Homogenization was achieved by passing five times through a hypodermic syringe (30G). 
Afterwards, samples were put on ice for 5 minutes before centrifugation was performed 
with 8000g for 10min at 4°C to pellet the cell debris. Supernatant (proteins) was 
transferred to an ice-cold new 1.5ml Eppendorf tube and stored at -20°C until further used. 
Protein extraction by fractions: Frozen tissues punches from every sample were 
homogenized in 200µl of ice-cold homogenization buffer comprising 2µl of each, protease 
and phosphatase inhibitor cocktail (P8340 and P0044, Sigma-Aldrich, Hamburg, 
Germany). Inhibitors were added just before use and homogenization was acquired by 
passing five times through a hypodermic syringe (30G). Subsequently, samples were 
centrifuged at 2000rpm for 10min. at 4°C to collect the nuclear pellet. Supernatant was 
further centrifuged at 20000g for 30min. to provide a crude mitochondrial pellet. The 
resulting supernatant of this centrifugation was filled with homogenization buffer up to 
500µl and ultracentrifuged at 105000g for 1h to separate the membrane from the 
cytoplasmic fraction (Optima XL 90, Beckman Coulter, Rotor SW55, Tubes 344090 and 
adaptor 356860). Nuclear pellets were washed three times in 0.5ml of homogenization 
buffer and resuspended in homogenization buffer with 0.5M KCl. Samples were incubated 
for 1h on ice (with frequent vortexing) and centrifuged for 10min with 8000rpm at 4°C. 
The resulting supernatant was used as nuclear extract. The crude mitochondrial pellets 
were washed three times in 0.5ml of homogenization buffer and centrifuged at 20000g for 
30min., lysed in lysis buffer comprising 2µl of each, protease and phosphatase inhibitor 
cocktail (P8340 and P0044, Sigma-Aldrich, Hamburg, Germany) and incubated on ice for 
1.5h with frequent vortexing. The resulting fraction was used as a final mitochondrial 
extract. Respective fractions were stored at -20°C until further used. 
Homogenization buffer Lysis buffer 
Substance Conc. Substance Conc. 
Tris-HCl, pH 7.2 20mM Tris-HCl pH 7.4 50mM 
Glycerol 10% glycerol 5% 
NaCl 50mM EDTA 1mM 
EDTA 1mM DTT 5mM 
EGTA 1mM Triton X-100 0.05% 
DTT 2mM   
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Estimation of protein concentration: Protein concentration was estimated by utilizing the 
bicinchoninic acid (BCA) protein assay (Thermo Scientific, Illinois, USA). All samples 
were measured in triplicates to increase accuracy and reliability of the obtained protein 
concentrations. Per sample, 200µl of reagent A and 4µl of reagent B were mixed to obtain 
a working solution. 10µl of both, BSA standards and samples (protein solution) were 
pipetted in a 96-well tissue culture test plate (Product number 92696, Techno Plastic 
Products, Trasadingen, Switzerland). 200µl of working solution was added to all samples 
and the 96-well plate was incubated for 30min. at 37°C. Samples were measured at 562nm 
in an enzyme-linked immunosorbent assay (ELISA) plate reader (Dynatech MR7000). 
Western Blot: Western blots were performed in protein blotting cells from Bio-Rad (Mini 
Protean Tetra Cell, Munich, Germany). Prior to use, samples were diluted to the same 
protein concentration and 20% of final volume of 5x protein loading buffer (PLB) was 
added. Samples were heated for 5min. at 95°C and 20µg of protein per sample was loaded 
to perform sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) page 
at 4°C (electrophoresis buffer: Tris 25mM, glycine 192mM) for 15min. with 70V followed 
by 90min. with 120V. Subsequently, samples were blotted (blotting buffer: Tris 25mM, 
glycine 190mM, 20% methanol) at 4°C for 60min. with 400mA on a nitrocellulose 
membrane (Protran, Whatman, Dassel, Germany). Transfer of proteins from the SDS gel to 
the nitrocellulose membrane was verified by incubation with Ponceau S solution 
(Applichem, Darmstadt, Germany) for 3min on a shaker (Mini Rocker MR-1, Peqlab, 
Erlangen, Germany). Next, membrane was incubated for 60min. in 50ml of 5% milk 
solution in Tris-buffered saline with 0.1% Tween (TBST) to  dissociate Poinceau S 
solution from the positive charged amino-groups and to block unsaturated binding sites for 
proteins. The protein ladder (Page Ruler prestained protein ladder, Fermentas, Leon-Rot, 
Germany) was used to determine the exact position for cutting the membranes in two parts 
to separate protein of interest and housekeeping or marker protein, respectively. 
Membranes were each incubated overnight (O/N) with 10ml of 2.5% milk solution in 
TBST comprising the respective primary antibody: 
Primary 
antibody 
Application Dilution Molecular 
weight (kD) 
Host Type 
GAPDH housekeeper 1:4000 35 goat polyclonal IgG 
H3(Lys9) nuclear marker 1:2500 17 rabbit polyclonal IgG 
α-Tubulin cytosolic marker 1:1000 55 mouse monoclonal IgG 
CRHR1 protein of interest 1:2500 48 goat polyclonal IgG 
GR protein of interest 1:500 95 rabbit polyclonal IgG 
 
Next, membranes were washed three times by shaking in TBST to remove unbound 
primary antibody and incubated each for 2h at RT with 10ml of 2.5% milk solution in 
TBST comprising the respective secondary antibody: 
Secondary 
antibody 
Dilution Nature 
GAPDH 
1:10000 
donkey anti-goat IgG-HRP 
H3(Lys9) goat anti-rabbit IgG-HRP 
α-Tubulin goat anti-mouse IgG-HRP (Fab specific) 
CRHR1 donkey anti-goat IgG-HRP 
GR goat anti-rabbit IgG-HRP 
 
Again, membranes were washed three times by shaking in TBST to remove unbound 
secondary antibody. Membranes were incubated with 33ml of enhanced 
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chemiluminescence (ECL) solution for 2min on a shaker. ECL solution was prepared just 
before use by mixing 30ml of solution A (0.1M Tris, 50mg luminol per liter), 3ml of 
solution B (DMSO, 0.11% para-hydroxycoumarin acid) and 11µl of hydrogen peroxide 
(H2O2). All secondary antibodies were conjugated to horseradish peroxidase (HRP), which 
catalyzed the oxidation of luminol to 3-aminophthalate under the presence of H2O2. This 
reaction caused chemoluminescent emission of light at 428nm, which was further 
enhanced by the presence of para-hydroxycoumarin acid up to several 100-fold (Carlsson 
et al., 2005). The intensity of emitted light correlates with the amount of “protein-primary-
secondary-antibody-HRP-complex”. Proteins were visualized using the ChemiDoc MP 
system and finally quantified via ImageLab 4.0 software (Bio-Rad, Munich, Germany). 
Analysis of mutations in the promoter of Crhr1: To unambiguously attribute changes in 
gene expression to differences in promoter methylation, we performed Sanger sequencing 
(tab. 7) for the proximate promoter region (-2069bp to +93bp relative to TSS, NCBIM 37) 
to detect SNPs and indels (insertions and deletions): 
Region amplified Orientation Primer sequence 5’- 3’ Product size 
A (-2069 to -1584) forward GCCCACTCTATCTTGATGAT 485 
 reverse CCTCCTTCCTAATTCCCAAC 
B (-1732 to -1136) forward CTTCAGGACTTTGCTTCACTG 596 
 reverse TTCTAATTCCACTTCCAGCC 
C (-1296 to -738) forward CCTGAGAGGTGAAGATGTTTC 558 
 reverse CAATTTAGTGGGGAGGGGAG 
D (-954 to -263) forward CCGCTGTCACCACTTATCTT 691 
 reverse TCGTGTCCCCTCCTCTTTCT 
E (-479 to 93) forward TTTTCCCTAGCTGCGGTGGC 572 
 reverse GTCCTCTCTTACCTTCACGA 
These mutations occur regularly within the genome and are well known to alter gene 
expression and this fact corroborates the necessity to determine their possible regulatory 
effects. 
Analysis of promoter methylation: We employed two different techniques to analyze 
promoter methylation of Crhr1: pyrosequencing and bisulfite sequencing of a bacterial 
vector carrying the region of interest. 
Pyrosequencing: This technique is based on the “sequencing by synthesis” principle, i.e. 
the desired sequence can be analyzed by light emission due to the iterative incorporation of 
complementary nucleotides into the template: single-stranded DNA (ssDNA) of the region 
of interest, generated by a first round of PCR. The intensity of emitted light represents the 
number of identical nucleotides in a row within the analyzed sequence (e.g. light emission 
of a GG peak would be ca. double the height compared to a GC, GA or GT peak). 
Therefore, 12-15µl of the respective template was immobilized to 2µl Streptavidin 
Sepharose (GE Healthcare, Munich, Germany) followed by annealing to 0.8 - 1.0µl of the 
respective biotinylated sequencing primer (5µM) for 2min. at 80°C (fig. 12a). To allow 
light emission by incorporation of a complementary nucleotide, the enzymes DNA 
polymerase, ATP sulfurylase, luciferase and apyrase were added concomitantly with the 
substrates adenosine phosphosulfate (APS) and luciferin. The sequencing reaction per se 
was started by addition of one of the four deoxynucleoside triphosphates (dNTPs) (fig. 
12b), which was incorporated by the Klenow fragment of DNA polymerase I at the 3'-end 
Tab. 7: Primers used to monitor the existence of mutations, which might influence gene 
transcription of Crhr1. (corticotropin-releasing hormone receptor 1). 
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Fig. 12: Pyrosequencing is based on the iterative addition of dNTPs causing a release of 
PPi, which in turn converted APS into ATP to provide the energy to form an unstable 
luciferase-luciferin-AMP complex. In the presence of oxygen, light is released 
proportional to the amount of ATP. Abbreviation: AMP (adenosine monophosphate), 
APS (adenosine phosphosulfate), (dNTP (deoxynucleoside), PPi (pyrophosphate). 
Adapted and modified from Tost and Gut, 2007. 
of the pyrosequencing primer and led 
to the release of PPi (fig. 12c). This, 
in turn, converted APS into ATP, 
which provided the energy to form an 
unstable luciferase–luciferin–AMP 
complex. In the presence of oxygen, 
light was released proportional to the 
available amount of ATP and thus PPi 
(fig. 12d). Apyrase degraded 
unincorporated -S- dATP and the 
sequencing reaction was continued by 
adding a different dNTP. A 
methylated CpG site is represented as 
“R” in the template sequence. The 
ratio of incorporated C (methylated 
cytosine before bisulfite treatment) or 
T (unmethylated cytosine before 
bisulfite treatment) yields the 
methylation degree at this position 
(fig. 12 C and D) (Gharizadeh et al., 
2001; Tost and Gut 2007). The 
following primers and PCR routines 
were designed by Varionostic GmbH. 
The CpGi ranging from -1336bp to 
+1323bp comprised 186 CpG sites in 
total and was sequenced with eight 
biotinylated primers (P1-8). Every 
region amplified by a biotinylated 
primer was sequenced finally with 1-4 
sequencing primers (S1-4), generating 
a nomenclature like P1S1, P1S2, 
P1S3, P2S1 etc. Due to the short read 
length (ca. 100bp) of pyrosequencing, 
several sequencing primers are 
needed per analyzed region, i.e. per 
biotinylated primer (average length of 
ca. 350bp). The nucleotide adenine of 
the start codon ATG was counted as 
+1bp, the first nucleotide before 
adenine was counted as -1bp (tab. 8). 
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Region 
sequenced 
Assay Orientation Sequencing primer 
(Biotin = B) 
Product 
length 
CpGs 
covered 
-1412 to -998 P1 
forward gttggtttttttattagga 
414 1-18 
reverse B-aaccaactaaacacctaatcta 
-1027 to -724 P2 
forward B-ttttttatagattaggtgtttag 
303 19-35 
reverse actaaaaactacatttaaataattc 
-757 to -560 P3 
forward B-tagggagggaattattt 
197 36-43 
reverse aaacaacctttcttctctaa 
-588 to -216 P4 
forward ataggaggttagagaagaaa 
372 44-75 
reverse B-cccacaactacctctctc 
-247 to +70 P5 
forward gggatttaggtaggagaga 
317 76-104 
reverse B-aacccctctaattaccc 
+24 to +362 P6 
forward gttagtgaaggtaagagagga 
339 105-130 
reverse B-atcccatccaaaacct 
+348 to +735 P7 
forward ggttttggatgggattt 
388 131-160 
reverse B-aactaccaaacacctaactctt 
+700 to +1164 P8 
forward ggatagagttagggaagagtta 
465 161-186 
reverse B-tccaacccttaaattcacta 
 
Varionostic GmbH (Ulm, Germany) used the Q24 system (Qiagen, Hilden, Germany) to 
perform pyrosequencing and the PyroMark Q24 software to conduct analyses of CpG sites. 
Bisulfite sequencing of clones: This technique is considered as the gold standard to 
analyze bisulfite modified DNA (Mikeska 
et al., 2010). It utilizes the different 
conversion of unmethylated and 
methylated cytosine residues when DNA 
is treated with sodium bisulfite: the CH3-
group attached to the 5th carbon atom 
protects the NH2-group from 
deamination, whereas unmethylated 
cytosine residues are converted to uracil 
(fig. 13a). During PCR, uracil is replaced 
by the nucleotide thymine and this 
evolved difference in sequence can be 
subsequently determined by Sanger 
sequencing (fig. 13b). 
 
 
 
 
 
 
Tab. 8: List of sequencing primers used for pyrosequencing of Crhr1. (corticotropin-
releasing hormone receptor 1) 
Fig. 13: Treatment with sodium bisulfite deaminates cytosine to Uracil (a), which can 
be sequenced subsequently to determine methylation status due to different nucleotide 
sequences (b). A adapted and modified from Schumacher, 2007. B adapted and 
modified from Hung et al., 2009. 
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Bisulfite conversion and bcPCR: We used the EpiTect Bisulfite Kit (Qiagen, Hilden, 
Germany) according to manufacturer’s protocol to convert extracted DNA from tissue 
punches. To amplify the complete CpGi, we designed primers using BiSearch (Tusnády et 
al., 2005) with default settings except: 
primer length min. 20 opt. 25 max. 30 
melting temp. min. 55 opt. 60 max. 65 
Max. Tm diff. 3°C 
Database Mus musculus 
The following list depicts all primers used to amplify the complete CpGi. Drawbacks of 
bisulfite conversion to differentiate between methylated and unmethylated cytosine 
residues are: i) the harsh conditions during bisulfite conversion were DNA was randomly 
fragmented to an average length of 300-400bp, giving rise to the necessity to utilize several 
overlapping primer pairs for Sanger sequencing of clones, ii) the reduced complexity of the 
genome due to the presence of merely three instead of four different nucleotides (cytosines 
are converted to uracil and finally to thymine after PCR) and iii) the necessity to create 
primers with so called wobble positions, i.e. a primer containing a CpG site mustn’t favor 
methylated or unmethylated sites to avoid an amplification bias. For this reason, a 
mismatch denoted as “Y” was created using cytosine or thymine at this position. (tab. 9) 
To verify correct amplifications of the respective amplicons, we performed agarose gel 
electrophoresis. 
 
Region 
sequenced 
Orientation Primer sequence 5’- 3’ Product 
length 
CpGs 
covered 
-1505bp to 
-1247bp 
forward ATTTTGTTTAGTGTGTTGAG 
258 1-3 
reverse ATTCTTTTAATTTCCTTCCC 
-1471bp to 
-1180bp 
forward AAGGGGAGTTGTATAAAGTA 
291 1-4 
reverse TAACTTTCTAATTCCACTTC 
-1345bp to 
-965bp 
forward TTTGAGAGGTGAAGATGTTTT 
380 2-19 
reverse TCTTTTTAATCCAAACCCCA 
-1198bp to 
-856bp 
forward AAGTGGAATTAGAAAGTTAA 
342 5-26 
reverse CCTAAAATATACTAAAACACT 
-981bp to -
732bp 
forward GGTTTGGATTAAAAAGATAG 
249 20-34 
reverse ACTACATTTAAATAATTCCC 
-875bp to -
557bp 
forward GTGTTTTAGTATATTTTAGGTG 
318 27-42 
reverse AAACAAACAACCTTTCTTCT 
-576bp to -
225bp 
forward AGAAGAAAGGTTGTTTGTTT 
352 43-74 
reverse TACCTCTCTCCTACCTAAATC 
-398bp to -
8bp 
forward AGGAGATTGGAGTTTGTAG 
390 61-96 
reverse TCACTCTATCAACATCCTAA 
-171bp to 
215bp 
forward GAGTAAGAGTTTGTTGGTGG 
387 79-118 
reverse AATTATCCCTCTATCTCCAA 
105bp to 
522bp 
forward GGGTGTTGGAGGAGAGGATT 
418 111-144 
reverse GCACACCATCACCTCTCAAAA 
347bp to 
675bp 
forward AGGTTTTGGATGGGATTTTG 
329 130-155 
reverse CCCAACTTTAACCAATAAACACTA 
502bp to 
836bp 
forward AGGTTTTGGATGGGATTTTG 
335 143-171 
reverse CCCAACTTTAACCAATAAACACTA 
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622bp to 
957bp 
forward GAGTTTTAGAAAGTTTTTAG 
335 155-178 
reverse CTTTCCTAACCACAATTAAC 
798bp to 
1150bp 
forward GGGTATTAGTATTTTAGTTTTGG 
352 172-186 
reverse TCACTAAAACTCCCTTAAAT 
 
Clean-up and subsequent ligation: Amplicon was run on a 1.5% agarose gel to verify 
correct product size and subsequently cleaned up using the Nucleo Spin Extract II kit 
(Macherey-Nagel, Düren, Germany) according to the manufacturer’s instructions. 
Removal of all fragments shorter than the desired product was controlled on a 1.5% 
agarose gel. Next, the amplicon was cloned into the pGEM® T-vector system I (Promega, 
Mannheim, Germany) according to the manufacturer’s instructions (samples were 
incubated overnight together with amplicon in a 1.5ml Eppendorf tube to increase 
maximum number of transformants). 10µl of overnight incubated pGEM® T-vectors were 
purified by an in-house protocol: 20µl of 100% ethanol, 1µl glycogen (10mg/ml) and 1µl 
of sodium acetate 3M pH 5.2 were added before samples were shock-frozen for 30s on dry 
ice and centrifuged for 15min. at 4°C with maximum speed. Supernatant was removed 
carefully with a pipette, 200µl of 100% ethanol were added and samples were centrifuged 
for 15min. at 4°C with maximum speed. This washing step was repeated with 70% ethanol 
and supernatant was removed carefully with a pipette. 1.5ml Eppendorf tubes containing 
the pGEM® T-vectors were dried at RT until remaining liquid was evaporated. Cleaned-up 
vectors were resuspended in 10µl of water and stored on ice to prepare lysogeny broth 
(LB) agar plates for following transfection and blue/white selection. 
Transfection and blue/white selection: Petri dishes (100 x 15mm) were prepared the day 
before by filling ca. 25ml of LB-Lennox agar pH 7 comprising 100mg of ampicillin 
sodium salt (Sigma-Aldrich, Hamburg, Germany) into them. This LB-Lennox agar was 
autoclaved for 2h (Vakulab S3000, Münchner Medizin Mechanik GmbH, Germany) and 
2ml of an ampicillin stock solution (50mg/ml) was added when LB-Lennox agar cooled 
down to ca. 50-60°C to prevent degradation of ampicillin. These prepared LG agar plates 
were covered with 100µl of a blue/white selection mix using a Drygalski spatle and petri 
dish rotary plate (petri turn-M, Schuett-biotec.de, Germany): 
blue/white selection mix 
Substance 
 
Volume (µl) 
RNAse free H2O 52,5 
DMSO 20 
IPTG, 100mM 15 
x-Gal, ready to use solution 12,5 
Petri dishes prepared for blue/white selection were stored upside down for 45min. at 37°C. 
We used highly competent JM109 cells from Promega for transfection (genotype: recA1, 
endA1, gyrA96, thi, hsdR17 (rK–,mK+), relA1, supE44, Δ(lac-proAB), [F´, traD36, 
proAB, lacI qZΔM15]). Competent cells were thawed on ice and 100µl of cells were added 
to 5µl of every sample (pGEM® T-vectors carrying the amplicon) and gently mixed by 
tapping. Samples were incubated on ice for 30min. to increase transfection efficiency. 
Samples, i.e. competent cells and pGEM® T-vectors carrying the amplicon, received a heat 
shock at 42°C for 45s and were allowed to recover 2min. on ice to reduce damage to the 
competent cells. 250µl of pre-warmed (37°C) SOB medium without antibiotic were added 
to every sample and incubated on a thermomixer (model 5436, Eppendorf, Hamburg, 
Tab. 9: Primers used to identify the methylation of Crhr1 via bisulfite sequencing of 
clones. (corticotropin-releasing hormone receptor 1). 
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Deutschland) for 1h at 37°C with 250rpm. Transfected cells were gently resuspended by 
tapping and 120µl were spread on LB-Lennox plates prepared with blue/white selection 
mix as described before. JM109 cells were grown overnight at 37°C and positive colonies 
were picked about 12-16 hours later. pGEM® T-vector confers resistance to ampicillin to 
the competent cells to enable only growth of those cells, which were successfully 
transfected. The vector also contains a lacZ gene, which enables the JM109 cells to use the 
x-Gal substrate and confers them a blue appearance. If the amplicon was ligated 
successfully into the pGEM® T-vector, the lacZ gene was disrupted and the colonies 
appeared white instead of blue. Since white colonies still might carry no or a wrong insert 
(due to inserted primer dimers, linearized vectors etc.) we performed colony PCR to 
unambiguously identify vectors harboring the desired amplicon. 
Colony PCR and bisulfite sequencing: Thus, white colonies were picked and transferred 
to a non-skirted 96-well plate (Thermofast 96, Thermo Scientific, Illinois, USA) containing 
the following PCR mix per sample: 
Substance Primer sequence 5’- 3’ Volume (µl) 
MgCl2 (25mM)  3 
Taq Buffer with (NH4)2SO4  2,5 
dNTPs (10mM each)   1,5 
T7 primer (4µM) TAA TAC GAC TCA CTA TAG GG 1,5 
SP6 primer (4µM) ATT TAG GTG ACA CTA TAG 1,5 
Taq polymerase 1U/µl  1 
RNAse free H2O  14 
PCR was performed under the following conditions: initial denaturation for 5min at 94°C, 
followed by 5 cycles of denaturation (94°C for 30s), annealing (56°C for 30s) and an 
extension phase (72°C for 45s). Next, we performed 35 cycles of denaturation (94°C for 
30s), annealing (48°C for 30s) and an extension phase (72°C for 45s). Final elongation was 
performed for 10min. at 70°C. For clean-up, samples were transferred to a NucleoFast 96 
PCR plate (Macherey-Nagel, Düren, Germany) and 100µl of RNase-free water was added 
to every sample. Centrifugation was performed at 9°C with 4.500g for 10min. (Heraeus 
Multifuge 4KR, Thermo Fisher Scientific, Waltham, MA). Flow-through was discarded 
and washing step was repeated. Samples were resolved by shaking 10min. on a 
thermomixer with 25µl of RNAse-free H2O. Sequencing reaction was performed by 
adding the following substances to a ThermoFast 96 PCR plate (ABgene, Hamburg, 
Germany): 
Substance Composition Volume (µl) 
sequencing buffer Tris 350mM, pH 8.8 
MgCl2 2.5mM 
1 
Big Dye Terminator v3.1  0.5 
T7 primer (forward) or 
SP6 primer (reverse) 
 1 
sample  2.5 
Big Dye Terminator v3.1 cycle sequencing kit (Life Technologies, Darmstadt, Germany) 
was used to perform PCR under the following conditions: initial denaturation for 1min at 
96°C, followed by 35 cycles of denaturation (96°C for 10s), annealing (50°C for 5s) and an 
extension phase (60°C for 240s). Samples were transferred to a Montage SEQ96 plate 
(Millipore, Billerica, MA) and cleaned-up by washing twice with 20µl of injection solution 
(Millipore, California, USA) via a vacuum pump (Biomek 2000 Laboratory Automation 
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Workstation, Beckman Coulter, Fullerton, CA) for 5 min. Samples were resuspended in 
20µl of RNAse free water by shaking for 10 minutes (Biomek 2000) and sequenced in the 
genome analysis center located within the Helmholtz Center (Neuherberg, Germany). 
Radio immunoassay (RIA): 10µl of blood plasma were used to determine the 
concentration of CORT via a RIA kit from MP Biomedicals (article number 07120103, 
Solon, Ohio, USA) according to the manufacturer’s instructions, except by diluting all 
samples 1:200, basal and reactive samples were diluted 1:13.5 and 1:100, respectively. All 
samples were measured in duplicates. Intra- and inter-assay coefficients were below 10%. 
RIA is based on the competition between 125I-labeled and non-radioactive-labeled CORT 
within the samples for a limited amount of binding sites – the higher the CORT 
concentration in the samples, the fewer binding sites can be bound by the radioactive-
labeled CORT. Secondary antibody was added in excess and unbound antigen was 
decanted after centrifugation. Radioactivity within the precipitate was measured via a 
gamma-counter. 
3.4 Pharmacological manipulation: We used pharmacological treatment to elucidate 
whether the anxiolytic phenotype elicited by EE can be mimicked pharmacologically. To 
achieve this, we used two different approaches: firstly, we used a CRHR1 antagonist 
known as a classical target from psychiatric research and, secondly by injecting drugs 
known to exert epigenetic alterations to reduce anxiety-related and depression like 
behavior. 
CRHR1 antagonist: 24 Male mice were housed under standard conditions in groups of 
three until week 10. Subsequently, animals were transferred next to the testing room and 
habituated for 3d before they were single-housed and randomly assigned either to the 
treatment or vehicle group. Six animals per day underwent surgery by two trained and 
skilled persons, implicating four days of surgery in total (PND 73-76). For this purpose, 
mice were anesthetized for 10s with Forene and quickly fixed into a stereotaxic apparatus 
(Technical & Scientific Equipment GmbH, Bad Homburg, Germany). Anesthesia was 
continued via a self-made face mask supplying the animals with an oxygen/forene mixture. 
In addition, each animal received 0.1ml Metacam (Boehringer Ingelheim Vetmedica 
GmbH, Ingelheim/Rhein, Germany) subcutaneously and additionally 100µl/200ml in 
drinking water to minimize post-surgical pain. Prior to surgery, eyes were covered with a 
thin layer of panthenol eye ointment (Jenapharm, Jena, Germany) to avert searing. Fur on 
the head was removed via an electrical shaver (Wahl GmbH, Unterkirnach, Germany), 
followed by disinfection of the exposed skin (Kodan, Schülke & Mayr GmbH, 
Norderstedt, Germany). Afterwards, fur was transected longitudinally with a scalpel 
starting medial behind the eyes to the beginning of the neck. Incision was kept as short as 
possible, approximately 2-3cm. Bregma and Lambda were visualized via a cotton bud 
soaked with 3% H2O2. Exact coordinates of Bregma were determined using a magnifying 
glass and a guide cannula (Microlance canula 21G, BD Bioscience, Heidelberg, Germany) 
was implanted bilaterally in the BLA (-1.00mm rostral, ±3mm lateral and -4.00mm 
dorsoventral; mouse brain in stereotaxic coordinates 2nd ed., 2001). Holes for implanting 
the two guide cannulas and one screw for stabilizing purposes were drilled via a drephine 
(EWL type 970 K9, Kavo Dental GmbH, Biberach/Riß, Germany). The guide cannulas and 
screw were connected and fixed with multiple layers of dental cement (Kallokryl, Dr. 
Speier GmbH, Münster, Germany). After 5-10min. of hardening, animals were removed 
from the stereotaxic apparatus, transferred back to their home cage and were allowed to 
recover for 4 days. Starting on PND 77, animals were injected three times within a time 
interval of 36h either with 2µl of CRHR1 antagonist (α-helical CRF 9-41, Sigma-Aldrich, 
Hamburg, Germany) or vehicle (ringer solution) bilaterally in the BLA. Therefore, a glass 
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fiber (Polymicro Technologies, Arizona, USA, ID 74µm and OD 154µm), a priori adjusted 
to the length necessary to penetrate the BLA, was inserted into the guide cannula. The 
glass fiber was connected to a tubing (Smiths Medical International Ltd, Haye, USA, ID 
0.28mm and OD 0.61mm) filled with an air bubble at the end to determine the amount of 
delivered liquid. 
PND Time behavioral testing 
77 05:00 p.m. yes 
78 
05:00 a.m. no 
05:00 p.m. yes 
We performed a behavioral battery consisting of OF, EPM and LD to assess anxiety-
related behavior either 40min. after a single or after three injections because total amount 
of antagonist necessary to trigger an effect was unknown. Since both groups, i.e. treatment 
and vehicle were retested, test-retest reliability should not be compromised. After 
behavioral testing, animals were killed as described and correct injection into BLA was 
verified by injecting 1µl of 1% methylene blue B solution (Merck, Darmstadt, Germany) 
into the guide cannula. Mice were excluded from statistical analysis when the distance of 
one or both guide cannulas from BLA deviated ≥0.5mm. 
Application of epigenetic drugs: Accumulating evidence suggests that epigenetics might 
constitute the previously missing link among genetics, environment and disease (Barros 
and Offenbacher, 2009). Per definitionem, it comprises heritable changes of molecular 
factors and processes that regulate genome activity without altering the DNA sequence 
(Skinner et al, 2010) like methylation of CpG dinucleotides and/or covalent modifications 
of histones. As a consequence, genes are silenced via a condensed chromatin structure 
inaccessible for the transcription machinery (Szyf et al, 2008) and these mechanisms allow 
regulation of gene expression by integrating environmental signals in the genome 
(Murgatroyd et al, 2009) - Interindividual differences in epigenetic marks would thus result 
in interindividual phenotypic differences (Szyf et al, 2008). Indeed, distinct profiles of 
histone acetylation and DNA methylation patterns that arise during the lifetime of 
monozygotic twins corroborate that environmental influences account for a substantial 
proportion of the population variance for depression and anxiety (Davis et al, 2009). These 
differences might contribute to some of their phenotypic discordances and the differential 
frequency/onset of common diseases (Barros and Offenbacher, 2009). Moreover, the 
epigenome seems to react to a variety of environmental influences including maternal care 
and responses to environmental stimuli (Szyf et al., 2008) throughout the whole life span 
of an individual: fetal development, the plastic phase of early childhood and with 
increasing evidence in adulthood. Thus, it is of outstanding interest to identify new drugs, 
which alter the pathological epigenetic state of risk genes for psychiatric disorders. Several 
new and already known drugs like valproic acid exhibit their effects via epigenetic 
mechanisms and are tested in clinical trials at the moment. This is true for both, inhibitors 
of histone deacetylase (HDACi) and DNA methyltransferase (DNTMi) (fig. 14). 
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Fig. 15: Time schedule depicting the experimental procedure to assess the effects of 
treatment with epigenetic drugs. 
 
Interestingly, trichostatin A was shown to exert an anxiolytic (Weaver et al., 2006) and 5-
Aza-2’-deoxycytidine an antidepressive (Sales et al., 2011) effect in animal studies. These 
are striking examples of an epigenetic reprogramming to rescue the behavioral phenotype 
of mice. Therefore, we injected our animals intraperitoneally (IP) from PND 28-42 three 
times a week either with valproic acid or 5-Aza-2’-deoxyuridine (both from Sigma-
Aldrich, Hamburg, Germany) to investigate whether i) the behavioral phenotype can be 
shifted from EE to SE or vice versa and ii) whether there is an additive anxiolytic and/or 
antidepressive effect as a combination of concomitant environmental and pharmacological 
manipulation (fig. 15). 
 
 
 
 
Fig. 14: Depicted are epigenetic drugs, which are tested currently in clinical trials. 
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3.5 Statistical analyses 
All data are presented as mean ± SEM and one-, two- or three-way analyses of variance 
(ANOVAs) were used for analysis, followed by either Tukey or Fisher as post-hoc test. 
Repeated measures ANOVA was used to analyze independent groups for which at least 
one parameter was measured repeatedly (e.g. home cage activity). Three independent 
groups were analyzed via Kruskal-Wallis ANOVA (KWA) with Mann-Whitney-U 
(MWU) as post-hoc test followed by Dunn-Šidák correction for multiple testing. When 
testing multiple times, statistical significance will occur by chance in every 20 th test. Thus, 
one has to correct for multiple testing by adjusting the significance level to counteract this 
effect. The Dunn-Šidák method uses the following formula to adjust the significance level: 
       
 
  
Thus, to still reach statistical significance when multiple parameters are tested 
simultaneously, their p-value must be below the new significance level α of: 
number of parameters tested p-value Dunn-Šidák significance level 
1 
0.05 
0.05 
2 0.025 
3 0.017 
4 0.013 
The Dunn-Šidák method should be preferred over Bonferroni correction for multiple 
testing due to the high chance of false negatives for the latter (Abdi, 2007). The following 
table summarizes the used statistical tests: 
 
 
A trend or significance were accepted when p≤0.1 or p≤0.05, respectively. When the 
Dunn-Šidák correction for multiple testing was used, the new significance level is 
explicitly mentioned in the test. For the sake of clarity, significance levels mentioned in the 
text or depicted in graphics are categorized in p≤0.05, p≤0.01 and p≤0.001 and are shown 
as *, ** or *** respectively. 
EE was performed several times to assess different behavioral aspects and to evaluate 
reproducibility and reliability of the obtained data. Meta-analysis was performed by using 
“z-score”, […] “which standardizes observations obtained across experiments and from 
different cohorts, thereby allowing their compilation and/or comparison. Z-scores are 
standardized scores, which indicate how many standard deviations (σ, SD) an observation 
(X) is above or below the mean of a control group (μ)” (Guilloux et al., 2011). 
   
    
 
 
Statistical test Post-hoc test Multiple correction Type of test 
MWU x Dunn-Šidák non-parametric 
KWA MWU Dunn-Šidák non-parametric 
repeated measures 
ANOVA 
Tukey or Fisher x parametric 
2/3-way ANOVA Tukey or Fisher x parametric 
χ²-test x x sample 
distribution 
Z-score 2/3-way ANOVA x parametric 
Tab. 10: Summary of statistical tests performed to assess statistical significance.  
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Mouse behavior is multimodal, changes rapidly between emotional states (Ramos et al., 
2008) and can only be fully quantified by utilizing multiple behavioral tests covering a 
wide range of behaviors on several days (Crawley et al., 1997; Crawley and Paylor, 1997). 
Z-scores allow the integration of several parameters per test, like percent time spent in 
center (TC), distance travelled in the center (DC), latency to enter center (LCe), total 
entries light center (EC) and total distance travelled (TD): 
            
(  
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 )   (  
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Moreover, it is possible to generate a final score averaging the observed effect sizes of 
multiple tests (e.g.: OF, EPM, LD, SIH etc.): 
              
                         
               
 
The directionality of z-scores was adjusted so that a decrease reflects an anxiolytic and an 
increase an anxiogenic effect, respectively. Importantly, psychiatric disorders like 
depression are diagnosed by a set of variable symptoms (4-5 out of 10) over an extended 
time period since changes of emotionality can manifest via different aspects over time 
(Guilloux et al., 2011). Thus, a method like z-score, taking advantage of several parameters 
per test and multiple tests reflects the human situation indeed in a more realistic fashion. Z-
scores are more resistant to fluctuating behavior (“behavioral noise”) by testing whether an 
experimental group deviates from mean behaviors in converging directions across tests and 
time. Z-scores were calculated for parameters assessing emotionality and locomotor 
activity, thereby eliminating the latter as confounding factor (for a review see Guilloux et 
al., 2011). 
We used a 2x3 contingency table to perform a χ² goodness of fit test to evaluate whether 
the sample distribution of effect sizes was shifted after EE. This test is used when data are 
present as mutually exclusive categorical variables and utilizes observed versus expected 
frequencies. Thereby, Cramers V is used as a measure of effect size: 
Effect size Cramers V 
small V<0.1 
medium 0.1≤V≤0.5 
high V≥1.0 
Murine gene symbols and the respective mRNA are written in italicized letters with the 
first letter in capital. Murine peptides and proteins are held in non-italicized capital letters. 
As human and murine, genes, proteins and peptides apply to the same script conventions, 
the associated organism is explicitly mentioned in the respective text. The symbols and 
gene definitions are based on the information provided by the Mouse Genome Database 
(MGD, Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, ME. World 
Wide Web URL: http://www.informatics.jax.org; September, 2012) and are subject to 
change. 
All data are presented as bar plots with male HAB mice being displayed as red and female 
HAB as pink bars. Male and female NAB and CD1 are depicted as dark and light green 
and grey bars, respectively. Male and female LABs are shown in dark and light blue. In 
addition, bars of EE animals are hatched, bricks were used for non-responders (NRs) and 
bars of animals tested for transgenerational inheritance (EESE) are dotted. P-values in 
tables highlighted in red or blue indicate significance or a trend, respectively. All data were 
analyzed via Statistica 8 (Statsoft, Hamburg, Germany). 
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Fig. 16: EE exhibits an anxiolytic effect indicated by an increased distance travelled in the 
inner zone for both sexes (A), whereas only males entered more often into it. N (males) = 
21 (SE, EE); N (females) = 21 SE and 20 EE  
4. Results 
4.1.1. Effect of EE on anxiety-related behavior 
EE exhibits significant anxiolytic effects in a mouse model with a rigid genetic 
predisposition resembling pathological anxiety and comorbid depression. 
We performed OF, EPM, LD and SIH to assess as many aspects of anxiety-related 
behavior as possible. All results and effects presented in this section are representative for 
the beneficial effects of EE and originate from multiple experiments since the variety of 
tests was never performed in a single experiment. 
We observed significant anxiolytic effects of housing on percent time spent in the center 
(F(1,79) = 17.43; p≤0.05), percent distance travelled in the center (F(1,79) = 17.48; p≤0.001) 
and total entries into center (F(1,79) = 15.36; p≤0.001) without effects of sex or interaction 
of housing x sex. No effects were seen for latency to enter the inner zone and importantly, 
total distance travelled was not different between EE and SE mice, thus excluding 
locomotion as a masking factor for the observed anxiolytic effects:  
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
total distance travelled 0.321 0.802 0.233 
latency to enter inner zone 0.844 0.250 0.729 
percent time spent in inner zone 0.025 0.350 0.385 
percent distance travelled in inner zone ≤0.001 0.741 0.743 
total entries inner zone ≤0.001 0.409 0.495 
Tukey post-hoc tests revealed that EE significantly increased percent distance travelled in 
the inner zone for both, males (p≤0.01) and females (p≤0.01) and total entries inner zone 
for males (p≤0.01), whereas females were close to a trend (p = 0.011). Significance of 
percent time spent in inner zone did not survive post-hoc testing with Tukey (fig. 16)  
To assess the overall anxiolytic effect of EE on anxiety-related behavior in the OF, we 
calculated “Z-open field” (fig. 17) by normalizing all measured parameters to z-scores and 
dividing them by the number of parameters. A 2-way ANOVA (F(1,79) =  15.13; P≤0.001) 
followed by a Fisher post-hoc test revealed that EE significantly reduced anxiety in males 
(p≤0.01) and females (p≤0.05) by 0.78 SDs and 0.56 SDs below the mean of standard 
housed mice, respectively. 
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The beneficial effect of EE observed in the OF is corroborated by an anxiolytic effect in 
the EPM. There is a significant effect of housing on percent time spent on the open arms 
(F(1,66) = 19.17; p≤0.001) and significant effects of sex and housing x sex for percent 
entries into open arms (F(1,66) = 15.36; p≤0.001) without a difference for total distance 
travelled (F(1,66) = 0.758; p=0.387). 
Parameter measured 
P-value for main effect of: 
Housing Sex Housing x sex 
total distance travelled 0.387 0.720 0.685 
percent time spent on open arms ≤0.001 0.450 0.830 
percent entries into open arms 0.612 ≤0.001 0.001 
Tukey post-hoc tests offered that EE increases the percent time spent on open arms for 
both sexes (p≤0.05), in contrast to percent entries into open arms whereat only EE females 
showed a strong trend to enter the open arms more often (p=0.058) but not males 
(p=0.158) (fig. 18). 
 
Fig. 17: Z-open field reveals a strong anxiolytic effect of EE for males and females 
suggested by a decrease of 0.78 SDs and 0.56 SDS below the mean of respective 
controls. N (males) = 21 SE and EE; N (females) = 21 SE and 20 EE 
 
Fig. 18: EE significantly increases “percent time spent on open arms” for both sexes 
(A), while only EE females offer a trend towards entering the open arms more often (B). 
N (males) = 21 SE and EE; N (females) = 21 SE and 20 EE  
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2-way ANOVA for Z-elevated plus maze reveals a strong overall anxiolytic effect of EE 
(F(1,66) = 19.17; p≤0.001), confirmed by Tukey post-hoc test for males (p≤0.001) and 
females (p≤0.001). Males and females exhibit an overall reduction of 0.87 and 0.85 
standard deviations from the mean compared to their standard housed controls (fig. 19).
 
Like OF and EPM, LD uncovers an anxiolytic effect of EE indicated by an effect of 
housing and a trend of sex on percent time spent in the light compartment (F(1,79) = 12.04; 
p≤0.001 and F(1,79) = 19.17; p=0.097, respectively) and effects of housing on percent 
distance travelled in the light compartment (F(1,79) = 27.93; p≤0.001), latency to enter the 
light compartment (F(1,79) = 7.494; p≤0.01) and total entries into light compartment (F(1,79) 
= 7.764; p≤0.01). Again, total distance travelled was not significantly different between EE 
and SE housed animals (F(1,79) = 0.223; p=0.638). 
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
total distance travelled 0.638 0.157 0.315 
latency to enter light compartment 0.008 0.604 0.826 
percent time spent in light compartment 0.001 0.097 0.294 
percent distance travelled in light compartment ≤0.001 0.222 0.927 
total entries in light compartment  0.007 0.165 0.343 
 
As revealed by Tukey post-hoc tests, EE significantly increases percent time spent in light 
compartment for females (p≤0.05) but not males (p=0.322), percent distance travelled in 
light compartment for both sexes (p≤0.01) and total entries in light compartment for 
females (p≤0.05) without affecting males (p=0.563). Significance of latency to enter the 
light compartment did not survive post-hoc testing.  Z-score for LD (F(1,79) = 10.17; 
p≤0.01) confirms the anxiolytic effect by Fisher post-hoc test for females (p≤0.01) and 
with a trend for males (p=0.084) with 0.76 and 0.48 standard deviations below the mean of 
SE mice, respectively (fig. 20). 
Fig. 19: Z-elevated plus maze reveals an anxiolytic effect of EE for both sexes by a 
reduction of 0.87SDs and 08.85SDs for males and females, respectively below the mean 
of SE controls. N (males) = 21 SE and EE; N (females) = 21 SE and 20 EE  
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We performed SIH to assess whether the SAM-system is involved in the beneficial effects 
elicited by EE. A significant reduction of temperature increase, tantamount to an anxiolytic 
effect, was revealed for EE mice by a 2-way ANOVA (F(1,68) = 11.51; p≤0.001). A 3-way 
ANOVA identified the following factors and the combination thereof as related to 
differences in basal and stress body temperature (F(1,136) = 14.05; p≤0.001). 
Factors P-value for main effect: 
housing ≤0.001 
time (basal or stress) ≤0.001 
sex ≤0.001 
housing x time 0.011 
housing x sex 0.149 
time x sex 0.028 
housing x time x sex 0.356 
Tukey post-hoc tests show a significant lower increase of body temperature after stress for 
males (p≤0.01) and a trend for females (p=0.10) (fig. 21a). We observe no significant 
differences of body temperature after stress for both sexes (p=0.993 for males; p=0.999 for 
females) and no difference concerning basal temperature between EE and SE females 
(p=0.401). Only EE males exhibit an increased basal body temperature compared to SE 
mice (p≤0.01) (fig. 21b). Stress significantly increased body temperature for both housing 
conditions and sexes (p≤0.001 for all). 
Fig. 20: EE increases entries (A) and percent time in light compartment (B) for females, 
while increasing percent distance light compartment (C) and decreasing z-score (D) for 
both sexes, clearly indicating an anxiolytic effect. N (males) = 21 SE and EE; N (females) 
= 21 SE and 20 EE  
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To evaluate the overall anxiolytic effect of EE, we averaged the z-scores from OF, EPM. 
LD and SIH. In more detail, we calculated the z-scores for the parameters measured in a 
respective test (e.g. EPM: percent time and entries open into arms, total distance travelled), 
and averaged these z-scores (fig. 22) to obtain a parameter denoted as “emotionality 
score”. 
 
 
Fig. 21: EE causes a significantly smaller temperature increase after a stressor for males 
and shows a trend for females (A) - This indicates an anxiolytic effect. Merely EE 
males show a higher basal body temperature compared to their SE controls. N (males) = 
21 SE and EE; N (females) = 21 SE and 20 EE  
 
Fig. 22: Emotionality score is an average of the z-scores from open-field, elevated plus 
maze, light-dark box and stress-induced hyperthermia test. It represents a possibility to 
assess the overall effect of enriched environment on anxiety-related behavior. 
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Emotionality score reveals a robust anxiolytic effects of EE (F(1,79) = 37.29; p≤0.001). Even 
after taking all measured parameters into account (including the ones, which are not 
significantly different), males show a reduction of 0.61 and females of 0.56 standard 
deviations below the mean of their SE housed controls (fig. 23; p≤0.001 for both). 
Importantly, all z scores used to generate the emotionality score were obtained from 
behavioral tests performed during a single experiment. 
4.1.2. Effects of EE on exploratory behavior and locomotion 
Enriched environment increases exploration independent of locomotion. Instead, 
home cage activity is slightly decreased compared to SE housed controls. 
To assess exploration independent of locomotion, we performed the EP test. Indeed, EE 
increased the number of head dips as indicated by an effect of housing (F(1,79) = 19.74; 
p≤0.001). EE Males (p≤0.05) and females (p≤0.01) performed head dips more often 
compared to SE controls as demonstrated via Tukey’s post-hoc test (fig. 24).  
Factors P-value for main effect: 
housing ≤0.001 
sex 0.761 
housing x sex 0.891 
 
Due to the absence of freezing behavior, we couldn’t assess anxiety-related behavior. 
 
Fig. 23: Anxiety-related behavior is significantly reduced by EE. Emotionality score of 
males and females is 0.61 and 0.56 standard deviations below the mean of the 
respective housed SE mice. N (males) = 21 SE and EE; N (females) = 21 SE and 20 EE  
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To assess further aspects of exploratory behavior, we counted number of rearings 
performed during OF. Our data corroborate an increased exploratory behavior for EE mice 
in relation to their SE housed counterparts seen as an effect of housing (F(1,79) = 7.75; 
p≤0.01). 
Factors P-value for main effect: 
housing 0.007 
sex 0.953 
housing x sex 0.764 
Fisher’s post-hoc test revealed a significantly higher number of rearings for females 
(p≤0.05) and a trend for males (p=0.081) (fig. 25). 
 
 
Fig. 24: Exploratory behavior significantly increased for both sexes, indicated by a 
higher number of head dips of EE animals compared to SE mice. N (males) = 21 SE and 
EE; N (females) = 21 SE and 20 EE  
 
Fig. 25: As shown for EP, OF points towards an increased exploratory behavior for EE 
compared to SE animals. N (males) = 21 SE and EE; N (females) = 21 SE and 20 EE  
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Finally, we counted rearings performed during LD test. 2-way ANOVA revealed no 
significant difference between EE and SE mice. Neither housing (F(1,79) = 0.03; p=0.957) 
or sex (F(1,79) = 1.08; p=0.302), nor an interaction of housing x sex (F(1,79) = 0.001.; 
p=0.982) were significantly different between the groups. 
To evaluate the overall effect of EE on exploration, we calculated an “exploration score” 
(fig. 26) by averaging the z-scores from EP, OF and LD (same procedure as for 
emotionality score). This included the parameters head dips performed during EP, rearings 
performed during OF and “rearings performed during LD”. Indeed, EE increases 
exploratory behavior as shown by an effect of housing (F(1,79) = 14.379; p≤0.001). 
Factors P-value for main effect: 
housing ≤0.001 
sex 0.338 
housing x sex 0.338 
Fisher post-hoc tests revealed a significant increase of exploratory behavior for males 
(p≤0.05) and females (p≤0.01) with 0.80 and 1.35 SDs above the mean of SE controls (fig. 
26). 
 
Locomotion is a cross-test dimension of anxiety and thus, we analyzed locomotor activity 
during behavioral tests including OF, EPM, LD and in a more natural-like situation, 
namely HCA. There was no significant effect of housing in any of the behavioral tests: 
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
open field 0.321 0.802 0.233 
elevated plus maze 0.387 0.720 0.685 
light-dark box 0.638 0.157 0.315 
 
Fig. 26: EE indeed increases exploration for both sexes significantly compared to SE 
housed animals. N (males) = 21 SE and EE; N (females) = 21 SE and 20 EE  
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Activity, including locomotion can be very different between an artificial test situation and 
within the home cage. Repeated measures ANOVA revealed no difference in activity for 
males (F(1,16) = 0.317; p=0.581) and a trend indicating lower activity for females (F(1,16) = 
4.23; p=0.057) (fig. 27). 
home cage activity 
p-value for main effect of: 
housing time housing x time 
males 0.581 ≤0.001 ≤0.001 
females 0.057 ≤0.001 ≤0.001 
 
 
 
Fig. 27: EE does not increase activity, instead a trend for females indicates even less 
activity compared to standard controls. Black bars indicate dark phases. N (males) = 21 
SE and EE; N (females) = 21 SE and 20 EE 
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There was a significant effect of time for both sexes, showing higher activity during the 
dark compared to the light phase (F(1,16) = 13.028; p≤0.001 for males and F(1,16) = 12.510.; 
p≤0.001 for females). The significant interaction of housing x time points towards a lower 
activity for both, EE males (F(1,16) = 2.802; p≤0.001) and females (F(1,16) = 4.221; p≤0.001) 
in relation to SE mice. 
In summary, we observed no differences concerning locomotor activity in behavioral tests 
and a significantly decreased activity in the home cage for EE animals. 
4.1.3. Effects of EE on coping style and stress reactivity 
EE does not alter coping style but stress reactivity in a mouse model of pathological 
anxiety and comorbid depression. 
There was a significant effect of housing on latency to first immobile episode (F(1,71) = 
22.134; p≤0.001), but no effects of housing, sex or an interaction of housing x sex on 
percent time spent immobile and number of immobile episodes.  
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
latency to first immobile episode ≤0.001 0.273 0.163 
number of immobile episodes 0.660 0.510 0.190 
percent time spent immobile 0.166 0.755 0.223 
Tukey’s post-hoc confirmed a significant short latency for EE females (p≤0.001) and a 
trend for males (p=0.091) compared to their respective controls (fig. 28). 
 
 
FST was performed only for males. A MWU test revealed a significant decrease for EE 
males in latency to first struggling episode, which did not survive Dunn-Šidák correction 
for multiple testing (α=0.017). 
 
Fig. 28: Latency to first immobile episode during TST is significantly reduced for 
females after EE, with males showing a trend. N (males) = 21 SE and EE; N (females) = 
21 SE and 20 EE 
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To assess stress reactivity, we performed a SRT for male HABs with either a mild (15min. 
immobilization) or severe stressor (6min. FST; please refer to material and methods). 
Indeed, we found a significant effect of housing (F(1,54) = 5.996; p≤0.05), time (basal or 
stress; F(1,54) = 643.722; p≤0.001) and paradigm (mild or severe; F(1,54) = 58.472; p≤0.001) 
as well as an interaction of housing x time (F(1,54) = 6.974; p≤0.05) and time x paradigm 
(F(1,54) = 64.699; p≤0.001). Tukey post-hoc tests reveal a significant increase of CORT 
after application of a stressor for both paradigms (p≤0.001 for all). EE males show a strong 
trend to release less CORT after a mild stressor (p=0.063). Moreover, EE males that 
performed the mild paradigm show a significant reduction (p≤0.01) of CORT release when 
we do not compare the mild and severe paradigm (i.e. experiments) but every experiment 
separately (fig. 29). 
 
 
Moreover, we observe that the HPA-axis reactivity of EE males in intact. When a severe 
stressor is applied, the protecting neuroendocrine effect of EE disappears and CORT levels 
are indistinguishable between EE and SE males. This indicates that the significant 
reduction of CORT release after a mild stressor in EE males is not due to ceiling effects. 
4.2 Variability and reproducibility of EE: a meta-analysis of beneficial effects  
4.2.1. Meta-analysis of anxiolytic effects 
The anxiolytic effect on a mouse model of pathological anxiety is stable, reproducible 
and exhibits a small to strong effect size. 
Meta-analysis of anxiety-related behavior was performed by averaging the emotionality 
scores of all conducted experiments. Thus, we averaged the z-scores of OF, EPM and LD 
for every experiment to obtain the respective emotionality score. These emotionality scores 
were then averaged to receive a “final emotional score” comprising the effect sizes of all 
performed experiments. In total, 4 experiments for males and 3 experiments for females 
were conducted (fig. 30). 
Fig. 29: EE significantly reduces the released CORT after application of a mild stressor. 
N (mild) = 6 SE and 10 EE; N (severe) = 7 SE and EE  
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Z-score of LD test from female experiment 3 and OF from male experiment 4 were 
excluded from emotionality score and thus from meta-analysis because merely few SE 
mice entered the light or inner zone at all, thereby creating a standard deviation (σ) close to 
zero and finally a z-score ≥10, which is much higher in relation to all other conducted 
experiments (   
   
 
). 
Meta-analysis revealed an effect of housing (F(1,125) = 86.23; p≤0.001), sex (F(1,125) = 12.27; 
p≤0.001) and an interaction effect of housing x sex (F(1,125) = 13.37; p≤0.001). Tukey’s 
post-hoc test showed that EE significantly reduced anxiety-related behavior for males 
(p≤0.001) and females (p≤0.001) by 1.04 and 0.44 SDs below the mean of respective 
standard housed controls (fig. 31). 
 
Fig. 30: Workflow to obtain a “final emotionality score”. This meta-analysis allows an 
overall assessment of EE on anxiety-related behavior. 
Fig. 31: Overall assessment of anxiolysis by emotionality score reveals a strong and 
small effect size for males and females, respectively. N (males) = 61 SE and 68 EE; N 
(females) = 48 SE and 52 EE  
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Guilloux (2011) proposed the following ranges for observed effect sizes: 
effect size strength 
≤0.5 small 
0.5 - 1.0 medium 
≥1.0 strong 
Thus, we performed a χ²-test with a 2x3 factorial design: 2 housing conditions (SE or EE) 
and 3 effect sizes (small, medium and strong). It revealed a significantly increased number 
of EE animals showing a medium or strong effect size compared to standard housed 
controls. This is true for both sexes (p≤0.001) with EE males showing an even more 
skewed distribution to a higher effect size compared to EE females (p≤0.001). 
Interestingly, we observed no difference between SE males and females (p=0.209). 
comparison χ² degree of freedom p-value Cramer’s V 
male SE vs. EE 58.36 2 p≤0.001 0.5402 
female SE vs. EE 15.17 2 p≤0.001 0.2754 
male vs. female EE 30.15 2 p≤0.001 0.3883 
male vs. female. SE 3.13 2 p=0.2091 0.1251 
Fig. 32 depicts a significant decrease of small as well as a significant increase of strong 
effect size for both sexes reflecting an anxiolytic effect. Here, the distribution of males is 
almost exclusively shifted from a small to strong effect size, whereas effect size of females 
is shifted to equal parts from small to medium and strong. 
 
 
To interpret the strength of the anxiolytic effect elicited by EE we used Cramer’s V. It is a 
Fig. 32: EE causes a shift in effect size, which reflects an anxiolytic effect. It is shifted 
from small to strong for males, whereas for females, effect size is shifted from small to 
medium and strong. N (males) = 61 SE and 68 EE; N (females) = 48 SE and 52 EE  
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Fig. 34: EE increases locomotion by 0.42 and 0.23 SDs for males and females compared 
to respective controls. N (males) = 61 SE and 68 EE; N (females) = 48 SE and 52 EE  
 
contingency coefficient, independent of sample size, which expresses the strength of an 
observed effect. It ranges from 0 ≤ x ≤ 1, whereat 1 is the highest effect size possible. It 
reveals a strong effect for EE compared to SE males (0.54), in contrast to females, which 
offer a medium effect strength (0.28) corroborating a stronger anxiolytic effect for males in 
relation to females. 
4.2.2. Meta-analysis of locomotion 
Enrichment does not alter locomotion of females, whereas merely a trend was 
observed for males. This indicates that locomotion, a cross test parameter of anxiety, 
is not masking the observed anxiolytic effects elicited by EE. 
To evaluate the effect of locomotion on anxiety-related behavior, we averaged the z-scores 
of “total distance travelled in OF” for all performed experiments, i.e. 4 for males and 3 for 
females. This parameter is the most intensively used index of assessing confounding 
locomotor effects (fig. 33). 
 
2-way ANOVA (fig. 34) revealed a significant effect of housing (F(1,222) = 2.080; p≤0.05), 
which did not survive significance after a Tukey post-hoc test for females (p=0.785) and 
showed a trend for males (p=0.070). 
  
Fig. 33: We observe a trend for EE males to travel more distance compared to controls, 
which exhibit an increase of 0.42 standard deviations above the mean of SE animals. 
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4.2.3 Meta-analysis of coping style 
Enrichment does not improve depression-like behavior or alter coping style, 
respectively. 
To assess the overall effect of EE on coping style, we averaged the z-scores from TST and 
FST to obtain a “depression score” (fig.  35) comprising nine parameters in total: latency to 
first immobile episode, number of immobile episodes and percent time spent immobile for 
both, TST and FST, as well as number of struggling episodes, latency to first struggling 
and percent time struggling for FST. There was a significant effect of housing on 
depression score (F(1,71) = 6.697; p≤0.05), without an effect of sex (F(1,71) = 1.23; p=0.269) 
or an interaction effect of housing x sex (F(1,71) = 1.23; p=0.269). Fig. 34. shows that the 
significant effect of housing did not survive Tukey’s post-hoc test for males (p=0.840) and 
females (p=0.145), respectively. 
factors p-value for main effect: 
housing ≤0.05 
sex 0.146 
housing  x sex 0.146 
 
Males showed a reduction of 0.24 and females of 0.05 SDs below the mean of controls 
indicating a small effect size. 
4.3 Impact of enrichment on “normal” anxiety-related behavior animals 
4.3.1. Effects of enrichment on anxiety-related behavior 
Anxiety-related behavior is significantly reduced in males with minor effects in 
females entailing a small effect size for NABs compared to HABs. 
To assess anxiety-related behavior, we performed OF, EPM and LD. For OF, 2-way 
ANOVA reveals a significant effect of housing on total distance travelled (F(1,35) = 17.424; 
Fig. 35: Enrichment does not ameliorate depression-like behavior or alter coping style, 
respectively. N (males) = 47 SE and 44 EE; N (females) = 32 SE and 30 EE  
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p≤0.001), latency to enter inner zone (F(1, 35) = 7.387; p≤0.01), percent time spent in inner 
zone (F(1, 35) = 6.097; p≤0.05), percent distance travelled in inner zone (F(1, 35) = 6.333; 
p≤0.05) and total entries inner zone (F(1, 35) = 11.584; p≤0.01) without an effect of sex or an 
interaction of housing x sex. 
parameter measured 
p-value for main effect of: 
housing sex housing x sex 
total distance travelled ≤0.001 0.592 0.833 
latency to enter inner zone 0.010 0.723 0.904 
percent time spent in inner zone 0.019 0.271 0.623 
percent distance travelled in inner zone 0.017 0.240 0.484 
total entries inner zone 0.002 0.481 0.696 
Fisher post-hoc tests reveal for males a significant increase in percent distance travelled 
and percent time spent in inner zone as well as shorter latency to enter (p≤0.05 for all) and 
“more entries” (p≤0.01) into it (fig. 36). EE Females merely show a trend (p=0.10) to enter 
the inner zone with a shorter latency in relation to SE controls. These parameters indicate a 
significant anxiolytic effect for males but not females. 
To assess the overall anxiolytic effect of EE, we calculated z-open field exactly as 
described before for HAB mice. 2-way ANOVA shows a significant effect of housing (F(1, 
35) = 4.484; p≤0.05) without effects of sex or an interaction of both. 
 
 
Fig. 36: OF points towards an anxiolytic effect of EE for males but not females with 
significant increases in percent distance travelled (A) and percent time spent inner zone 
(B), total entries into (C) and a reduced “latency to enter inner zone” (D). N (males) = 
12 SE and 11 EE; N (females) = 8 SE and EE  
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Factors P-value for main effect: 
housing 0.041 
sex 0.427 
housing x sex 0.427 
Fisher post-hoc test confirmed a significant anxiolytic effect for males (p≤0.05) but not 
females (p=0.398) with 0.53 and 0.24 SDs below SE housed controls (fig. 37). 
  
Importantly, we still observe an anxiolytic effect though z-open field corrects for existing 
differences in total distance travelled, thereby excluding confounding effects of locomotion 
on anxiety-related behavior. 
For EPM, 2-way ANOVA detected a trend of housing (p=0.076) with EE animals entering 
percent open arms more often compared to controls. This trend did not survive Fisher post-
hoc test for males (p=0.258) and females (p=0.161). There is neither an effect of housing, 
sex or interaction of both for percent time spent on open arms, nor total distance travelled. 
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
total distance travelled 0.811 0.402 0.741 
percent entries open arms 0.076 0.871 0.712 
percent time spent on open arms 0.115 0.957 0.533 
As expected, there is no overall effect of housing (F(1, 35) = 0.01; p=0.115), sex (F(1, 35) = 
0.444; p=0.511) or housing x sex (F(1, 35) = 0.444; p=0.511) on z-EPM indicating no 
anxiolytic effect of enrichment captured by parameters of this behavioral test (fig. 38). EE 
males are 0.1 SDs above, whereas females are 0.03 SDs below their respective SE controls. 
Fig. 37: Z-open field corroborates the anxiolytic effect of enrichment for males without 
decreasing anxiety-related behavior for females. N (males) = 12 SE and 11 EE; N 
(females) = 8 SE and EE  
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LD corroborates the anxiolytic effect of OF by an effect of housing on percent time spent 
in light compartment (F(1, 35) = 34.75; p≤0.001) and entries into light compartment (F(1, 35) = 
7.842; p≤0.01) as well as a trend for percent distance travelled in light compartment (F(1, 35) 
= 3.722; p=0.062) and total distance travelled (F(1, 35) = 3.726; p=0.062). 
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
total distance travelled 0.062 0.084 0.356 
latency to enter light compartment 0.841 ≤0.001 ≤0.001 
entries into light compartment 0.008 0.304 0.279 
percent distance travelled in light compartment 0.062 0.122 0.059 
percent time spent in light compartment ≤0.001 0.356 0.020 
Fisher post-hoc tests reveal a significant increase in percent time spent in light 
compartment for both, EE males (p≤0.01) and females (p≤0.001) as well as decreased 
latency to enter the light compartment for both sexes (p≤0.01 and p≤0.05 for males and 
females, respectively). Enriched compared to standard housed females performed 
significantly more entries into the light compartment and travelled more percent distance in 
the light compartment (p≤0.05 for both), whereas males do not exhibit a difference for both 
(p=0.193 and p=0.988, respectively) (fig. 39). 
Fig. 38: Z-elevated plus maze depicts no difference between enriched and standard 
housed mice. N (males) = 12 SE and 11 EE; N (females) = 8 SE and EE  
 
 
71 
 
To evaluate the overall anxiolytic effect of enrichment, we calculated the “emotionality 
score”, as described earlier, by averaging z-scores of OF, EPM and LD. 2-way ANOVA 
revealed a trend of housing (F(1, 36) = 3.726; p≤0.05), indeed confirming an anxiolytic effect 
of enrichment for “normal” anxiety-related mice, too. 
Factors P-value for main effect: 
housing 0.062 
sex 0.084 
housing x sex 0.356 
Tukey post-hoc revealed a significant anxiolytic effect of enrichment by 0.38 SDs below 
the mean of SE males (p≤0.05). Females do not differ significantly, but EE mice are 0.16 
SDs below the mean of their controls (fig. 40). 
Fig. 39: EE reduces anxiety-related behavior significantly for males with females 
exhibiting an ever stronger anxiolytic effect compared to males. Enrichment reduces 
latency to enter light compartment (A) and increases entries (B), percent time (C) and 
percent distance travelled (D) into light compartment. N (males) = 12 SE and 11 EE; N 
(females) = 8 SE and EE 
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To analyze whether the distribution is shifted towards a medium or strong effect size, we 
performed a χ²-test with a 2x3 factorial design as described before. Indeed, males show a 
shift of effect size, i.e. an anxiolytic effect, from a small to a medium effect size (χ² = 
19.17; p≤0.001). Thus, effect size of enriched males is shifted by 25% from small to 
medium. 
Comparison χ² Degree of freedom P-value Cramer’s V 
male SE vs. EE 19.17 2 p≤0.001 0.3096 
female SE vs. EE 0 2 p=1.000 0 
male vs. female EE 12.65 2 p=0.002 0.2515 
male vs. female. SE 0.89 2 p=0.641 0.0667 
Cramer’s V indicates a medium effect size for EE in relation to SE males. Standard housed 
groups do not differ significantly, whereas EE males in contrast to females show an 
anxiolytic effect (fig. 41). 
 
Fig. 40: An anxiolytic effect for males, not females seems to be elicited by EE. N 
(males) = 12 SE and 11 EE; N (females) = 8 SE and EE 
Fig. 41: Male NABs show an anxiolytic effect after EE depicted as a shift of effect size 
from small to medium. N (males) = 12 SE and 11 EE; N (females) = 8 SE and EE 
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Similar to HABs, the overall anxiolytic effect of NABs seems to be more pronounced for 
enriched-housed males compared to females. This entails that EE in relation to SE females 
do not differ significantly anymore and the shift of effect size observed for male EE NABs 
is medium in contrast to a high shift seen merely for male EE HABs. 
4.4.2. Impact of EE on exploratory behavior 
Enrichment increases exploratory behavior as indicated by a significantly increased 
number of rearings. 
Differences in exploration might entail altered locomotion, which in turn is a confounding 
factor of anxiety. Thus, we counted rearings performed during OF and LD to assess the 
impact of exploration on locomotion and thus anxiety-related behavior. We do not observe 
a significant effect of housing (F(1, 35) = 2.679; p=0.111), sex (F(1, 35) = 1.176; p=0.286) or 
an interaction of housing x sex (F(1, 35) = 0.184; p=0.670) on rearings performed during OF. 
In contrast, 2-way ANOVA reveals a significant effect of housing (F(1, 35) = 16.137; 
p≤0.001) for LD, with EE mice performing significantly more rearings. 
Factors P-value for main effect: 
housing ≤0.001 
sex 0.127 
housing x sex 0.867 
 
 
Fisher post-hoc test confirmed an increased number of rearings for males and females (fig. 
42; p≤0.01 for both). To finally assess the effect of EE on exploration, we calculated 
“exploratory score” as described before for HABs by averaging z-scores of rearings for OF 
and LD. 2-way ANOVA revealed a significant effect of housing (F(1, 36) = 13.675; p≤0.001) 
without effects of sex or an interaction of both factors. 
Factors P-value for main effect: 
housing ≤0.001 
sex 0.648 
housing x sex 0.766 
Fig. 42: Exploratory behavior is significantly increased for both sexes after 
environmental enrichment. N (males) = 12 SE and 11 EE; N (females) = 8 SE and EE 
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Tukey post-hoc tests corroborated a significant increase in rearings for enriched-housed 
males (p≤0.05) and a trend for females (p=0.065) compared to controls. Males and females 
were 0.82 and 1.01 SDs above the mean of their respective standard-housed counterparts 
(fig. 43), therewith pointing toward an increased exploratory behavior after EE. 
 
4.3.3 Effect of environmental enrichment on coping style and anhedonia 
EE does not alter coping style in NABs. 
We performed TST to evaluate the impact of EE on coping style or depression-like 
behavior, respectively. We observe a trend of housing (F(1, 34) = 4.089; p=0.051), but no 
significant effect of sex (F(1, 34) = 1.718; p=0.199) or housing x sex (F(1, 34) = 0.377; 
p=0.544) on latency to first immobile episode. This trend does not survive Fisher post-hoc 
test for both sexes (p=0.251 and p=0.108 for males and females, respectively). Thus, EE 
does not ameliorate depression-like behavior or alter coping style, respectively (fig. 44). 
  
 
Fig. 43: Exploratory score confirms an increased exploration for both sexes, with males 
performing 0.82 and females 1.01 SDs more rearings related to respective controls. N 
(males) = 12 SE and 11 EE; N (females) = 8 SE and EE 
Fig. 44: Coping style is not significantly altered when NABs were housed in an EE (B). 
N (males) = 12 SE and EE; N (females) = 6 SE and 8 EE 
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4.4 Impact of environmental enrichment on anxiety-related behavior of outbred CD1 
mice. 
EE does not cause anxiolysis in “normal” anxiety-related, genetically heterogeneous 
CD1 mice. 
We performed OF, EPM and LD to evaluate whether enrichment causes an anxiolytic 
effect in outbred CD1 mice: 
Test Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
OF 
 
total distance travelled 0.849 0.631 0.389 
latency to enter inner zone 0.996 0.130 0.624 
total entries inner zone 0.114 0.343 0.367 
percent time spent in inner zone 0.081 0.222 0.195 
percent distance travelled in inner zone 0.185 0.082 0.207 
EPM 
total distance travelled 0.176 0.828 0.383 
percent time spent on open arms 0.933 0.039 0.683 
percent entries in open arms 0.312 0.306 0.202 
LD 
total distance travelled 0.559 0.214 0.003 
percent distance travelled in light compartment 0.863 0.627 0.005 
percent time spent in light compartment 0.739 0.289 0.009 
We observe a trend of housing to spent more percent time in the inner zone in the OF (F(1, 
30) = 3.272; p=0.081). Fisher post-hoc tests reveal a significant difference for females 
(p≤0.05) but not males (p=0.737) for percent time spent in the inner zone indicating a 
minor anxiolytic effect (fig. 45). 
In all other parameters measured during OF, EPM and LD, we do not see an effect of 
housing. Fisher post-hoc tests reveal a significant difference or trend for the following 
parameters measured during LD (fig. 46): total distance travelled for males (p=0.067) and 
females (p≤0.05), percent time spent in light compartment for males (p≤0.05) and females 
(p=0.096) and percent distance travelled in light compartment for males (p≤0.05) and 
females (p=0.052). 
Fig. 45: Latency to enter the inner zone is significantly decreased for females. N (males) 
= 6 SE and 9 EE; N (females) = 5 SE and 14 EE 
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To evaluate the anxiolytic effect of OF and anxiogenic effect of LD, we calculated the 
“emotionality score” to assess the overall impact of EE on CD1 mice. Therefore, we 
averaged the z-scores of OF, EPM and LD. 2-way ANOVA shows no significant effect of 
housing on anxiety-related behavior (F(1, 37) = 0.018; p=0.895). 
Factors P-value for main effect: 
housing 0.895 
sex 0.053 
housing x sex 0.027 
No significant difference survived Tukey’s post hoc test for both groups and sexes, 
indicating no impact of enriched environment on genetically heterogeneous and “normal” 
anxiety-related mice. 
Due to the already missing effect of EE on coping style of NABs, we didn’t perform 
behavioral tests to asses coping style in CD1 animals. 
4.5 Impact of duration on the effects elicited by environmental enrichment  
4.5.1 Effects on prolonged enrichment on anxiety-related behavior 
Ten instead of four weeks of enrichment further improve the anxiolytic effects 
observed in females but not males. 
We performed OF, EPM and LD to evaluate anxiety-related behavior in HAB mice. 
Instead of four weeks, HAB mice were housed for ten weeks in EE to investigate the effect 
of duration on anxiety. For OF, 2-way ANOVA revealed a significant effect of housing for 
total distance travelled (F(1, 53) = 30.21; p≤0.001), total entries inner zone (F(1, 53) = 31.89; 
p≤0.001), percent time spent in inner zone (F(1, 53) = 30.04; p≤0.001), percent distance 
travelled in inner zone (F(1, 53) = 35.39; p≤0.001) and latency to enter inner zone (F(1, 53) = 
38.53; p≤0.001). Tukey post-hoc tests show a significant increase in total distance travelled 
comparing EE males (p≤0.05) and females (p≤0.001) to its respective controls. Likewise, 
there is a significant increase for total entries into inner zone, percent distance travelled in 
inner zone, percent time spent in inner zone and latency to enter inner zone for females 
(p≤0.001 for all) but not males (p=0.144, p=0.142, p=0.205 and p=0.241, respectively) 
(fig. 47A-D).  
 
 
Fig. 46: Enrichment entails a significant anxiogenic effect for males and a minor 
anxiolytic effect for females indicated by a higher or lower percentage of time (A) or 
distance (B) travelled in the light compartment, respectively. N (males) = 7 SE and 11 
EE; N (females) = 7 SE and 10 EE 
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Fig. 47: ten instead of four weeks cause a significant anxiolysis in female HABs, seen in 
more “total entries inner zone” (A), “percent time” (B) and “percent distance travelled 
in inner zone” (C) as well as a decreased “latency to enter the inner zone” (D). N 
(males) = 12 SE and 15 EE; N (females) = 15 SE and EE 
 
Parameter measured 
P-value for main effect of: 
Housing Sex Housing x sex 
total distance travelled ≤0.001 0.455 0.177 
latency to enter inner zone ≤0.001 0.230 ≤0.001 
total entries inner zone ≤0.001 0.397 0.160 
percent time spent in inner zone ≤0.001 0.244 0.013 
percent distance travelled in inner zone ≤0.001 0.275 0.008 
We calculated Z-open field to assess the overall anxiolytic effect for OF by correcting for 
locomotor differences and averaging z-scores of every measured parameter. 2-way 
ANOVA confirmed a significant effect of housing (F(1, 53) = 6.199; p≤0.05) without an 
effect of sex (F(1, 53) = 0.012; p=0.912) or an interaction of sex x housing (F(1, 53) = 0.012; 
p=0.912). Tukey post-hoc tests show a trend for an effect of housing for males (p=0.080) 
and females (p=0.089) indicating an anxiolytic effect of prolonged enrichment for both 
sexes (fig. 48). Males are 0.58 and females 0.53 SDs below the mean of their respective 
housed controls indicating a medium effect size. 
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The anxiolytic effect of OF is corroborated by EPM (fig. 49). 2-way ANOVA shows a 
significant effect of housing, i.e. significantly more percent entries into open arms (F(1, 53) = 
19.76; p≤0.001) and percent time spent on open arms (F(1, 53) = 48.91.; p≤0.001) without 
any difference related to locomotion (F(1, 53) = 0.124.; p=0.726). 
We evaluated the overall impact of prolonged EE on anxiety-related behavior measured by 
EPM via Z-EPM as described earlier. 2-way ANOVA shows a highly significant effect of 
housing (F(1, 53) = 68.86.; p≤0.001) suggesting a strong anxiolytic effect confirmed by 
Tukey post-hoc tests for males and females (p≤0.001 for both). Males are 1.25 and female 
0.91 SDs below the mean of their respective standard-housed controls, representing a 
strong and medium to strong effect size, respectively (fig. 50). 
 
Fig. 48: Z-score for open field corroborates the anxiolytic effects observed for single 
parameters by integrating and averaging their z-scores and correcting for locomotion. N 
(males) = 12 SE and 15 EE; N (females) = 15 SE and EE 
 
Fig. 49: Both sexes show an anxiolytic effect after EE apparent as increased percent 
time (A) and entries (B) spent on the open arms. N (males) = 12 SE and 15 EE; N 
(females) = 15 SE and EE 
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For LD, we observe significant effects of housing implied by a decrease of latency to enter 
light compartment (F(1, 53) = 21.04; p≤0.001), more entries into light compartment (F(1, 53) = 
30.17; p≤0.001), percent time (F(1, 53) = 23.68; p≤0.001) and percent distance travelled in 
light compartment (F(1, 53) = 25.5; p≤0.001) for EE mice. 2-way ANOVA also reveals a 
significant increase in total distance travelled (F(1, 53) = 25.5; p≤0.01) for animals housed in 
EE. 
Parameter measured 
P-value for main effect of: 
Housing Sex Housing x sex 
total distance travelled 0.002 0.891 0.003 
latency to enter light compartment ≤0.001 0.496 0.09 
total entries light compartment ≤0.001 0.711 ≤0.001 
percent time spent in light compartment ≤0.001 0.460 ≤0.001 
percent distance travelled in light compartment ≤0.001 0.284 ≤0.001 
Tukey post-hoc tests reveal a significant anxiolytic effect for females but not males 
indicated by an increased time spent and distance travelled in light compartment as well as 
a shorter latency to enter light compartment and more entries into it (p≤0.001 for all) 
(p=0.965, p=0.900, p=0.214 and p=0.643 for males, respectively) (fig. 51). 
Fig. 50: Z-EPM implies a strong anxiolytic effect for both sexes as indicated by a 
reduction of 1.25 and 0.91 SDs below the mean compared to controls. N (males) = 12 
SE and 15 EE; N (females) = 15 SE and EE 
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Z-light dark box was calculated (fig. 52) for evaluation of the overall effect of prolonged 
EE on parameters measuring anxiety-related behavior via LD. 2-way ANOVA suggests 
strong anxiolytic effect for females but not males, indicated by an effect of housing (F(1, 53) 
= 43.08.; p≤0.001), being 1.56 (0.24 for males) SDs below the mean of SE mice. 
Factors P-value for main effect: 
housing ≤0.001 
sex ≤0.001 
housing x sex ≤0.001 
 
 
 
 
 
 
Fig. 51: Females but not males exhibit a strong anxiolytic effect after prolonged EE as 
seen by more percent time spent (A), distance travelled (B) and more entries (D) as well 
as a shorter latency to enter the light compartment (C) related to SE controls. N (males) 
= 12 SE and 15 EE; N (females) = 15 SE and EE 
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Finally, we averaged z-scores of OF, EPM and LD to calculate “emotionality score” for 
prolonged EE lasting ten weeks. 2-way ANOVA indicates a significant reduction of 
anxiety-related-behavior shown by an effect of housing (F(1, 53) = 71.38.; p≤0.001), without 
an effect of sex (F(1, 53) = 2.27.; p≤0.138) or housing x sex (F(1, 53) = 2.27.; p≤0.138) (fig. 
53).  
 
 
Tukey post-hoc tests show a significant anxiolytic effect for both males and females 
(p≤0.001 for both) by 0.7 and 1.0 SDs below the mean of their respective controls, 
respectively. This implies a medium effect for males and a strong effect for females. 
 
Fig. 52: As indicated by single LD parameters, merely females show in LD an 
anxiolytic effect after prolonged EE. They are 1.56 SDs below the mean of SE controls, 
in contrast to 0.24 SDs for EE males. N (males) = 12 SE and 15 EE; N (females) = 15 
SE and EE 
Fig. 53: Prolonged EE entails a significant anxiolytic effect for both sexes. N (males) = 
12 SE and 15 EE; N (females) = 15 SE and EE 
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To analyze whether the distribution is shifted towards a medium or strong effect size, we 
performed a χ²-test with a 2x3 factorial design as described before. Indeed, males show a 
shift of effect size almost exclusively from a small to a medium effect size (χ² = 88.27; 
p≤0.001). Females show an even stronger shift from a small equally to a medium and 
strong effect size (χ² = 102.9; p≤0.001). Thus, shift of effect size, i.e. an anxiolytic effect is 
clearly observed after prolonged enrichment for both sexes with females exhibiting an even 
more pronounced shift (fig. 54). 
Comparison χ² Degree of freedom P-value Cramer’s V 
male SE vs. EE 88.27 2 p≤0.001 0.6643 
female SE vs. EE 102.9 2 p≤0.001 0.7173 
male vs. female EE 25.95 2 p≤0.001 0.3602 
male vs. female SE 12.5 2 p=0.019 0.2500 
Cramer’s V indicates a strong effect size for EE in relation to SE males (0.66) and females 
(0.72). Interestingly, both standard and enriched females show a shift towards a medium 
and strong effect size compared to respective male HABs.  
 
 
4.5.2 Impact of prolonged enrichment on coping style 
Ten instead of four weeks of environmental enrichment do not alter the coping style 
of males, whereas females seem to switch their coping style from active to passive. 
We performed TST and FST to assess coping style of prolonged enrichment. For TST, 
there is no significant effect of housing on percent time spent immobile (F(1, 53) = 2.27; 
p≤0.138), number of immobile episodes (F(1, 53) = 1.97; p=0.166) and latency to first 
immobile episode (F(1, 53) = 1.228; p=0.273) suggesting no difference of coping style after 
prolonged enrichment. 
Fig. 54: EE Males shift their effect size mostly from small to medium in contrast to 
females, which show a shift to medium and predominantly strong effect size compared 
to respective controls. N (males) = 12 SE and 15 EE; N (females) = 15 SE and EE 
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Parameter measured 
P-value for main effect of: 
Housing Sex Housing x sex 
percent time spent immobile 0.138 0.047 0.993 
number of immobile episodes 0.166 0.466 ≤0.001 
latency to first immobile episode 0.273 0.316 0.531 
A Tukey post-hoc test indicates significantly more immobile episodes of EE compared to 
SE females (p≤0.01). To evaluate the overall impact of prolonged enrichment on coping 
style, we calculated Z-TST and indeed, we observe a significant effect of housing (F(1, 53) = 
5.59; p≤0.05), sex and interaction of housing x sex (F(1, 53) = 9.216; p≤0.01 for both) via 2-
way ANOVA (fig. 55). Enriched housed females are 1.45 SDs above the mean of their SE 
counterparts, pointing towards a shift of coping style from active to passive. There is no 
significant difference between male groups seen as a decrease of 0.18 SDs of EE compared 
to SE males. 
 
For FST, 2-way ANOVA reveals a significant effect of housing on number of immobile 
episodes (F(1, 53) = 4.995; p≤0.05) and latency to first immobile episode (F(1, 53) = 5.626; 
p≤0.05).  
Parameter measured 
P-value for main effect of: 
Housing Sex Housing x sex 
number of immobile episodes 0.030 0.442 0.003 
latency to first immobile episode 0.021 0.573 0.432 
A Tukey post-hoc test shows a significant higher number of immobile episodes (p≤0.01) for 
EE in relation to SE females. Latency to first immobile episode does not survive Tukey’s 
post-hoc test (p=0.110). 2-way ANOVA for Z-FST reveals no significant effect of housing 
(F(1, 53) = 2.44; p=0.124) but an effect of sex and an interaction of housing x sex (F(1, 53) = 
10.98; p≤0.01 for both). Similar to Z-TST, EE females show a significant shift from active 
to passive coping compared to SE females by 0.52 SDs above their mean (fig. 56). In 
Fig. 55: Prolonged enrichment seems to shift the coping style of females from active to 
passive. N (males) = 12 SE and 15 EE; N (females) = 15 SE and EE 
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contrast, there is no significant difference of EE related to SE males with the former being 
0.18 SDs below the mean of controls. 
To assess the overall effect of prolonged enrichment on the coping style of HABs, we 
calculated “depression score” by averaging z-scores of FST and TST. A 2-way ANOVA 
followed by a Tukey post-hoc test (p≤0.001) for depression score corroborates a significant 
shift from active to passive coping for EE related to SE females (F(1, 53) = 6.41; p≤0.05) 
(fig. 57). 
EE females and males are 0.98 and 0.18 SDs above and below the mean of respective 
Fig. 56: Similar to Z-TST, FST indicates that prolonged enrichment seems to shift the 
coping style of females from active to passive. N (males) = 12 SE and 15 EE; N 
(females) = 15 SE and EE 
Fig. 57: Depression score depicts a significant shift from active to passive coping for EE 
related to SE females, whereas there is no difference between male groups. N (males) = 
12 SE and 15 EE; N (females) = 15 SE and EE 
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control groups. Depression score indicates a medium to strong effect for females and a 
weak effect for males. 
4.6 Comparison of the impact of environmental enrichment between NABs and HABs 
receiving either 4 or 10 weeks of EE. 
HABs compared to NABs show a stronger anxiolytic effect after enrichment, which 
can be further increased for females when housed for 10 instead of 4 weeks in an EE. 
In contrast, the anxiolytic effect observed of males does not seem to be increased any 
further by prolonged housing in an EE. 
We performed a 2-way ANOVA to compare the anxiolytic effect size, i.e. emotionality 
score, between NABs and HABs receiving either 4 or 10 weeks of enrichment. Indeed, 
there is a significant effect of subline (NAB, HAB 4 weeks of EE, HAB 10 weeks of EE) 
and an trend for the interaction of subline x sex. 
Factors P-value for main effect: 
housing ≤0.001 
sex 0.898 
housing x sex 0.052 
Fisher post-hoc tests indicate a significant increase of effect size comparing NABs with 
HABs receiving four (p=0.100 and p≤0.05 for males and females, respectively) or ten 
weeks (p≤0.05 and p≤0.001 for males and females, respectively) of EE (fig. 58). 
The anxiolytic effect observed in females can be in increased significantly by prolonging 
housing in an EE for 10 weeks, whereas males seem not to benefit from 10 instead of 4 
Fig. 58: HABs related to NABs show a stronger anxiolytic effect after EE, which can be 
further increased for females by prolonging EE from 4 to 10 weeks. N (males) = 12 
(NAB), 21 (4 weeks EE) and 15 (10 weeks EE); N (females) = 8 (NAB), 20 (4 weeks 
EE) and 15 (10 weeks EE) 
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Fig. 59: SE related to EE dams spent more time sitting together with body contact (A) 
and more time with pups in total (B), whereas EE mothers spent more time to interact 
with their environment indicated by an increased locomotion (C) and more frequent 
digging (D). N (cages) = 4 SE and 5 EE 
weeks of enrichment. The difference of effect size for females between the groups seems 
to be more pronounced compared to males. 
4.7 Contribution of maternal, pup and adolescent behavior to the anxiolytic effect 
elicited by environmental enrichment in HABs. 
4.7.1 Impact of maternal behavior on anxiety-related behavior during enrichment. 
Maternal behavior does not contribute to the anxiolytic effect elicited by EE. Instead, SE 
compared to EE dams seem to take more care of their pups. 
All data of section 3.7 were gained in close collaboration with Sergey V. Sotnikov who 
contributed invaluably to ensure successful completion. We performed 2-way ANOVA to 
investigate whether maternal care contributes to the anxiolytic effect observed after EE in 
HABs. This analysis enables us to identify differences between the groups on the 
respective days of observation (PND 15 and 17) and whether the behavior of the EE or SE 
mothers differs significantly between these days. There is no effect of housing on 
licking/grooming or nursing (F(1, 14) = 0.354; p=0.562 for both), but we detected a 
significant impact of housing  on sitting together with body contact on (F(1, 14) = 7.955; 
p≤0.05). Tukey post-hoc test identifies that SE mothers spent more time sitting together 
with body contact with their pups compared to EE dams on PND 17 (p≤0.05) (fig. 59A). 
Moreover, we monitor a significant effect of housing on locomotion on PND 15 (F(1, 14) = 
8.134; p≤0.05), time mother spent with pups on PND 15 (F(1, 14) = 5.536; p≤0.05) and 
digging on PND 17(F(1, 14) = 21.86; p≤0.001). Tukey post-hoc tests reveal that there is a 
trend for SE mothers to spent more time with their pups (p=0.064), whereas we observe a 
trend of increased locomotion (p≤0.064) and significant increase in digging (p≤0.001) for 
EE in relation to SE dams (fig. 59 B-D). 
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In total, SE dams spent more time with their pups by actively taking care of them (PND 15 
and 17) contrary to EE mothers, which spent more time to interact with their environment 
indicated by increased locomotor (PND 15) and digging (PND 17) activity. There is no 
significant difference for both housing conditions for any of the monitored behaviors 
comparing PND 15 and 17. 
We monitored the behavior of the dams during the night of PND 15 to 16. During that 
time, mothers and pups are in their home cage, which is identical for EE and SE groups 
during partial enrichment lasting from PND 15-28. A MWU test reveals a significant 
increase of locomotion for EE related to SE dams (p≤0.05) without any difference for all 
other parameters monitored. Importantly, we observed very low levels of locomotion and 
digging during the night (≤10 time intervals) since dams spent a lot of time with 
eating/drinking as well as grooming and nursing their pups. 
4.7.2 Effect of EE on pup behavior 
Pups raised in EE actively use the provided toys and manipulate their 
microenvironment, whereas SE pups engage significantly more in running possibly 
due to a lack of alternatives. 
Fig. 60: EE pups actively use toys and manipulate their microenvironment by spending 
almost all of their active time with “play behavior” and “EE use” on both days of 
observations. Contrary, SE pups significantly spent more time with “running”, possibly 
trying to compensate a lack of alternatives. N (cages) = 4 SE and 5 EE 
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Fig. 60 depicts the percentage that animals spent to perform all monitored behaviors. EE 
pups invest 30% (PND 22) and 40% (PND 24) of their total activity for active behaviors 
like interaction with EE and play behavior. At the same time, they spend 62% (PND 22) 
and 56% (PND 24) of their total activity for passive activities like sitting together with 
body contact. Contrary, SE pups spent more time for passive behaviors indicated by 
spending 77% (PND 22) and 66% (PND 24) of their total activity for sitting together with 
body contact. In parallel, SE pups spend more time, i.e. 15% (PND 22) and 22% (PND24) 
of their total activity for “running” around. 
2-way ANOVA revealed a significant effect of housing on running (F(1, 13) = 80.33; 
p≤0.001) and for sitting together with body contact (F(1, 13) = 4.816; p≤0.05), but no 
significant effect of housing on sociopositive behavior comprising grooming (F(1, 13) = 
0.409; p=0.533) and play behavior (F(1, 13) = 1.873; p=0.194). A Tukey post-hoc test 
reveals a significant increase of running in the home cage for SE compared to EE pups on 
PND 22 (p≤0.01) and PND 24 (p≤0.001) (fig. 61). 
It seems like SE pups shift their behavior: on the one hand the are significantly more 
inactive indicated by an increased time sitting together with body contact (F(1, 13) = 4.816; 
p≤0.05) and on the other hand their active behavior is predominantly reduced  to running 
due to a lack of alternatives. This is corroborated by the fact that the significant increase of 
running gets lost when EE and SE pups are housed in an identical home cage during the 
dark period of partial enrichment (fig. 62; MWU; U=3, p=0.111). 
 
 
 
 
 
Fig. 61: SE related to EE pups significantly engage more in “running around” in their 
home cage on both days of observation. N (cages) = 4 SE and 5 EE 
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A Tukey post-hoc test shows that SE pups significantly increase running from PND 22 to 
PND 24 (p≤0.05). This might indicate that, with increased time, housing in SE not only 
thwarts highly motivated behaviors, which might be compensated by running - the 
thwarting seems to be further increased causing even higher levels of running (fig. 61). 
4.7.3 Impact of EE on adolescent behavior 
Enrichment increases the number of actively performed behaviors like social 
interactions contrary to SE adolescents, which significantly sleep more during the day 
and spent more time with body contact during the nighttime compared to the 
daytime. Moreover, EE adolescents intensively use the provided toys and manipulate 
their microenvironment, whereas SE adolescents perform significantly more rearings 
during day and night, maybe reflecting a lack of alternatives. 
SE in relation to EE adolescent mice show more passive behaviors during the day- and 
nighttime of PND 35. 2-way ANOVAs reveal an effect of time (F(1, 15) = 25.94; p≤0.001) 
and an interaction of time x housing (F(1, 15) = 25.94; p≤0.001) for sitting together with 
body contact. A Tukey post-hoc test surprisingly reveals that SE adolescents spend even 
more time sitting together with body contact during nighttime in relation to daytime 
(p≤0.001) though mice are nocturnal mammals being mostly active during the night (fig. 
63A). However, there is no significant difference between EE and SE adolescents for 
sitting together with body contact during day- and nighttime (p=0.891 and p=0.296, 
respectively). Furthermore, we observe an effect of housing on sleeping (F(1, 15) = 25.94; 
p≤0.001) with SE compared to EE adolescents sleeping significantly more during daytime 
(p≤0.001). Not surprisingly, a Tukey post-hoc test shows that SE animals sleep less during 
night- related to daytime (p≤0.001). On contrary, this is not true for EE adolescents 
(p=0153) corroborating a shift to more active behaviors during daytime. During nighttime, 
SE adolescents invest the time gained due to less sleeping predominantly in “sitting 
together with body contact”, indicated by an increase from 11% during daytime to 23% 
during nighttime (increase of ca. 110%). 
Fig. 62: When EE and SE pups are housed in identical home cages during the dark 
period, the increase of running of SE pups disappears. N (cages) = 4 SE and 5 EE 
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A trend of housing for “running” (F(1, 15) = 3.79; p≤0.071) and a significant effect of 
housing for “rearings” (F(1, 15) = 20.63; p≤0.001) indicates that SE adolescents invest the 
remaining time in “rearing” and “running”. A Tukey post-hoc confirms a significant 
increase of locomotion for SE adolescents from day- to nighttime (p≤0.001) from 11% to 
20% (increase of ca. 80%), thereby reaching levels of EE mice. Though a significant effect 
of housing, “rearings” of SE mice do not increase significantly from day- to nighttime as 
shown by a Tukey post-hoc test (p=0.829), but SE in relation to EE adolescents show a 
trend to perform more rearings during day- (p=0.063) and significantly perform more 
rearings during nighttime (p≤0.05). EE related to SE animals show a trend to perform more 
social interactions during the nighttime (p=0.065) 
 
Fig. 63: SE compared to EE adolescents engage more in passive behaviors indicated by 
sleeping significantly more during daytime and by sitting significantly more together 
with body contact during night- in relation to daytime. SE mice sleep less during 
nighttime and invest the gained time predominantly in sitting together with body contact 
and to a less amount in running and rearing. N (cages) = 5 SE and 6 EE 
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As a summary, EE adolescents are more active during the daytime (less sleeping) and 
show significantly more social interactions during nighttime. SE mice split the time gained 
due to less sleeping almost equally to sit together with body contact and for running (fig. 
64). Interestingly, locomotion of EE and SE adolescents is not significantly different 
anymore compared to EE and SE pups but the latter perform more rearings during day- and 
nighttime. We would like to emphasize two differences related to housing conditions: i) SE 
adolescents in contrast to SE pups were housed in same sex groups of three instead of 
mixed sex groups of eight pups and ii) and SE adolescents were housed in a smaller cage 
comprising 363cm² in place of 825cm², thereby reducing the possibility to run per se. 
4.8 Identification of candidate genes related to anxiety-related behavior. 
4.8.1 Quantitative real-time PCR 
We identified Ucn, DBH, Tmem132d and Crhr1 as genes likely to be associated with 
the anxiolytic effect observed after EE. Thereby, Crhr1 emerges as the major gene of 
interest. 
We used qPCR to identify gene expression differences in brain regions known to be 
associated with anxiety-related behavior. Thus, we combined literature research with a list 
of candidate genes (tab. 11) identified by Czibere (2008) to obtain brain regions and genes 
of interest: 
 
 
 
Fig. 64: EE causes a significant decrease of sleeping during daytime (A) and a 
significant increase of social interactions during nighttime (B). SE adolescents invest 
the time gained due to less sleeping during nighttime in sitting together with body 
contact and locomotion. N (cages) = 5 SE and 6 EE 
A B 
C 
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Gene name Gene symbol Brain region 
arginine vasopressin Avp PVN 
corticotropin-releasing hormone receptor 1 Crhr1 BLA 
corticotropin-releasing hormone Crh BLA 
dopamine beta hydroxylase Dbh LC 
neuropeptide S receptor 1 Npsr1 LC 
transmembrane protein 132d Tmem132d CG 
urocortin 1 Ucn BLA 
We observe a significant difference of relative gene expression comparing SE and EE mice 
for the following genes by performing MWU-tests: 
Gene symbol Significance 
Tmem132d p≤0.01 
Dbh p≤0.01 
Crhr1 p≤0.05 
Ucn p≤0.01 
Tab. 11: Depicted genes were analyzed by qPCR after extraction of RNA from the 
corresponding brain regions. 
Fig. 65: EE significantly increases Tmem132d, Dbh and Crhr1 mRNA levels. Contrary 
to EE, Tmem132d expression is higher in HABs related to LABs, thereby highlighting 
Crhr1 as the gene of major interest since EE is able to reduce overexpression of HABs. 
Ucn can bind to Crhr1 and rather potentiates than masks the anxiogenic effect of Crhr1 
because it is significantly less expressed after EE too. Data of Tmem132d mRNA 
expression comparing HAB vs. LAB were kindly provided by Dr. Czibere from Erhardt 
et al. (2011). N = 5-9 for HAB, 4-5 for LAB and 6-7 for EE  
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Fig. 65 depicts a significant increase of Tmem132d expression in CG after EE, which is 
surprisingly in the opposite direction we expected: HAB mice show higher levels of 
Tmem132d expression compared to LABs, pointing towards an anxiogenic effect of 
Tmem132d in SE HAB, whereas our data indicate an anxiolytic effect in EE HAB mice. 
Moreover, EE causes a highly significant reduction of Dbh within LC to ca. 20% of HAB 
expression indicating an important contribution of this gene to the observed anxiolytic 
effect elicited by enrichment. However, a MWU-test shows no difference comparing HAB 
and LAB mice (p=0.537). Crhr1 emerges as the gene of major interest since EE entails a 
significant reduction of gene expression and HAB compared to LAB animals show higher 
expression of Crhr1 in the BLA. Our data indicate an anxiogenic role of Crhr1, which 
seems to be determined by genetic predisposition and is amenable for environmental 
stimuli as provided by EE. Because Ucn can bind to Crhr1 and mask possible effects 
caused by EE, we compared EE and SE animals for gene expression differences and found 
a significant decrease of UCN after enrichment. Thus, Ucn rather potentiates than masks 
the anxiolytic effect of EE since we observe less Crhr1 and less Ucn expression in EE 
related to SE mice.  
Importantly, we do not find a significant difference of Crh expression within the BLA 
comparing EE and SE HABs, thereby minimizing possible masking effects of the ligand 
(p>0.1). Though, our group identified Npsr1 (Slattery, Naik et al, in preparation) and AVP 
(Bunck et al. 2009) as candidate genes likely to be associated with anxiety-related behavior 
due to significantly different expression levels between HAB and LAB, we were not able 
to verify a significant difference for Npsr1 in LC (p=0.818) and AVP within the PVN 
(p>0.1).  
4.8.2 Western Blot 
Low protein levels within the amygdala of both, CRHR1 and GR within the nucleus 
prevented verification of significant differences on protein level as indicated on 
mRNA level by qPCR. 
Though a multitude of different protocols for protein extraction and pooling of up to five 
animals per group were used, GR concentration was still under the detection limit of the 
antibody. Similar, CRHR1 antibodies used were not specific, i.e. bands appeared at 
unexpected positions (ca. 95kd instead of 47kD) or were not specific enough and bound to 
CRHR1 and 2 (fig. 66). This problem has been recently described by Refojo et al. (2011). 
 
 
 
Fig. 66: Due to lacking antibody specificity of CRHR1, observed differences on mRNA 
level couldn’t be confirmed on protein level. Corticotropin-releasing hormone receptor 
1 (CRHR1), Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). N = 5 per sample 
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4.9 Pharmacological validation of CRHR1 via an α-helical antagonist 
Bilateral injection of the α-helical CRF (9-41) antagonist within the BLA confirms the 
involvement and anxiogenic role of Crhr1. 
We injected an α-helical CRF (9-41) antagonist bilaterally into the BLA of HAB animals 
to verify whether CRHR1 indeed contributes to the anxiolytic effect of EE. We excluded 5 
and 6 animals from the vehicle and treatment group, respectively since histology revealed 
that these animals did not met the criteria to guarantee an injection into the BLA. We 
performed OF, EPM and LD to assess the effect of the α-helical antagonist after one and 
three bilateral injections of the antagonist. We do not observe a significant behavioral 
change after one injection, but, indeed, a MWU test shows a significant increase of percent 
time spent in the inner zone (p≤0.05) and a trend for more entries into the inner zone 
(p≤0.1) of the OF after three injections (fig. 67 A and B). Moreover, we observe a 
significant reduction of 1.91 SDs of EE below the mean of SE mice (p≤0.05) corroborating 
an anxiogenic effect of CRHR1 utilizing Z-open field as an indicator (fig. 67C). Thus, we 
averaged z-score of latency to enter inner zone, total entries inner zone and percent time 
spent in inner zone but not total distance travelled and percent distance travelled inner zone 
due to technical problems, which ensued loss of these parameters. 
 
 
We do not observe a significant difference in EPM and LD test between vehicle and 
treatment group. 
 
Fig. 67: A significant reduction of “percent time spent in inner zone” (A), a trend for 
“total entries inner zone” (B) and a significant reduction of “Z-open field” (C) indeed 
point toward an involvement and anxiogenic effect of CRHR1. N = 6 SE, 7 EE 
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4.10 Assessment of Crhr1 promoter methylation by pyrosequencing 
EE significantly increases methylation of a CpG site located -1348bp before the start 
codon. 
Pyrosequencing was performed to identify methylation levels of all 186 CpG sites located 
within the CpGi of Crhr1. However, merely methylation of 174 out of 186 CpG sites could 
be assessed due to low signal intensity for the respective missing sites. Low signal 
intensity can be caused by different reasons with an adverse secondary structure of DNA, 
sequencing primers or both being the most likely. We were interested whether total 
promoter methylation differs between HAB and LAB on the one and EE compared to SE 
HABs on the other hand. Kruskal-Wallis ANOVA reveals no significant difference 
between the groups (H (2, N=522) = 1.586; p=0.452). As expected, total methylation of the 
Crhr1 promoter is low, i.e. ≤5% and thereby under the detection limit of the 
pyrosequencing technique. Thus, we must assume that the promoter of EE and SE HABs 
as well as LABs is overall unmethylated exhibiting an average methylation of 2.54%, 
2.28% and 2.48%, respectively. 
A vast body of literature suggests that DMRs might play an important role in regulating 
gene expression. Though total methylation is not significantly different, DMRs can be. 
Therefore, we analyzed single CpGs for significantly different methylation comparing 
HAB to LAB and EE to SE mice. We observe no significant differences relating HAB to 
LAB CpG sites, suggesting a different mechanism than methylation to regulate the 
increased expression of Crhr1 in HABs related to LABs. Contrary, a MWU test identified a 
trend for a differentially methylated CpG site, i.e. a DMR comparing EE to SE mice 
(p=0.083) (fig. 68). This DMR is located -1348bp before TSS and constitutes the first CpG 
site of the CpGi whereat EE increases methylation, which could explain the reduced Crhr1 
levels. 
 
Fig. 68: HAB and LAB do not significantly differ, whereas EE shows a trend to 
increase methylation at the identified DMR located -1348bp before TSS. N = 4 for 
HAB, LAB and EE  
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4.11 Identification of transcriptional regulators by in silico analysis 
In silico analysis with subsequent qPCR identified the transcription factor Yin Yang 
1 (YY1) as a potential regulator of Crhr1. Moreover, Nr4a1 and D3Ertd300e together 
with Crh1 and YY1 might constitute a small interacting network. 
We performed an in silico analyses of transcription factor binding sites using the “Jaspar 
Core Vertebrate” database and selecting M. musculus as organism (fig. 69). We submitted 
the sequence “GATGGAGACCCGGACCTGAGAG” comprising 10bp up- and 
downstream of the identified DMR highlighted in red. Analysis yielded the following 
transcription factors as potential regulators of the DMR: 
YY1 emerges as the TF with the highest probability to bind in the near proximity (4bp) of 
the Crhr1 DMR indicated by a relative score of 0.949 with 1.0 being the maximum score to 
be achieved (fig. 70). 
 
We performed qPCR to verify whether YY1 is really involved in transcriptional regulation 
of Crhr1 as indicated by in silico analyses. Indeed, a MWU test reveals a strong trend for 
YY1 to be expressed less in EE compared to SE animals (p=0.053) (fig. 71). 
 
Fig. 69: in silico analysis using the “Jaspar Core Vertebrate” database identified YY1 as 
the TF with the highest probability to bind the DMR of Crhr1. 
Fig. 70: YY1 binds next to the DMR of Crhr1 rendering it very likely to block the TF 
and thereby reducing gene expression. Binding site of YY1 is highlighted in red. 
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To elucidate the potential connection between YY1 and Crhr1, we performed a gene 
network analysis by “Pubgene” (www.pubgene.org) utilizing a literature network search to 
identify genes, which co-occur in scientific publications. Subsequently, we verified 
connections illustrated by Pubgene by reading the respective literature. By doing so, we 
identified two factors, which interact with Crhr1 or YY1 in a small network (fig. 72). 
 
 
We used the gene ontology database (Amigo v1.8) to verify the functions of the identified 
factors. Nr4a1, also known as “nur77” is a nuclear receptor and belongs to a large 
superfamily of transcription factors. We found a functional association for “steroid 
hormone receptor” activity, namely “Nr3c1” also referred as “GR” (p = 3x10-6) together 
with Fkbp4 (1.5 x 10-74) and Fkbp5 (1.4 x 10-119). Moreover, we found an association with 
“adrenocorticotropin-releasing hormone activity” (p = 1.23 x10-6). 
Fig. 71: YY1 expression is indeed reduced after EE in HABs. N = 5 for HAB and EE 
Fig. 72: Pubgene with subsequent literature search identified D3Ertd300e and Nr4a1 as 
factors interacting with Crhr1 and YY1 in a small network. 
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D3Ertd300e also known as “p38IP” is strongly associated with “transcription factor 
complex” (p = 1.31 x 10-122) and seems to exhibit a positive regulatory role for YY1 (p = 
2.8 x 10-5), which in turn is associated with a “negative epigenetic role for gene 
expression” (p = 1.16 x 10-6). Thus, YY1, D3Ertd300e and Nr4a1 exhibit the potential to 
from a transcriptional complex in the nucleus and to exert regulatory influence on each 
other and finally Crhr1. 
4.12 Modulation of behavior by epigenetic drugs 
The DNMTi 5-Aza-2’-deoxyuridine seems to exert an anxiogenic effect on SE and EE 
animals contrary to the HDACi valproic acid, which might exert an anxiolytic effect 
in SE and anxiogenic effect in EE animals, respectively. We do not observe an 
additive effect of EE and (epigenetic) drug treatment to ameliorate depression-like 
behavior. 
To investigate whether the anxiolytic effect of EE on HABs is (partially) of epigenetic 
nature, we tried to shift the phenotypes of both groups by injecting drugs, known to exert 
an effect via an epigenetic mechanism. Thus, we performed OF, EPM and LD to assess 
anxiety-related behavior. A 2-way ANOVA for OF reveals no significant effect of 
treatment, but a significant effect of housing on latency to enter inner zone (F(1, 47) = 9.438; 
p≤0.01), total entries inner zone (F(1, 47) = 10.35; p≤0.01), percent time spent in inner zone 
(F(1, 47) = 4.227; p≤0.05), percent distance travelled inner zone (F(1, 47) = 4.271; p≤0.05) and 
total distance travelled (F(1, 47) = 4.59; p≤0.05). 
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
latency to enter inner zone 0.004 0.141 0.141 
total entries inner zone 0.002 0.279 0.279 
percent time spent in inner zone 0.045 0.169 0.169 
percent distance travelled in inner zone 0.044 0.229 0.229 
total distance travelled 0.037 0.770 0.314 
Importantly, EE again exerts an anxiolytic effect on HABs comparing EE and SE animals 
receiving saline. Tukey post-hoc tests depict that EE compared to SE mice exhibit a 
significantly lower latency to enter the inner zone, enter the inner zone more often, spent 
more percent time and travel more percent distance in it (all p≤0.01). 
Moreover, Fisher post-hoc tests show a significantly higher latency to enter the inner zone 
of EE HABs, which received the HDACi compared to DNMTi (p≤0.05) and saline 
(p≤0.01) (fig. 73B). Similarly, EE mice receiving HDACi enter the inner zone significantly 
less (fig. 73C) and spent less percent time in it (fig. 73D) in relation to saline controls 
(p≤0.05 and p≤0.01, respectively) indicating an anxiogenic effect of the used HDACi 5-
Aza-2’-deoxyuridine on EE mice, though we did not observe an effect of treatment. In 
addition, DNMTi compared to saline treated EE mice spent significantly less percent time 
in the inner zone (p≤0.05) pointing towards a mild anxiogenic effects of the utilizes 
DNMTI valproic acid. 
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A 2-way ANOVA of EPM indicates an effect of housing and treatment for percent entries 
open arms (p≤0.01 and p≤0.05, respectively) and percent time spent on open arms (both 
p≤0.05) demonstrating that i) EE again elicited an anxiolytic effect and that ii) application 
of drugs indeed had an effect on the behavior of SE and EE HABs. Fisher post-hoc tests 
reveal a significant increase of percent time spent on open arms (p≤0.05) and a strong trend 
for entering the open arms more often (p=0.055) for SE HABs, which received HDACi 
related to saline controls. Contrary, we do not observe any difference comparing saline to 
DNMTi SE mice (fig. 74). Surprisingly, DNMTi had the complete opposite effect on EE 
mice as HDACi had on SE animals: we monitor an anxiogenic effect revealed by Fisher 
post-hoc tests showing a significant decrease of entries in (p≤0.05) and a trend for percent 
time spent on open arms (p=0.093) of EE mice, which received DNMTi in relation to 
saline controls. These results are corroborated by the fact that SE compared to EE mice, 
which received DNMTi as well as HDACi do not differ significantly anymore in regard to 
entries into (p=0.182 and p=0.514 , respectively) and percent time spent on open arms 
(p=0.303 and p=0.700, respectively). 
Fig. 73: The HDACi 5-Aza-2’-deoxyuridine seems to exhibit anxiogenic properties 
indicated by an increased latency (B), less entries (C) and less percent time spent in the 
inner zone (D) related to saline EE controls. Merely saline EE animals travel 
significantly more total distance compared to their SE counterparts (A). N = 8 for all SE 
groups and 9 for all EE groups 
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Finally, a 2-way ANOVA for LD revealed a significant effect of treatment on Latency to 
enter the light compartment, total entries into (both p≤0.01) and percent time spent in it 
(p≤0.05). 
Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
latency to enter light  compartment ≤0.001 0.008 0.801 
total entries light compartment ≤0.001 0.004 0.423 
percent time spent in light compartment ≤0.001 0.018 0.567 
Fisher post-hoc tests reveal an anxiogenic effect of DNMTi on both, SE and EE animals 
compared to their respective saline controls. Treatment with valproic acid reduced entries 
into (p≤0.05 for SE and p=0.053 for EE, respectively) and increased the latency to enter 
the light compartment (p≤0.01 for SE). These results are corroborated by Z-light-dark box, 
which shows an anxiogenic effect of DNMTi by an increase of 1.03 SDs above the mean 
of SE mice. Likewise, the anxiolytic effect of EE on HABs was reduced from 1.42 to 0.56 
SDs below the mean of EE mice by treatment with DNMTi (fig. 75). 
Fig. 74: The DNMTi valproic acid exhibits an anxiogenic effect on EE mice, whereas 
the HDACi 5-Aza-2’-deoxyuridine possesses an anxiolytic effect on SE mice. This is 
indicated by a respective significant in- or decrease of entries in (A) and percent time 
spent on open arms (B) for SE and EE mice receiving HDACi or DNMTi, respectively 
compared to saline controls. N = 8 for all SE groups and 9 for all EE groups 
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In total, there seems to be a clear cut anxiogenic effect of the DNMTi valproic acid on 
both, SE and EE animals indicated by all three tests. The HDACi 5-Aza-2’-deoxyuridine 
might possess an antidromic effect on SE and EE mice: an anxiolytic effect on SE and an 
anxiogenic effect of EE HABs. 
4.13 Evaluation of transgenerational effects 
There might be a transgenerational anxiolytic effect priming some male individuals, 
denoted as responders, to future environmental conditions. Moreover, two successive 
generations of EE seem to increase the anxiolytic effect for both sexes. 
To investigate transgenerational effects of anxiety-related behavior, we performed EE as 
described earlier and again, we observe a significant reduction of anxiety-related behavior 
without masking effects of locomotion for the parental generation (fig. 76) 
Fig. 75: The DNMTi valproic acid exhibits an anxiogenic impact on SE and EE mice, 
depicted as less entries into (A), an increased latency (B) to enter the light compartment 
and Z-light-dark box (D) showing an increase of 1.03 and a decrease from 1.42 to 0.56 
standard deviations compared to the mean of their SE and EE controls, respectively. N 
= 8 for all SE groups and 9 for all EE groups 
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2-way ANOVA reveals a significant effect of housing for Z-open field (F(1, 67) = 9.298; 
p≤0.001), Z-elevated plus maze (F(1, 64) = 13.25; p≤0.001) and Z-light-dark box (F(1, 66) = 
4.59; p≤0.05). Tukey post-hoc tests show a significant anxiolytic effect for females 
depicted as a reduction of 0.86 SDs below the mean of SE controls in EPM (p≤0.001), 
whereas males show a significant reduction in all tests: 1.26 SDs in OF (p≤0.001), 0.87 
SDs in EPM (p≤0.001) and 0.69 SDs in LD (p=0.082) below the mean of respective 
controls. 
By performing this experiment, we would like evaluate whether: i) the anxiolytic effect of 
EE be passed on to the next generation (i.e. transgenerational inheritance), an additive 
effect of EE exist, which can be seen as ii) an increase of the anxiolytic effect size and/or 
iii) an antidepressive effect, which can’t be observed after a singular EE. To verify whether 
a transgenerational effect exists, we mated three males each with two females for both 
housing conditions to generate F1. We performed OF, EPM and LD to assess anxiety-
related behavior. 2-way ANOVAs show the following effects: 
Test Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
OF 
 
total distance travelled 0.011 0.123 0.994 
latency to enter inner zone 0.009 0.584 0.957 
total entries inner zone 0.008 0.855 0.635 
percent time spent in inner zone 0.446 0.483 0.727 
percent distance travelled in inner zone 0.239 0.727 0.692 
Z-open field ≤0.001 0.006 0.001 
Fig. 76: EE ensues a significant anxiolytic effect indicated by z-scores of OF (B), EPM 
(C) and LD (D) without a masking effect of locomotion (A). N (males, females) = 18 
SE, 21 EE   
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EPM 
percent time spent on open arms 0.279 0.937 0.008 
percent entries in open arms 0.764 0.150 0.731 
Z-elevated plus maze 0.026 0.003 0.013 
LD 
latency to enter light compartment 0.011 0.123 0.994 
percent time spent in light compartment ≤0.001 0.138 0.699 
total entries light compartment ≤0.001 0.224 0.904 
Z-light-dark box ≤0.001 0.610 0.333 
For OF, Z-open field was the only parameter surviving a Tukey post-hoc test with EE 
females showing a reduction of 4.41 SDs below the mean of SE controls (p≤0.001) 
revealing the expected anxiolytic effect of EE for females. 
Surprisingly, females whose parents had been housed in EE but mice themselves were 
raised in SE (EESE) show a strong trend to spent more time on open arms compared to SE 
mice (p=0.059) and do not significantly differ from EE females (p=0.619) indicating a 
transgenerational effect for females. We would like to emphasize that SE females exhibited 
a mean value close to zero, thus increasing Z-open field to levels that might not be 
representing real effect size (please refer to materials and methods). A fact that is 
corroborated by the absence of transgenerational effects in all other measured parameters. 
For LD, we observe a significant effect of housing for all measured parameters, thereby 
confirming the anxiolytic effect of EE on both sexes. We monitor significantly more 
entries into and time spent within the light compartment for EE males (p≤0.001 for both) 
and females (p≤0.05 for both) compared to their SE counterparts, but we do not observe a 
transgenerational effect by comparing any of the measured parameters between SE and 
EESE animals. These data are corroborated by Z-light-dark box showing a significant 
reduction for EE mice of 2.57 and 2.63 SDs below the mean of male (p≤0.05) and female 
SE controls (p≤0.01), respectively (fig. 77). 
 
 
Fig. 77: As expected, EE ensues a significant anxiolytic effect for both sexes depicted 
as a reduction of z-score of 2.57 and 2.63 SDs for males and females, respectively 
related to controls. Like in all other tests, LD does not point towards a transgenerational 
anxiolytic effect apparent as a missing difference between SE and EESE mice. N 
(males) = 14 SE, 13 EESE and 8 EE; N (females) = 8 SE and EESE and 6 EE 
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Though we do not monitor transgenerational inheritance of the anxiolytic effect for all 
mice, we further analyzed our data similar to Elliot et al., (2010) who showed that some 
animals might respond to a certain treatment (denoted as responders), whereas others do 
not (referred to as non-responders, NR). Indeed, we found a bimodal distribution of male 
F1 animals exhibiting and not exhibiting an anxiolytic effect. Out of 13 male EESE mice, 5 
did not enter the light compartment at all, thereby resembling the behavior and phenotype 
of SE mice contrary to EESE females, which do not show this bimodal distribution. We 
took out these 5 male possible non-responders and analyzed them as a separated group 
when performing Kruskal-Wallis ANOVA (KWA) followed by MWU as post-hoc test and 
Dunn-Šidák correction for multiple testing (significance at p≤0.013 due to 4 simultaneous 
tests). This action did not alter the results for OF and EPM, but had a dramatic effect on 
LD analysis – the test which yielded the most significant results of EE before separating 
responders and NR (fig. 78). We observe a significant difference (p≤0.001 for all) for 
latency to enter light compartment (H=20.71), percent time spent in light compartment 
(H=21.01), total entries light compartment (H=18.56) and Z-light-dark box (H=17.57). 
Parameter measured SE vs. EESE SE vs. EE EESE vs. EE SE vs. NR 
latency to enter light comp. 0.006 
p≤0.001 
0.279 0.391 
% time spent in light comp. 0.029 0.007 0.391 
total entries light comp. 0.005 0.050 0.391 
Z-light-dark box 0.008 0.021 0,186 
Fig. 78: A subgroup of males indeed might show an inherited anxiolytic effect 
originating from their EE parents. They have a shorter latency to enter (A) and more 
entries into the light compartment (B) as well as a significantly reduced Z-score of 1.1 
SDs compared to SE controls (D). Importantly, on the one hand, EESE males do not 
significantly differ from EE males except by percent time spent in light compartment 
(C), on the other hand SE and NR do not differ in any of the measured parameters 
indicting a similar phenotype. N = 5 NR, 14 SE, 8 EESE and 8 EE 
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These results suggest that male F1 indeed can be separated in responders and non-
responders and that the first differ significantly from SE mice by having a shorter latency 
to enter and more entries into the light compartment as well as a strong reduction of 1.10 
SDs below the mean compared to controls. At the same time, EESE and EE F1 males do 
not differ significantly anymore in all parameters except percent time spent in light 
compartment (p=0.007). We emphasize that F1 SE and NR do not significantly differ in 
any of the parameters suggesting that these two groups are indeed similar. 
Research suggests that a transgenerational effect should be inherited to F3 since dams 
expose their embryos, which in turn expose their gametes to the environmental conditions, 
which elicit a certain effect. Thus, a true transgenerational effect should be inherited to F3 
to exclude any confounding effects (Skinner, 2011). Therefore, we tested F2 and F3 for an 
inherited anxiolytic effect originating from the parental generation. F2 SE animals of both 
sexes exhibited means close to zero or were equal to zero, thereby increasing z-scores to 
values not representing real effect sizes. Due to this reason we were not able to perform z-
scores for F2. The anxiolytic effect of EE was again observed in F2 corroborating the 
robustness and reproducibility of our paradigm but we did not monitor transgenerational 
inheritance of the anxiolytic phenotype (fig. 79). 
-
 
A 2-way ANOVA revealed significant effects of the following parameters: 
Fig. 79: As expected, EE again caused an anxiolytic effect but we do not observe an 
inherited anxiolytic phenotype in any of the measured parameters of OF, EPM and LD. 
A reduced latency to enter the inner zone of OF (A), an increased percent time spent on 
open arms of EPM (B) and more entries in the light compartment of LD (C) are 
examples of the anxiolytic effect elicited by EE. N (males) = 4 SE, 8 EESE, 9 EE; N 
(females) = 5 SE, 4 EESE and 15 EE 
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Test Parameter measured P-value for main effect of: 
Housing Sex Housing x sex 
OF 
 
total distance travelled 0.018 0.099 0.998 
latency to enter inner zone 0.004 0.843 0.889 
total entries inner zone 0.019 0.713 0.858 
percent time spent in inner zone 0.038 0.902 0.982 
percent distance travelled in inner zone 0.038 0.992 1.000 
EPM 
percent time spent on open arms 0.033 0.780 0.523 
percent entries in open arms 0.010 0.950 0.537 
LD 
latency to enter light compartment ≤0.001 0.244 0.491 
percent time spent in light compartment ≤0.001 0.397 0.359 
total entries light compartment ≤0.001 0.718 0.701 
Fisher post-hoc tests for OF reveal that EE males and females compared to: 
 
- respective EESE animals show a trend to travel more total distance (p=0.081 for 
males and p= 0.059 for females), 
- have a shorter latency to enter the inner zone compared to SE (p=0.065 for males 
and p≤0.05 for females) and EESE mice (p=0.085 for males and p≤0.05 for 
females), 
- enter the inner zone more often than male SE (p=0.075) and EESE (p≤0.05) HABs, 
- spent more percent time in the inner zone than EESE males (p=0.077) and 
- travel more percent distance in the inner zone related to EESE males (p=0.096). 
For EPM, EE related to SE males enter the open arms more often (p≤0.05) and spent more 
percent time on the open arms compared to male SE and EESE mice (p≤0.05 for both), 
whereas EE in relation to SE females show a trend for the latter (p=0.090). Fisher pots-hoc 
tests for LD reveal a significantly shorter latency for both EE sexes to enter the light 
compartment compared to SE (p≤0.01 for males and p≤0.05 for females) and EESE HABs 
(p≤0.01 for males and p=0.087 for females). Moreover, male but not female EE HABs 
spent significantly more percent time in the light compartment in relation to SE (p≤0.01) 
and EESE counterparts (p≤0.001). EE males and females enter the light compartment 
significantly more often than SE mice (p≤0.05 for both), which is also true comparing EE 
and EESE males (p≤0.01). 
Finally, we assessed inheritance of anxiety-related behavior in F3 mice. As expected, EE 
compared to SE F3 animals - like F2 HABs – show an anxiolytic effect after EE but this 
effect was not passed from (F2) parents to (F3) offspring. Fig. 79 shows z-scores of OF, 
EPM and LD illustrating the anxiolytic effect of EE and the absence of transgenerational 
inheritance. 2-way ANOVAs show a significant effect of housing on Z-open field (F(1, 78) = 
5.736; p≤0.001), Z-elevated plus maze (F(1, 79) = 6.971; p≤0.001) and Z-light-dark box (F(1, 
79) = 14.4; p≤0.001).  
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Fisher post-hoc tests depict for EE males a significant decrease of 1.10 SDs in OF and 2.92 
SDs in LD below the mean of respective SE controls indicating a strong effect size, 
whereas EE in relation to SE females show a reduction of 3.49 SDs below the mean in 
EPM (fig. 80). 
We were interested whether successive generations of EE might cause an anti-depressive 
effect, which is not seen after single EE. Thus, we conducted FST for F3 mice whereby a 
2-way ANOVA reveals a significant effect of housing (F(1, 76) = 8.311; p≤0.001) and sex 
(F(1, 76) = 6.89; p≤0.01) for time spent floating but no significant effect of housing for 
number of immobile episodes (F(1, 76) = 1.091; p=0.341) and latency to first immobile 
episode (F(1, 76) = 1.458; p=0.239). A Tukey post-hoc test indicates a trend for female EE 
related to EESE HABs to spent more percent time floating (p=0.065). To our surprise, this 
results points towards a mild pro-depressive or passive coping phenotype for EE females 
and opposes our hypothesis of a beneficial additive effect of EE but resembles the pro-
depressive phenotype of females housed for 10 weeks in EE (fig. 81). 
 
 
 
Fig. 80: Like in F1 and F2, we observe a significant anxiolytic effect of EE without 
transgenerational transmission indicated by significant decrease of z-score for OF (A), 
EPM (B) and LD (C). N (males) = 20 SE, 5 EESE, 13 EE; N (females) = 9 SE, 17 
EESE and 20 EE 
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Multiple generations of enrichment might increase the anxiolytic effect size and thereby 
show a preferable additive effect. Since F2 SE mice possess mean values close to zero or 
equal to zero, we compared parental, F1 and F3 for differences in effect size by comparing 
z-scores of OF, EPM and LD wherever possible. 2-Way ANOVAs reveal a significant 
effect of generation for Z-OF (F(1, 80) = 18.2; p≤0.001) and Z-LD (F(1, 77) = 10.66; p≤0.001) 
as well as a strong trend for Z-EPM (F(1, 79) = 3.103; p=0.051). 
Parameter measured 
P-value for main effect of: 
Generation Sex Generation x sex 
Z-OF 0.002 0.053 ≤0.001 
Z-EPM 0.051 0.042 0.078 
Z-LD ≤0.001 0.002 ≤0.001 
Tukey post-hoc tests depict that EE females indeed increase the anxiolytic effect size from 
the parental generation to F1 by a significant decrease of Z-OF from -0.20 SDs to -4.41 
SDs (p≤0.001) and of Z-LD from -0.57 SDs to -2.64 SDs (p≤0.001) below the mean of 
respective SE controls. EE Males too, show a significant decrease of Z-LD from -0.69 SDs 
to -2.57SDs below the mean of SE HABs (p≤0.05), thereby achieving a level very similar 
to that of females. These results might be a hint for a beneficial additive effect of EE when 
successively applied to 2 generations. 
Comparing F1 to F3, we observe an antidromic shift of effect size: EE females show a 
further increase of anxiolytic effect size in Z-EPM from -1.22 SDs to -3.49 SDs (p≤0.001) 
but a significant decrease of the same in Z-OF from -4.41SDs to -0.13SDs in OF (p≤0.001) 
and from -2.64 SDs to 0.21 SDS in LD (p≤0.001) below and above the mean of respective 
SE animals. Contrary to females, EE males maintain the anxiolytic effect size in all tests, 
i.e. they do not significantly differ between F1 and F3 indicating no further in- or decrease 
of the anxiolytic effect size (fig. 82). 
 
Fig. 81: Surprisingly, EE females show a mild pro-depressive or passive coping style 
after 3 generations of EE compared to EESE mice. N (males) = 22 SE, 5 EESE, 12 EE; 
N (females) = 9 SE, 14 EESE and 20 EE 
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In total, 2 generations of EE seem to entail a beneficial additive effect, which further 
increases the anxiolytic effect size for both sexes. Females compared to males might 
benefit more since 2 out of 3 tests suggest an additive effect, whereas 1 out of 3 tests does 
so for males. Males maintain effect size until F3, whereas females show an antidromic shift 
preventing an unambiguous statement about a further beneficial or a detrimental effect of 
EE when applied for 2 more generations. 
5 Discussion and future experiments 
A beneficial environmental manipulation such as EE can indeed mitigate even 
extreme trait anxiety - but not depression-like behavior - in a mouse model of 
pathological anxiety. 
The process of selective bidirectional breeding focusing on anxiety-related behavior 
created a highly valid mouse model of pathological anxiety (i.e. HABs), which has proven 
its extreme trait anxiety in behavioral tests assessing anxiety-related behavior either via an 
approach-avoidance conflict (e.g. OF, EPM, LD; Kromer et al, 2005; Markt unpublished 
data, 2009; Markt and Sotnikov, in preparation; Muigg et al, 2009) or conditioned 
paradigms (fear conditioning; Gaburro et al, 2011; Sartori et al, 2011b). Our main focus 
Fig. 82: 2 successive generations of EE might ensue a beneficial additive increase of 
anxiolytic effect size for both sexes. Males do not show a change of effect size when 
housed for further generations in EE, whereas females show an antidromic shift 
preventing an unambiguous statement whether further generations of EE have a 
beneficial or detrimental effect. Shift of effect size is depicted for OF (A), EPM (B) and 
LD (C). N (males) = 21 P, 8 F1, 13 F2; N (females) = 18 P, 6 F1 and 20 F3 
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applied to whether an environmental manipulation such as EE is capable of rescuing the 
rigid genetic drive of high anxiety in this mouse model via GxE or epigenetic processes. 
Indeed, EE is able to mitigate even extreme trait anxiety of HABs throughout all 
behavioral tests assessing anxiety-related behavior, apparent as a shift from high towards 
normal anxiety-related behavior for both sexes, though this is difficult to achieve using 
classical pharmacological treatment, at least in male mice (Sah, in preparation; Landgraf, 
personal communication). Importantly, home cage locomotion - a cross test dimension of 
anxiety (Henderson et al, 2004) - is indistinguishable from SE housed controls indicating 
no masking or confounding effect of locomotion on anxiety-related behavior. In addition, a 
significantly increased exploration activity in EE HABs may further corroborate anxiolytic 
effects since the behavioral tests performed exploited an approach-avoidance conflict (i.e. 
exploration vs. anxiety). A meta-analysis using z-score to evaluate the overall effect of EE 
on anxiety, locomotion and exploration confirms our data obtained from single 
experiments - a strong anxiolytic effect for EE males (≥1 SD) and a small for EE females 
(≤0.5 SD), which is not masked by locomotion and ensued a significantly increased 
exploration. A χ²-test accentuates the sex-specific differences of anxiolysis: females 
showed a shift of effect size predominantly from small to medium, whereas males 
exhibited a shift mainly from small to strong. Our data are in line with the majority of 
previous studies indicating an anxiolytic effect of EE (Arai et al, 2009; Benaroya-Milshtein 
et al, 2004; Kuzumaki et al, 2011; Markt and Sotnikov, in preparation) and extend them by 
demonstrating that even a rigid genetic predisposition modeling pathological anxiety can 
be mitigated or even rescued by EE. Importantly, our meta-analysis illustrates that a well-
chosen and appropriate design of EE indeed increases reproducibility and decreases 
variability, whereas the use of different mouse strains and/or designs (Chapillon et al, 
1999; Nevison et al, 1999; Van de Weerd et al, 1994) might lead to controversial results 
with few studies even demonstrating an anxiogenic effect of EE (Pietropaolo et al, 2006). 
Surprisingly, EE did not alter the coping style (indicative of depression-like behavior) in 
HABs, though many studies were able to show an antidepressive effect in “normal” 
rodents (Brenes et al, 2009; Hattori et al, 2007). A study by Xu et al. (2009) indicates that 
an elevation of glucocorticoid levels seems to be required for the antidepressive effects of 
EE. They monitored a significant reduction of depression-like behavior associated with 
increased serum CORT levels in animals, which have been exposed for two months to EE. 
Contrary, EE animals that received a low dose of CORT supplement after adrenalectomy 
did neither exhibit increased serum CORT levels, nor a significant decrease of depression-
like behavior. Our data show that male HABs housed in EE relative to SE seem to exhibit 
lower serum levels of CORT after application of a mild stressor. Moreover, CORT levels 
are indistinguishable between male groups when facing a severe stressor. It might be 
speculated that both, an attenuated CORT release after a mild stressor and a missing 
increase of CORT after facing a severe stressor, may be accounted for the missing 
antidepressive phenotype in male EE HABs. Another possibility for the missing 
antidepressive phenotype might be duration of exposure to EE. Xu et al. (2009) exposed 
their animals in comparison to ours 8 instead of 4 weeks to EE. Our results indicate that 
duration of EE exposure seems to be of minor importance for coping style since a 
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prolongation of EE exposure from 4 to 10 weeks did not alter the phenotype in our male 
HABs, thus pointing towards elevated glucocorticoid levels as one major factor. Contrary, 
EE females showed a shift to a pro-depressive phenotype after 10 weeks of EE. We 
hypothesize that their CORT levels might be further decreased after prolonged EE, thereby 
causing the monitored shift. Depression-like behavior in NABs was neither attenuated by 
EE. We did not assess HPA axis reactivity in NABs, thus it may be concluded that either 
EE NABs i) lack an increase of glucocorticoids after application of a stressor similar to EE 
HABs and/or ii) do not exhibit the genetic predisposition modeling pathological anxiety 
and comorbid depression and, thus, do no exhibit a depressive phenotype, which can be 
attenuated. The latter possibility may be more likely since it is known that antidepressive 
treatment does not cause an effect in healthy individuals. 
In essence, our model clearly suggests that anxiety and depression-like behaviors are not 
necessarily associated with each other, providing a unique opportunity to focus on the 
former. 
Genetic background, duration of exposure and behavioral differences between EE 
and SE HABs observed during the juvenile and early adolescent phase seem to be 
factors that contribute to the anxiolytic effect elicited by EE. Thereby, sex steroids 
might affect anxiety-related behavior in a sex-specific manner. 
After confirming that even a rigid genetic predisposition can be rescued by EE, we were 
interested to identify processes and behaviors that contribute to the observed anxiolysis in 
HABs. 
The onset of pathological anxiety may be attributed to a maladaption to environmental 
demands resulting from an interaction of genetic predisposition and environmental 
influences (Svrakic et al, 2011). To assess the contribution of a rigid genetic predisposition 
modeling pathological anxiety to the anxiolytic effect elicited by EE, we subjected NABs 
instead of HABs to EE. As expected, EE induced in male NABs only a small anxiolytic 
effect (≤0.5 SD) compared to HABs (≥1 SD), whereas the anxiolytic effect got almost 
completely lost in NAB females. They still show a trend or a significant reduction in some 
of the monitored anxiety-related parameters but lost the overall anxiolytic effect using 
emotionality score as a comprehensive anxiolytic index. Again, we observed sex-specific 
differences related to the anxiolytic effect mimicking those observed in HABs. Moreover, 
the genetic background (outbred CD1 animals vs. inbred HABs) of an animal may exert a 
critical influence on the impact of environmental stimuli. CD1 mice of both sexes 
compared to inbred HABs and NABs did not show an anxiolytic effect at all. Our result 
may highlight the importance of inbred mouse models to eliminate the “noise” of genetic 
heterogeneity. Anxiety is a complex, multigenic disease comprising a multitude of genes 
likely to be involved in the onset of pathological anxiety. Therefore, it seems plausible that 
every single gene contributes to a small extent, which might be revealed only at the 
behavioral level if masking effects including genetic heterogeneity are minimized. 
In addition to the genetic background, our data might illustrate that the accumulation of 
risk factors in HABs (due to selective inbreeding) seems to be an important factor 
influencing the strength of the anxiolytic effect observed after EE. It might be speculated 
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that these results not only show that a rigid genetic predisposition modeling pathological 
anxiety might be mitigated by EE, but suggests an increased amenability to beneficial 
environmental stimuli. It seems conceivable that HABs exhibit different (epi-) genetic, 
neuronal and physiological mechanisms that contribute to their high anxiety phenotype, 
and exactly this multiplicity of altered processes increases the likelihood that one or 
several of these processes might be amenable to beneficial environmental manipulation. 
To evaluate the contribution of exposure duration, we increased the time HABs were 
housed in EE from 4 to 10 weeks. Solely females showed a further significant increase of 
the observed anxiolytic effect, whereas males do not seem to benefit from prolonged EE. 
These results further corroborate that EE may have a sex-specific impact on anxiety-related 
behavior, a phenomenon that has been described earlier in the literature (Lin et al, 2011). 
Our data extend earlier findings by showing that even mitigation of extreme trait anxiety 
by EE in mice with a rigid genetic predisposition seems to exhibit sex-specific differences. 
Which mechanism might be accounted for the observed differences? Experimental 
evidence suggests that male and female brains are differing on structural, molecular and 
cellular levels (Lebron-Milad and Milad, 2012). Sexual dimorphisms are eminent in 
amygdala, HIP and PFC (Goldstein et al, 1999; 2001), brain regions that are important for 
the regulation of anxiety and the stress response. Thereby, the hypothalamic-pituitary-
gonadal (HPG) axis plays a major role in the regulation and release of sexual hormones. 
Interestingly, Bakos et al. (2009) showed that EE increased testosterone levels in male rats, 
which is likely to reduce the cortisol response and HPA axis reactivity (Hermans et al, 
2007; Rubinow et al, 2005). Moreover, EE seems to increase the synthesis of 
allopregnanolone from progesterone in male rats (Munetsuna et al, 2011), with 
allopregnanolone being known to exert anxiolytic effects when infused in the amygdala or 
mPFC (Akwa et al, 1999; Engin et al, 2007). Further experiments determining testosterone 
and allopregnanolone levels via RIA will be performed to verify a contribution of these sex 
steroids to the observed sex-specific differences in anxiety-related behavior of HABs. 
Importantly, both estrogen receptor types are expressed within the amygdala with estrogen 
receptor α offering obviously anxiogenic (Weiser et al, 2008) and estrogen receptor β 
exhibiting anxiolytic properties (Imwalle et al, 2005; Krezel et al, 2001). Up to now, no 
studies assessing the impact of EE on these receptors exist. It might be speculated that 
these receptors contribute to and/or attenuate the anxiolytic effect of EE on female HABs. 
A qPCR and/or WB to assess the gene and/or protein expression of these receptors will 
unravel a possible sex-specific effect. Taken together, sexual hormones offer the potential 
to critically contribute to anxiety-related behavior. Interestingly, male sex steroids seem to 
be beneficially influenced by EE, whereas data for female sex hormones are lacking and/or 
suggest that they do not profit, thereby maybe explaining the weaker anxiolytic effect of 
EE on female HABs. Nevertheless, females are affected twice as much by psychiatric 
disorders as males (Lebron-Milad and Milad, 2012) emphasizing the necessity to increase 
treatment efficacy in women. It is tempting to speculate these findings raise the possibility 
that there might be indeed treatment strategies with a higher efficacy in women. Studies in 
humans investigating the impact of environmental influences (e.g. social) on the treatment 
outcome of women are needed to validate this hypothesis. 
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In addition to genetic background, accumulation of risk factors and exposure duration, 
Meaney and Champagne (2007) highlighted maternal care as an important factor 
contributing to anxiety. To our surprise, we did not observe any differences in nursing style 
comparing EE and SE HAB mothers. Instead, EE mothers spent less time with their pups 
and invested more time in behaviors to explore (e.g. running around) and manipulate (e.g. 
digging) their environment (fig. 59). These findings indicate that maternal care comprising 
nursing style is unlikely to contribute to the anxiolytic effect of EE on HABs. 
Besides the contribution of maternal care to the anxiety phenotype, the juvenile and early 
adolescent phases seem to be important for the development and refinement of a species-
specific behavioral repertoire including motor, cognitive and social skills. This seems to be 
necessary to foster a general disposition for neurobehavioral plasticity (Martin and Caro, 
1985; Terranova and Laviola, 2005), and it is conceivable that these skills contribute to the 
regulation of anxiety. Indeed, EE in relation to SE juveniles seem to invest more time in 
behaviors that are thought to be important for establishing the aforementioned skills. They 
actively used their provided EE (fig. 60, 63), whereas SE juveniles spent most of their time 
with passive behaviors. Moreover, EE in relation to SE adolescents engage more in social 
interactions (fig. 63). Many studies describe that EE indeed increases prosocial (e.g. 
mutual grooming, vocalizations, social exploration) and play behavior (Schindler et al, 
2010), whereas aggressive behavior seems to be reduced (Schindler et al, 2010), perhaps 
because animals have the opportunity to escape from aggressive encounters by seeking 
protection in a shelter and seem to engage in a more affiliative and less aggressive social 
interaction strategy (FELASA working group standardization of enrichment; Pietropaolo et 
al, 2004). This highlights the possibility that EE facilitates cognitive, sensory and motor 
stimulation and leads to the expression of a much wider range of social interactions and a 
more naturalistic behavioral pattern (Kempermann et al, 2010). 
Thus, it might be speculated that a broader and more naturalistic repertoire might be 
acquired by our animals, though we did not explicitly monitor all of the parameters 
mentioned in the literature. Importantly, behaviors falling in exactly these categories show 
the expected shift (e.g. increased social interactions during adolescence in EE HABs). It is 
tempting to conclude that a bigger behavioral repertoire increases the possibility that 
animals can indeed perform a behavior suited to reduce anxiety and the physiological 
consequences associated with it, when facing a stressor, since stressors are characterized 
by unpredictability and uncontrollability (Joels et al, 2009). A bigger behavioral repertoire 
might therefore reduce uncontrollability and thus facilitate behavioral and physiological 
adaptation. 
EE seems to reduce expression of Crhr1 by increasing site-specific methylation, which 
may be linked to reduced HPA axis activity and noradrenaline release. 
After identification of behaviors that likely contribute to the monitored anxiolytic effect of 
EE on HABs, we were interested to unravel particularly epigenetic processes that might be 
accounted to cause the respective behavioral changes. 
The HPA axis and the central noradrenergic system are thought to play a major role in the 
regulation of the stress response and in the etiology of psychiatric disorders (Itoi et al, 
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2009; Reul and Holsboer, 2002). Our results indicate that EE decreases the release of 
CORT in male HABs after application of a mild stressor. They are in line with previous 
human (Abelson et al, 2007) and animal studies (Flandreau et al, 2012; Mora et al, 2012) 
highlighting the role of a dysregulated HPA axis for the onset of anxiety disorders. 
Abelson et al. (2007) were able to show that a hyperreactive HPA axis seems to contribute 
to PD. Interestingly they identified novelty cues as a major factor contributing to the 
dysregulation of the HPA axis. Van Praag et al. (2000) suggested that reduced fear to 
novelty constitutes an important mechanism that contributes to the observed anxiolytic 
effect of EE. Indeed, EE offers animals an environment with more complexity, inter alia 
due to the offered variety of novel stimuli (e.g. toys, shelter) and the possibility to create 
novelty by manipulation of the microenvironment (e.g. rearrangement of bedding material 
to demarcate territories). Thus, it seems likely that EE HABs exhibit reduced neophobia, 
whereat a behavioral test assessing neophobia (e.g. modified hole board) may be used to 
definitely verify the aforementioned hypothesis. Taken together, these results might 
illustrate that a combination of both, mitigation of neophobia and the increased behavioral 
repertoire thought to reduce uncontrollability when facing a stressor, could be important to 
prevent or attenuate high anxiety, which on the other hand might reduce the release of 
CORT and normalize HPA axis activity. 
Therefore, it might be desirable to perform studies evaluating whether treatment of 
neophobia might be beneficial beyond the treatment of neophobia itself. This would raise 
the possibility that anxiety disorders like PD could benefit from the same or a similar 
treatment and whether it can be taken into account as a part of future treatment options for 
psychotherapies. Importantly, a lot of actual psychotherapies indeed try to alter or create 
new behavioral patterns to enable affected persons to cope with an unpleasant situation. 
Novel environments would thus represent a detrimental environment for affected persons, 
and as a logical consequence altered or new behavioral patterns would be referred to as an 
“enrichment” compensating maladaptive behavioral strategies. It might be speculated that 
EE for humans might comprise environmental situations or stimuli were preventive 
strategies or behavioral patterns are learned. Though research has just begun to explore this 
possibility, education in school might be a promising candidate not merely to treat, but also 
to prevent anxiety disorders in youth (e.g. the coping CAT program; Podell et al, 2010). 
Our results show that reduced neophobia and an increased behavioral repertoire contribute 
to a reduced HPA axis activity in male EE HABs, which, in turn, might cause a decreased 
release of NA from LC. This decrease might further attenuate CORT release by changing 
the activity of a neuronal circuit regulating emotionality as follows: when animals face a 
stressor, the mPFC disinhibits the amygdala, which in turn activates the HPA axis and 
noradrenaline release from LC (Belujon and Grace, 2011; Kröner et al., 2005; Rosenkranz 
and Grace, 1999). Importantly, PFC can regulate its catecholamine input via direct and 
indirect connections to LC (NA), substantia nigra and ventral tegmental area, where 
dopamine projections originate. Optimal levels of catecholamines ensue a “delicious 
cycle” enhancing PFC regulation, whereas stress causes an increased release of NA and 
dopamine linked to impaired PFC regulation and strengthened amygdala function causing 
a “vicious cycle” (Arnsten, 2009). This might be interpreted as a switch from task-relevant 
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“top-down” regulation via PFC to “bottom-up” regulation by sensory cortices, whereby the 
salience of the stimulus captures our attention (Buschmann and Miller, 2007). 
As a consequence, this would imply that a decreased NA release from LC in EE HABs 
predominantly activates the delicious cycle, whereas an increased release of NA from LC 
in SE HABs initiates the vicious cycle causing increased activity of the amygdala. 
Indeed, Avrabos (2012) was able to show that neuronal activity flow through the amygdala 
seems to be correlated with anxiety-related behavior, apparent by decreased activity 
propagation through the amygdalar network of male EE in relation to SE HABs (Avrabos, 
Markt et al, in preparation). In other words, SE compared to EE HABs exhibit a 
hyperreactive amygdala, which inherently propagates neuronal signals stronger, 
independent of stimulus origin. This feature can also be seen in patients suffering from 
anxiety disorders (Shin and Liberzon, 2010) and might underlie the bias to interpret neutral 
stimuli as dangerous. Based on the results by Avrabos (2012), we performed qPCR with 
earlier identified candidate genes likely to be involved in anxiety-related behavior 
(Czibere, 2008) to further elucidate the origin of decreased activity propagation through 
the amygdalar network. 
Thereby, we identified Crhr1 as a promising candidate: the expression of Crhr1 is 
increased under basal conditions in male HABs compared to LABs and, importantly, this 
increased expression can be reduced by exposing HABs to EE. Thus, it might be concluded 
that EE decreases Crhr1 expression, which in turn causes decreased activity propagation 
through the amygdala. Corroborating evidence comes from Avrabos (2012), who was able 
to show that non-responding HABs housed in EE do not exhibit decreased activity 
propagation through the amygdala, thereby establishing a direct connection between 
neuronal activity flow and EE. Further studies assessing the expression of Crhr1 in the 
BLA of non-responding EE HABs will be performed in the future to be able to verify a 
causal link. Moreover, EE significantly increases mRNA levels of Tmem132d in the 
mPFC, similar to individuals suffering from PD compared to controls, thereby contrasting 
earlier findings from Erhard et al. (2011). Tmem132d, also known as mature OL 
transmembrane protein, seems to be an important marker for the maturation from 
oligodendrocyte precursor cells to mature oligodendrocytes (Nomoto et al, 2003), which 
insulate axons in the CNS. When viewed in the light of Arnsten’s (2009) hypothesis, it is 
tempting to speculate that an increased expression of Tmem132d constitutes a mechanism 
to counteract the attenuated PFC control over the amygdala in individuals suffering from 
PD (to circumvent a vicious cycle), whereas an increased expression in EE HABs might 
strengthen the delicious cycle. Though both results seem to contradict each other, this is 
not necessarily the case because the increased expression observed in both studies might 
have the same aim - to increase top-down PFC control over the amygdala. These data are 
in line with the vicious cycle hypothesis from Arnsten (2009), whereat an impaired 
regulation of the mPFC could be verified by running a microdialysis study in the PFC of 
EE vs. SE HABs or by using immunohistochemistry to visualize the presence of NA in this 
brain region. 
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We identified reduced mRNA levels of Crhr1 in the BLA of EE HABs as an important 
process that contributes to reduced anxiety-related behavior in EE HABs. Since EE and SE 
HABs are genetically identical, we speculated that epigenetic processes participated in the 
reduction of Crhr1 expression. To follow our main aim and test the possibility of an 
epigenetic regulation of Crhr1 in BLA, we performed an in silico analysis to verify 
whether a CGi exists in this gene, which would render it amenable to epigenetic regulation 
via DNA methylation. Indeed, subsequent pyrosequencing of the in silico identified CGi 
was performed and identified a DMR in the promoter region of Crhr1. EE seems to 
increase the methylation of a CpG site -1348bp before TSS in male HABs, whereas we did 
not observe this or any other difference in DNA methylation comparing HABs and LABs, 
indicating that there might exist a different regulatory mechanism. We performed an in 
silico analysis to identify potential TFs that might interact with the aforementioned DMR  
and identified YY1 as a candidate, with subsequent qPCR in fact revealing a reduction of 
YY1 mRNA levels in male EE compared to SE HABs (fig. 71). This result is in line with 
the literature, since it is generally accepted that increased methylation causes gene 
repression or reduced TF binding (Mazzio and Solimann, 2012). 
To assess whether and how reduced CORT release and increased methylation of the DMR 
in EE HABs might be connected, we performed an additional in silico analysis and 
identified two co-TFs - Nr4a1 and D3Ertd300e - that seem to interact with YY1 (fig. 72). 
Interestingly, D3Ertd300e appears to have a positive regulatory role for YY1, which in 
turn is associated with a negative epigenetic role for gene expression. In other words, 
higher availability of D3Ertd300e seems to be associated with higher availability of YY1, 
which on the other hand might prevent or cause lower methylation of the Crhr1 DMR. 
Noteworthy, Nr4a1 seems to be associated and regulated by the quantity and availability of 
a TF complex of GR and Fkbp4/5, which raises the possibility that reduced CORT release - 
as observed in EE HABs (fig. 29) - entails reduced formation of this TF complex. 
Recently, Breuillaud et al. (2012) were able to show that mice lacking CREB-regulated 
transcription coactivator 1 - a TF important for Bdnf expression - indeed entailed lower 
levels of Nr4a1 in PFC and HIP and an increased anxiety-related behavior strengthening 
the importance of this TF in the regulation of anxiety. 
Our main findings discussed before could lead to the hypothesis that a reduced CORT 
release decreases the availability and thus binding of CORT to GR in the BLA. This, in 
turn decreases the binding affinity of Nr4a1 to D3Ertd300e, which then cannot positively 
regulate YY1 to decrease or even prevent methylation at the identified CpG site of Crhr1. 
This would finally result in a DMR with higher methylation levels in EE HABs, which 
underlies the observed gene expression differences. The DMR might therefore be used as a 
biomarker for high or pathological anxiety (fig. 83). Our findings support Belsky’s concept 
of plasticity genes: he suggested the existence of genes that “[…] make individuals more 
susceptible to environmental influences - for the better and the worse” (Belsky et al, 2009), 
thereby increasing phenotypic plasticity, which in turn is likely to increase adaptive 
capacity to environmental demands and finally survival. We would like to emphasize that 
our proposed epigenetic chain of events might have shifted the genetically driven 
 
117 
phenotype of high towards normal anxiety or vice versa, i.e. the behavioral profile was 
altered by EE and caused this epigenetic chain of events. 
A vast body of literature supports the dysregulation of Crhr1 in the etiology of psychiatric 
disorders (Arborelious et al, 1999; Heinrichs et al, 1997; Nemeroff, 2009; Reul and 
Holsboer, 2002). Our data indicate that Crhr1 might be regulated bidirectionally, 
depending on the quality of environmental stimuli. They are in line with earlier findings 
(Sztainberg et al, 2010b) and extend them by suggesting an epigenetic mechanism that is 
likely to contribute to the anxiolytic effect of EE. Altogether, it might be speculated - to the 
best of our knowledge - that Crhr1 seems to be first identified plasticity gene of anxiety, 
which is involved in the regulation of the stress response by an epigenetic mechanism. 
 
 
Fig. 83: Epigenetic chain of events. EE is likely to reduce neophobia and increase the 
behavioral repertoire of HABs, which is thought to minimize uncontrollability of 
stressful situations, thereby shifting their phenotype from high towards normal anxiety. 
This reduction causes a decreased expression of Crhr1 in the BLA, which in turn might 
reduce the neuronal activity flow through the amygdala. Thereby, a reduced release of 
CORT after a stressor decreases its availability and binding to GR and subsequently 
Nr4a1 in the BLA. This decrease reduces binding affinity of the TF complex 
comprising YY1, Nr4a1 and D3Ertd300e to the YY1 TFB, finally increasing 
methylation of a DMR in the promoter of Crhr1. Either, the epigenetic chain of events 
shifts the high anxiety related behavior towards normality or the altered behavior causes 
the epigenetic chain of events. Basolateral amygdala (BLA), corticotropin releasing 
hormone receptor 1 (Crhr1), enriched environment EE, transcription factor (TF), 
transcription factor binding site (TFB), Yin Yang 1 (YY1) 
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Though speculative, the possibility exists that the identified DMR is part of a CpG shore - 
a region ca. 2000bp before the TSS but without being part of a CGi. It is conceivable that 
the first CpG of the Crhr1 CGi might be the tip of the iceberg with several other CpGs 
being differentially methylated upstream of our identified DMR raising the necessity to 
perform pyrosequencing for these CpGs too. Indeed, several recent papers suggest that 
genes seem to be regulated by CpG shores rather than CGis, which are associated with 
tissue-specific gene expression of housekeeping genes (Doi et al, 2009; Irizarry et al, 
2009). In fact, upstream of our identified DMR are 15 more CpGs which could be part of a 
Crhr1 CpG shore (Ensembl version: ENSMUSG00000018634.10, date of accession 
12.09.2012). Importantly, TFs can have the size of several dozens to hundreds of amino 
acids leading to the assumption that increased methylation of exactly these CpGs might 
contribute to the observed decreased expression of Crhr1.  
Further evidence for the contribution of epigenetic mechanisms in the high anxiety 
phenotype of HABs might be provided by our results showing that the anxiety-related 
behavior of HABs is influenced by epigenetic drugs. There seems to be a robust 
anxiogenic effect of the DNMTi valproic acid on both, SE and EE animals (fig. 74, 75). 
These results allow two conclusions to be drawn: first, DNMTs would no longer be able to 
transfer a methyl group to the identified DMR in Crhr1, which in turn would mimic an SE 
expression phenotype that would entail an increased anxiety-related behavior - this is 
exactly what we monitor in EE HABs, which received valproic acid. Second, other 
epigenetically regulated genes contribute to the high anxiety phenotype of HABs and are 
associated with the anxiolytic effect of EE since DNMTis are known to exert effects on all 
genes amenable for DNA methylation. This might explain why valproic acid induced an 
anxiogenic effect in SE HABs too, though they exhibit low methylation of the Crhr1 
DMR. HDACi 5-Aza-2’-deoxyuridine might possess an antidromic effect with an 
anxiolytic impact on SE and an anxiogenic effect on EE HABs (fig. 73-75). Similar to 
DNMTIs, HDACis influence acetylation levels of all histones rendering it likely to alter 
the expression of genes with anxiolytic and anxiogenic properties. Thus, the overall effect 
is likely to be different between SE and EE HABs because it depends on environmental 
factors - which are likely to alter histone modifications itself - acting on the genetic 
predisposition. This emphasizes the potential of epigenetic regulation to contribute to or 
shape the final phenotypic outcome and to identify epigenetic factors and/or processes that 
may act as or represent novel therapeutic targets. 
To verify our suggested epigenetic chain of events, it is necessary to perform a chromatin 
immunoprecipitation, which could reveal whether YY1, Nr4a1 and D3Ertd300e together 
with GR and Fkbp4/5 really form a complex at Crhr1 to regulate its expression. Our data 
give rise to the proposed hypothesis, but do not show a direct association of the identified 
factors with Crhr1. It has to be mentioned that there is the possibility that YY1 can 
regulate one or several different genes than Crhr1 because qPCR can merely compare 
expression levels independent of the truly associated gene. Moreover, it is possible to alter 
the methylation of single CpGs, which raises the possibility to mimic the expression 
phenotype we observed in EE HABs to verify whether methylation is truly involved in the 
regulation of gene expression. Our findings are a first hint that beneficial environmental 
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conditions or stimuli indeed can mitigate or rescue even a rigid genetic predisposition of 
extreme trait anxiety obviously by triggering an anxiolytic epigenetic mechanism. This 
emphasizes the necessity to identify the influence of beneficial environmental stimuli as 
preventive or attenuating strategies in humans. The author is fully aware that mice can 
model merely some aspects of how beneficial environments can modify genetic regulation. 
The behavioral repertoire, brain architecture and genetic regulation in humans is likely to 
be far more complex compared to mice as corroborated very recently by the ENCODE 
project (http://www.nature.com/encode/#/threads), but our findings might indicate that also 
humans could benefit from enrichment strategies compensating maladaptive behavioral 
patterns or a detrimental genetic predisposition. This hypothesis is strengthened by an 
increasing number of papers trying to emphasize the importance of beneficial stimuli for 
human well-being (Kobau et al, 2012; Pedrals et al, 2012; Proyer et al, 2012) or to alleviate 
psychopathology by positive activity interventions like positive thinking, affect and 
behaviors, with at least the last parameter likely contributing to the anxiolytic effect of EE 
as well (Layous et al, 2011). 
A gene x environment correlation might transmit the anxiolytic effect of EE in a 
mouse model of pathological anxiety to a subgroup of male F1 individuals. 
The possibility to transmit acquired traits from one generation to the next has gathered 
increasing attention and might explain the rapidly growing body of literature dealing with 
this topic (Arai et al, 2009; Champagne and Meaney, 2007; Leshem and Schulkin, 2011). 
Many researchers argue that transgenerational effects must be transmitted at least to F3 
since the effect acts on the mother carrying the F1 generation, which on the other hand has 
already established germ line cells for F2, on which the effect might act. Our data suggest 
that the anxiolytic effect elicited by EE might be transmitted to a subgroup of male F1 
HABs without affecting animals from F2 and F3 and thus, excludes a transgenerational 
effect per definitionem. Interestingly, we observe a phenomenon earlier described by 
Elliott et al. (2010): obviously it is possible that some animals do and others do not 
respond to a treatment - a phenomenon well known from humans (Lanouette and Stein, 
2010). It has to be mentioned that our study tried to assess transgenerational transmission, 
whereas Elliott et al. (2010) monitored the behavior of adult mice.  
The majority of our male HABs housed in EE seems to offer an anxiolytic effect, which 
we can observe in LD but not OF and EPM (fig. 78). It is thought that different behavioral 
tests monitor different aspects of anxiety-related behavior (Bouwknecht and Paylor, 2008; 
Sartori et al., 2011) and, thus, it might be speculated that the anxiolytic effect of 
responding F1 HABs might be “diluted” compared to the parental generation since merely 
1 out of 3 tests suggests an anxiolytic effect. Our first hint is in line with recent studies 
(Curley et al, 2009; Walker et al, 2012) indicating that this anxiolytic transmission in fact 
might exist. Further studies with a higher number of animals are planned to pursue our first 
hint and to definitely verify whether such a mechanism might exist.  
The crucial question is whether such a mechanism would make sense in the light of 
evolution. The author would like to highlight one conceivable scenario: gene x 
environment correlation (rGxE) suggests that certain genetic variants influence 
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environmental exposure indirectly via behavior (Rutter et al, 2006). This mechanism is 
different from transgenerational transmission, but can be viewed complementary to prepare 
the animals in the best way possible: individuals exhibit a genetic predisposition, which 
causes them to seek certain environments, and epigenetic mechanisms may change these 
behaviors (by changing underlying gene expression) to fine-tune organisms to actual or 
future environmental demands. It seems plausible that selective breeding of HABs 
accumulated genes contributing to high anxiety entailing a behavioral phenotype, which 
actively avoids dangerous situations and stressful stimuli. This explains why SE HABs 
rarely enter the aversive zone of tests assessing anxiety-related behavior; but it might be 
beneficial to be able to change that phenotype if environmental changes demand it. If 
rodents life in an environment with rapidly changing conditions, this might in turn exert an 
influence on their emotionality (e.g. low food availability might entail decreased anxiety to 
forage for food). We have suggested one epigenetic mechanism that could contribute to the 
shift from high towards normal anxiety in HABs, but it is likely that several additional 
mechanisms contribute to anxiolysis. Now, two speculative scenarios are conceivable:  (i) 
some of these mechanisms were passed on to a subset of male F1 individuals (therefore, 
the effect was merely seen in 1 out of 3 tests) and/or (ii) the associated epigenetic changes 
cause the offspring to seek the environment of their parents, where the environmental 
conditions again can modulate their anxiety phenotype in the same manner it did for their 
parents (i.e. rGxE). To the best of our knowledge, this highlights for the first time the 
exciting possibility that an effect causing anxiolysis can be transmitted to the offspring but 
cannot be measured per se in exactly this offspring. This hypothesis is difficult to verify 
since rodents favor EE over SE housing, thereby excluding preference studies (van de 
Weerd, 2001). Maybe, field studies in a big semi-natural set-up enclosure can shed light on 
this hypothesis at a behavioral level. In addition, whole genome methylation studies 
assessing methylation levels in parents and offspring could aid to verify this hypothesis at a 
molecular level by identifying transmitted epigenetic states that might cause the proposed 
rGxE. The author is fully aware that new studies trying to verify this hypothesis have to be 
performed. 
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